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In the last twenty years, a great deal of attention 
has been focused upon understanding the molecular 
mechanisms of both the prokaryotic and eukaryotic 
succinate thiokinase (STK) enzymes. However, relatively 
little is known concerning the significance of the 
diversity of nucleotide specificity displayed by STK 
throughout Nature.
This thesis presents evidence for the existence of 
two distinct STK enzymes in animal tissues - one (G-STK) 
linked to guanine nucleotides and the other (A-STK) to 
adenine nucleotides. This finding prompted re-examination 
of prokaryotic organisms and lead to the discovery of an 
STK of novel nucleotide specificity for inosine 
nucleotides.
Investigations into the possible physiological roles 
of the distinct STKs within animal tissues involved 
induction of physiological dysfunction (diabetes and 
porphyria) together with comparative studies on different 
organisms. These findings support the proposal that the 
two STKs are responsible for catalysing the succinate 
thiokinase reaction in opposite directions. It appears 
that A-STK may be involved with the energy generation of 
the citric acid cycle, in the direction of succinyl-CoA 
hydrolysis, whereas G-STK is responsible for providing 
succinyl-CoA for ketone body metabolism and haem 
biosynthesis, in the direction of succinyl-CoA formation.
The physiological studies have been supported 
enzyme purification and molecular and kinetic 
characterizations of the STKs.
ABBREVIATIONS
The majority of abbreviations are those recommended 
in the Biochemical Society publication "Policy of the 





K(i n a CT.) First-order rate constant of thermal
inactivation (S )^
MET8 20 mM Tris-HCl + 1 mM EDTA + 2 mM MgCl2
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CHAPTER 1
INTRODUCTION




Discovery of the citric acid cycle 
The citric acid cycle, with few exceptions, is 
probably the most important pathway or unit of metabolism 
in aerobic organisms. The final steps, which completed 
the citric acid cycle, were elucidated by Krebs & Johnson 
(1937), building on the work of Szent-Gyorgyi and Martius 
& Knoop (Krebs, 1970). Krebs correctly identified that 
oxidation of citrate yielded oxaloacetate, which together 
with a proposed "unknown triose" derived from carbohydrate 
metabolism, reacted to regenerate citrate and so complete 
the cyclic set of reactions, termed by Krebs the "citric 
acid cycle". This discovery, following soon after the 
proposal of the urea cycle (Krebs & Henseleit, 1932), 
established metabolic cycling.as an important concept in 
biochemical pathways. The citric acid cycle was soon 
accepted and recognised as the terminal pathway for the 
oxidation of 'fuel1 molecules (carbohydrates, fats and 
even proteins) in all respiring animals, plants and 
aerobic micro-organisms.
After clarification of the energy-yielding catabolic 
role of the cycle, it was later proposed (Krebs et al . ♦ 
1952) that it may also possess an anabolic function,
- 2 -
providing intermediates for cellular biosynthetic purposes. 
Subsequent studies rapidly confirmed this proposal (Ajl, 
1958) establishing the dual roles of the citric acid 
cycle, in su-pplying both energy and cell components. The 
catabolic and anabolic roles of the citric acid cycle are 
illustrated in Figures 1 and 2, respectively.
Discovery of Coenzyme A and enzyme fP !
Not until the discovery of Coenzyme A (CoA) by 
Lipmann(1945), did the detailed schemes of the citric 
acid cycle and fatty acid metabolism emerge. In the 
meantime it had been suggested that an "activated acetate" 
(Lynen, 1942), rather than an "unknown triose" (Krebs,
1943) was introduced into the citric acid cycle.
Eventually, six years after the discovery of CoA, acetyl- 
CoA was demonstrated to be the "activated acetate" (Lynen 
et aLf 1951) involved in fatty acid metabolism and in the 
citric acid cycle, reacting with oxaloacetate to form 
citrate and CoA.
Conversion of o*xoglutarate to succinate + CO2 had 
been shown to be dependent upon the presence of CoA and 
NAD+ (Korkes et a l ., 1952). The oxidative decarboxylation 
of oxoglutarate was soon recognised to be analogous to the 
oxidative decarboxylation of pyruvate, with resultant 
acetyl-CoA + CC^ production. Therefore it was predicted 
that a similar reaction product would result, that is the 
acyl-CoA derivative, succiny1-CoA.
- 3 -
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It was assumed that an enzyme termed succinyl-CoA 
deacylase then hydrolysed succinyl-CoA to succinate + CoA 
(Gergely et al., 1952).
However, conversion of oxoglutarate to succinate 
+ co2 was known to be coupled to phosphorylation (Hunter, 
1951), Kaufman (1951) having also shown that soluble pig 
heart preparations catalysed the liberation of inorganic 
phosphate from ATP, only when both CoA + succinate were 
present. Further work (Kaufman, 1953) identified a 
"phosphorylating enzyme" as being responsible. 
Subsequently, Sanadi and co-workers (Sanadi et al.. 1956) 
were able to demonstrate that the enzyme from pig heart 
and kidney, when freed from nucleoside diphosphokinase 
(NDPK) activity, was specific for guanine nucleotides 
(GDP/GTP). Thus the substrate level phosphorylation step 
of the citric acid cycle (see Figure 3) was established.
succinyl-CoA + NDP + Pi succinate + CoA + NTP
(where NDP/NTP represent nucleoside diphosphate & 
triphosphate)
The enzyme responsible for the above reaction has been 
variously termed phosphorylating ( fP f) enzyme (Kaufman 
et al., 1953); GDP phosphorylating enzyme (Sanadi et al., 
1955); succinyl-CoA synthetase (Smith et al., 1957); and 
succinic or succinate thiokinase (Hager, 1957). The 
reaction was soon demonstrated to be freely reversible
- 6 -



























with an equilibrium constant of 3*7 at 20°c (Kaufman & 
Alivisatos, 1955). This value has recently been revised, 
after a careful study at physiological ionic strength, pH 
ranges and free [Mg^+ ], to 3*02 ± 0*07 and 1*29 ± 0*05 at 
25 and 38°c respectively (Lynn & Guynn, 1978). It is 
therefore apparent that, in the forward direction, 
succinate thiokinase (STK) may participate in the citric 
acid cycle in an energy conserving step, whereas in the 
reverse direction, it may control the provision of 
succinyl-CoA for biosynthetic purposes (see Section 1*7).
Interestingly, citrate synthase has in common with 
STK the utilization of an acyl-CoA derivative as a sub­
strate. STK couples the energy of succinyl-CoA hydrolysis 
to the phosphorylation of a nucleoside diphosphate, 
whereas citrate synthase uses the energy available on the 
hydrolysis of acetyl-CoA to form a covalent carbon-carbon 
bond of the citric acid molecule.
1 ■ 2 Location & Regulation of citric acid cycle
Kennedy and Lehininger (1949) established that, in
mammals, the cellular location of the cycle is the 
mitochondrion. Further work confirmed this, but has
identified the occurence of extra-mitochondrial isoenzymes 
of the cycle, e.g. NADP-linked isocitrate dehydrogenase
(Hogeboom & Schneider, 1950); malate dehydrogenase (Roodyn 
et al . , 1962) and, more recently, citrate synthase (Rickey
& Lewin, 1986).
- 8 -
To enable the citric acid cycle to display both 
anabolic and catabolic roles, a number of ancillary enzyme 
systems exist, supplying or removing cycle intermediates. 
These are known as ’ anaplerotic' and 1cataplerotic’ 
reactions respectively. Anaplerotic mechanisms comprise 
pyruvate or propionate carboxylations (Davis et al.♦ 1980), 
phosphoenolpyruvate carboxykinase (Penhkurinen, 1984), 
coupled transamination reactions of aspartate and alaine 
aminotransferases (Safer & Williamson, 1973), glutamate 
dehydrogenase and the purine nucleotide cycle (Aragon & 
Lowensteim, 1980). Cataplerotic reactions include the 
intra-mitochondrial NAD(P)- and NADP-linked malic enzyme, 
oxaloacetate decarboxylase, coupled transaminations and 
phosphoenolpyruvate carboxykinase (Penhkurinen, 1984).
Whilst the chemistry of the citric acid cycle and 
related reactions are well established, the precise manner 
in which the flux through these pathways is regulated is 
still subject to much study and debate. Substrate 
availability and intra-mitochondrial parameters such as 
the ATP/ADP, acetyl-CoA/CoA-SH, succiny1-CoA/CoA-SH and 
acetyl-CoA/succinyl-CoA ratios are all considered important 
effects. However, the key energy-linked regulatory factor 
determining citric acid cycle flux is thought to be the 
mitochondrial free NAD+/NADH ratio (Williamson, 1980). 
Considerable evidence also suggests that Ca^+ may play a 
crucial role in the activation of pyruvate, NAD-isocitrate 
and 2-oxoglutarate dehydrogenases and so increase cycle 
flux (McCormak & Denton, 1986).
- 9 -
Clearly, the multiple and varied metabolic 
constraints placed upon tissues and organisms, require a 
complex regulation of individual enzymes with the citric 
acid cycle.
1•3 Succinate Thiokinase - Molecular size and
Nucleotide substrate diversity
The STKs which have received the most attention are 
those from Escherichia coli and pig heart (Nishimura, 
1986). A marked difference in the molecular sizes of the 
two enzymes has been found. The E. coli enzyme is known 
to be an <*2^2 tetramer Mr ~ 140,000 (Ramaley et al., 
1967), whereas the pig heart enzyme is an a$ dimer of 
Mr ~ 75,000 (Brownie & Bridger, 1972).
Prompted by this difference, as well as the molecular 
size diversity already seen between citrate synthases from 
various prokaryotic and eukaryotic sources (Weitzman, 
1981), an examination was undertaken of the sizes of STKs 
in a wide range of organisms (Weitzman & Kinghorn, 1978) 
(see Figure 4). This was achieved by gel filtration of 
cell-free extracts through Sephradex G-200 using lactate 
dehydrogenase (LDH) as a marker protein (Mr ~ 140,000). 
STKs of a similar molecular weight to the E, coli enzyme 
were eluted from the Sephadex column slightly ahead of LDH 
and were termed 'large', whereas STKs with molecular 
weights similar to the pig heart enzyme were eluted much 
later than LDH and were termed 'small'. Remarkably it was 
discovered that the 'large' STK is found only in Gram-
- 10 -
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negative bacteria, the 'small* STK being associated with 
Gram-positive bacteria and eukaryotic organisms. This 
work provides a striking correlation between the incidence 
of 'large' and 'small' STKs and that of 'large' and 
'small' citrate synthases in a wide spectrum of organisms.
Another intriguing facet of STK diversity is their 
specificity for the nucleotide substrate. The mammalian 
enzyme was originally found to be specific for guanine 
nucleotides (GDP/GTP) or inosine nucleotides (IDP/ITP) 
(Sanadi et a l . » 1956) and this is still held to be true.
The enzyme from E . coli was reported to be specific for 
adenine nucleotides (ADP/ATP) (Robinson et al . , 1969), 
with plant and yeast STKs also being found to be adenine- 
linked (Kaufman & Alivisatos, 1955; Schwartz et al.» 1983). 
These results lead to the assumption that all animal STKs 
were guanine-linked, whereas bacterial and plant STKs were 
adenine-linked. However, Hansford (1973) reported an 
adenine-linked STK from blowfly flight muscle and 
subsequently other workers (McClellan & Ottaway, 1980) 
demonstrated the wider occurence of adenine-linked STK in 
a range of animal tissues, though not mammalian. Indeed, 
Burnham (1963) demonstrated that the enzyme from the 
photosynthetic bacterium Rhodopseudomonas spheroides could 
utilize ADP, GDP or IDP almost equally well. Further 
investigation of the E . coli enzyme has revealed that GDP 
and IDP can serve as substrate, albeit less effectively 
than ADP (Murakami et al,* 1972). Several other bacterial
- 12 -
STKs have been examined for their nucleotide utilization 
and variation in ADP, GDP and IDP utilization has been 
detected (Kelly & Cha, 1977).
On the basis of these results and the molecular size 
diversity exhibited by STK, an examination was undertaken 
of the nucleotide substrate specificity of a range of 
bacterial STKs (Weitzman & Jaskowska-Hodges, 1982). This 
revealed a distinct pattern of specificity which showed 
correlation with bacterial classification (see Figure 5). 
The Km values for the nucleotides appear to present four 
distinct classes of bacterial STKs. Groups I, II and III 
all comprise Gram-negative bacteria, whereas Group IV are 
all Gram-positive bacteria. Group I bacteria resembling 
Acinetobacter lwoffi (aerobic organisms) possess STKs with 
a very high Km for ADP ( -1 mM) but a much lower Km for 
GDP ( ~0*02 mM) . Group II, of which Pseudomonas 
aeruginosa is a representative, exhibit similar and low 
Km values ( -*0*05 mM) for both ADP and GDP, while Group 
III, in which the enterobacteria occur, show low Km values 
for ADP ( -0*01 mM) but significantly higher Km values for 
GDP ( -0*1 mM). Group IV STKs appear only to function 
with ADP (Km values ~ CL: 1 mM) displaying no activity with 
GDP as a substrate. It is worth noting that the same 
patterns of nucleotide substrate specificity are observed 
if the succinate thiokinase reaction is assayed in the 
reverse direction, in which the hydrolysis of ATP or GTP 
is coupled to the formation of succinyl-CoA.
-  13  -
Figure 5 Nucleotide specificity patterns 
of bacterial STKs
Group Organism Km AD P Km G D P
1 Acinetobacter anurpius 
Acinetobacter calcoaceiicus 
Bor de tel la bronchiseptica 
Brevibacterium leucinophagum  
Chromobacterium violaceum 
M im a polymorpha  
Xanthomonas hyac in th
\ Very high L o w
II Paracoccus demtnficans 
Pseudomonas aeruginosa 
Pseudomonas fluorescens 




\ L o w
1
L o w
III A1 co li genes faeca l is 
Arizona an  zonae
Cellulontonas cellasea . 
Escherichia coli
Klebsiella (Aerobacter) aerogenes j 
Serrano marcescens
High
IV Arthrobacter simplex 






,k L o w
1
J
N o  activity
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Such diversity in nucleotide utilization and 
molecular size of various STKs poses intriguing questions 
as to their significance and participation in metabolic 
control and cellular processes.
1•4 Detailed Molecular Characterization of STK 
1*4*1 Substrate specificity
Nucleotides & inorganic phosphate 
Nucleotide substrate specificity has already been 
discussed (see Section 1*3). However, it is worth noting 
that the pig heart enzyme has shown the ability to utilize 
certain guanine analogues such as 8-aza GDP/GTP and 6-thio 
GTP, albeit with lower affinities (Cha, 1969). The 
R . spheroides enzyme, as previously mentioned, utilizes 
ATP, GTP and ITP equally effectively, but no activity was 
detectable with the pyrimidines CTP or UTP (Burnham, 1963). 
Replacement of inorganic phosphate with arsenate in the 
forward direction leads to arsenolysis of succiny1-CoA 
which is independent of nucleotide phosphorylation and 
occurs at a rate of about 20% that of the phosphorolysis 
system. Phosphorylation of the enzyme from E. coli and 
pig heart has been shown to occur in the presence of Pi 
+ succinyl-CoA (Kreil & Boyer, 1964) or ATP and GTP 
respectively (Brownie & Bridger, 1972). It is now well 
established that the enzyme does indeed undergo 
phosphorylation during the catalytic reaction (see Section 
1*4*4).
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Succinate & CoA 
Surprisingly, Wang and co-workers (Wang et a l ., 1961) 
reported that itaconate could substitute for succinate 
with the pig heart enzyme although the af'finity of the 
enzyme for itaconate was not reported. For the E. coli 
enzyme only malate, out of a possible eleven organic acids 
tested as possible substrates, was utilized (Robinson 
et a l ., 1969). However, the activity with malate was 3% 
of that obtained with succinate and only observed at very 
high concentrations (^90 mM).
Only dephospho-CoA has been shown able to replace CoA 
in the catalytic reaction (Cha et al ., 1967).
Divalent metal ion requirement
There is an absolute requirement for a divalent metal
ion in the succinate thiokinase reaction. The magnesium 
2 +
ion (Mg ) is the most effective and widely employed
cation in all STK assays. After magnesium, in decreasing
order of effectiveness, are manganese and cobalt ions,
with only slight activity being observed with zinc and
2 +calcium ions (Gibson et al., 1967). However, Mg and 
Mn^ + have been reported to be equally effective at 6 raM 
with the pig kidney enzyme (Mazumder et a l ., 1960). A 
divalent metal ion is probably required to complex with 
the nucleotide for correct orientation of the nucleotide 
in the active site. Evidence for a divalent metal ion 
binding site, at or near the active site region, has been
- 16 -
obtained using electron paramagnetic resonance (EPR) 
(Buttlaire et al., 1977).
1*4*2 The E, coli Enzyme
Molecular weight & subunit organization 
Studies involving subunit cross-linking combined 
with SDS-polyacrylamide gel electrophorensis have revealed 
the a 2^2 structure t l^e enzyme, with no evidence of 
cross-linked a^, f t o r  aft pairings (Teherani & Nishimura, 
1975). Molecular weight estimates for the tetramer, of 
between 136,000 - 146,000 (Krebs & Bridger, 1974; Ramaley 
et al ., 1967) with a Mr of 29,600 ± 500 for the a subunit 
and a Mr of 38,700 ± 300 for the ft subunit (Bridger, 1971)
have been shown to be in very close agreement with the Mr
calculated from the primary structure of the enzyme (Buck 
et a l ., 1986). The a and ft subunits are derived from the 
sue D and sue C genes, respectively (Buck et al., 1986); 
the Mr of the a subunit is 29,000 and that of the ft 
subunit is 41.400. Significantly, the <*2^2 structure ^as 
now been confirmed as the active form of the enzyme by 
means of active enzyme centrifugation over a wide enzyme 
concentration range (Wolodko et al., 1986).
Crystallization of the enzyme has been achieved 
(Wolodko et al., 1984) as a prequisite for studying its 
3-dimensional structure. Preliminary X-ray diffraction 
studies have suggested that the aft dimers of the enzyme 
are arranged asymmetrically in the tetramer, as would be
- 17 -
expected if the alternating site co-operativity model is 
operational in the catalytic mechanism (see Section 1*4*4)
Subunit composition 
The a and 3 subunits are not only distinct in their 
size but also in their amino acid composition. The recent 
determination of the primary structure (Buck et al., 1985) 
shows very good agreement with the previous amino acid 
analysis of the isolated subunits (Bridger, 1974), with 
the subunit amino-terminal residues serine (a) and 
methionine (6) being confirmed. The a subunit is rich in 
glycine but deficient in asparagine, glutamate and serine 
and contains no tryptophan residues (Prasad et a l ., 1983), 
whereas the 8 subunit, although high in glycine and low in 
serine, contains 3 tryptophan residues per mol. Between 
16-18 titratable sulphydryl groups per enzyme
molecule have been reported (Nishimura et al ., 1973). 
However, a total of 24 cystene residues occurs, 6 per 
subunit (Buck et al., 1985). This means that either there 
are 6- 8 inaccessible sulphydryls or that 3-4 disulphide 
bonds occur in the enzyme. For details concerning the 
essential amino acids in substrate binding and catalysis 
see Section 1*4*4.
1*4*3 The Pig Heart Enzyme
Molecular size & subunit organization 
Molecular weight estimates for the enzyme range from
- 18 -
between 70,000 - 80,000 (Cha et a l ., 1967; Murakami & 
Nishimura, 1974). The enzyme is reported to consist of 
only one a and one 8 subunit of Mr values, 34,500 and 
42,300 respectively (Brownie & Bridger, 1974). Subsequent 
purification of the rat liver enzyme has yielded very 
similar molecular weights for the enzyme and subunits 
(Ball & Nishimura, 1980). Active enzyme centrifugation, 
as used to show the E. coli enzyme was a non-dissociating 
a 2^2 tetramer> has confirmed that the active form of the 
pig heart enzyme is a non-associating aB dimer (Wolodko 
et al . , 1986 ) .
Subunit composition 
Far less work has been carried out on the pig heart 
enzyme, partly due to the low yields obtained by 
purification. However, amino acid analysis of the a and 
8 subunits indicates, as with the E . coli enzyme, a lack 
of homology between the subunits. Interestingly, only one 
tryptophan residue has been found present on the 8 subunit 
(Nishimura, 1986), as compared with the 3 on each E. coli 
8 subunit. The amino acid composition would predict 14 
sulphydryl groups/mol of enzyme (Nishimura, 1986).
However, only 12 sulphydryl groups are detectable 
(Murakami & Nishimura, 1974). Therefore, again, either a 
disulphide bond occurs within the native enzyme or 2 
sulphydryl residues are inaccessible to the reagents used.
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1*4*4 The Molecular Mechanisms of STK
Substrate Binding Sites
In both the E. coli and pig heart enzymes a histidine 
residue located on the a subunit, identified in the 
E, coli enzyme as his-246 (Buck et al ., 1985), has been 
known for some time to be the residue phosphorylated by 
ATP/GTP in position N-3 of the imidazole ring (Kreil & 
Boyer, 1964; Vogel & Bridger, 1983) (see Figure 6 ). STK 
was the first enzyme demonstrated to involve a 
phosphohistidine in catalysis. Subsequent enzymes shown 
to utilize a phosphorylated histidine residue include 
ATP-citrate lyase, nucleotide,diphosphokinase and the 
heat-stable bacterial phosphoryl-transfer protein 
(Nishimura & Grinnell, 1972).
The fact that isolated a subunits undergo 
autophosphorylation with ATP (Pearson & Bridger, 1975) 
indicated that this subunit contains the nucleotide 
bindingsite and the catalytic machinery for phosphoryl 
transfer. However, the rate of phosphorylation was 
greatly increased in the presence of the 8 subunit, 
indicating that the active site may also involve the 8 
subunit. Significantly, phosphorylation of the a subunit 
by Pi and succinyl-CoA is only possibly in the presence 
of the 8 subunit (Kreil & Boyer, 1964). The concept that 
the nucleotide binding site is located at the a / 8 inter­
face is further supported by affinity labelling studies. 
Using the analogues 2 ’, 3 f-dialdehyde-GDP for the rat
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(A) The tautomeric form of the imidazole ring 
favoured in most proteins contains the lone 
pair of electrons on position (N — 1 )
(Blomberg et al., 1977).
(B) In STK phosphorylation occurs at position (N — 3) , 
it has been proposed that an anionic group 
stabilizes this tautomeric form
(Vogels & Bridger, 1983).
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liver enzyme (Ball & Nishimura, 1980) and 2', 3'- 
dialdehyde-ADP for the E . coli enzyme (Nishimura et al .* 
1983), inactivation was shown to be accompanied by cross- 
linking of the a and 3 subunits.
The location of the succinate and CoA binding sites
14
appears to be the 3 subunit. [ C] succinate is known to 
bind covalently to the E . coli subunit, in the presence 
of ATP and CoA (Pearson & Bridger, 1975_b) but, as yet, no 
studies on the residues involved have been presented. The 
CoA binding site in both E. coli and pig heart enzymes 
appears to contain at least one sulphydryl group on the 
8 subunit (Collier & Nishimura, 1978). Inactivation by 
CoA affinity analogues that react with active site 
sulphydryl groups, was completely reversible with 
dithiothreitol.
Additional evidence that the active site is located 
at the c*/3 interface comes from studies involving the 
tryptophan residues, found exclusively on the 3 subunits. 
The maximum fluorescence emission of STK occurs at 335 nra. 
Acrylamide quenching of this fluorescence is significantly 
increased, in both enzymes, by the respective nucleoside 
triphosphate and by CoA. However, in contrast to the 
E. coli enzyme, the fluorescence of the pig heart enzyme 
appears to be protected from the acrylamide quenching by 
succinate (Prasad et al., 1983; Nishimura, 1986).
Interestingly, chemical modification of a single 
tryptophan residue in isolated 3 subunits (E. coli) leads,
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upon reconstitution with unmodified a subunits, to a 
refolded enzyme which, although inactive in the overall 
reaction, still has the ability to undergo autophosphory­
lation with ATP (Nishimura et al., 1984).
It has now become widely accepted that the active 
site of STK is located at the point of contact between the 
a and 8 subunits. Substrate binding sites appear to be 
shared between the two subunits, being located very near 
the a / 8 interface.
The Reaction Mechanism 
The specific steps of the STK reaction have for a 
long time been in dispute. Unlike the ATP-generating 
reactions of glycolysis, which effect phosphoryl transfer 
from an activated phosphorylated metabolite to ADP, the 
STK reaction utilizes inorganic phosphate with two other 
substrates and must therefore operate through a more 
complex mechanism.
The realization that the enzyme is phosphorylated 
during catalysis led to a number of proposed mechanisms, 
of which two gained credence:
Mechanism I
E + succiny1-CoA^nz=±E-CoA + succinate 
E-CoA + Pi -■ * F.-P + CoA
E-P + NDP—  * E + NTP
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Mechanism II
E + succiny 1-Co A + Pi^rz±E. succiny 1-P + CoA 
E .succinv1-P  ^ ^ E-P + succinate 
E-P + NDP-— E + NTP
From mechanism I, an enzyme-bound CoA intermediate would
18be predicted. However, 0 studies revealed that the
expected transfer of oxygen from the enzyme or CoA to
inorganic phosphate did not occur and this was interpreted
as evidence against an enzyme-bound CoA intermediate
18during catalysis (Benson et al. * 1964). Other 0 exchange 
studies have demonstrated oxygen transfer between 
succinate and phosphate during the catalytic reaction 
(Cohn, 1959), thus giving support to mechanism II and the 
existence of an enzyme-bound succiny1-phosphate. Further 
direct evidence for such a covalent intermediate came from 
detection of its NMR signal (Vogel & Bridger, 1982) when 
ATP was added to a solution containing succinate and the 
phosphorylated enzyme. The possible reason for the ATP 
requirement in the formation of the succiny1-phosphate 
intermediate is discussed below.
Half sites reactivity and Alternating site co-operativity 
Half-sites reactivity (Moffet et al.» 1972) is- the 
term given to observations that, although the tetrameric 
enzyme possesses two possible phosphorylation sites 
(his -ot 246), only one phosphoryl group appears to be
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incorporated per a2^2 molecu^e * was subsequently shown
that both a subunits are equally available for 
phosphorylation (Wolodko et al., 1981). Unfortunately, 
discrepancies exist concerning the number of phosphoryl 
groups binding to the tetramer, with ratios of 1*6 - 1*8 
mol Pi/mol enzyme reported (Nishimura, 1986). These 
higher ratios are suggested to be produced by enzyme which 
is almost completely dephosphorylated, whereas the enzyme 
which is already phosphorylated would yield a ratio of one. 
However, the concept of half-site reactivity and other 
evidence has led to a conformation model for the enzyme 
during catalysis, known as alternating site co-operativity 
(Bild et al . , 1980). In this model the two ot3 halves are 
viewed as being arranged asymmetrically to each other (see 
Figure 7). Evidence from preliminary X-ray diffraction 
studies appears to confirm such asymmetry in the enzyme 
(Wolodko et al . , 1984). It is proposed that the synthesis 
and release of succinyl-CoA occurring at one active site 
would be facilitated, due to structural rearrangements, by 
the binding of ATP at the second site. After undergoing 
phosphorylation by ATP the second site would in turn 
become the site for further succinyl-CoA synthesis, so 
that the continual turnover of the enz-yme would occur in 
an alternating co-operative fashion between the two active 
sites.
This model has been tested by a number of methods. As
31previously mentioned, P NMR studies (Vogel & Bridger,
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1982) confirmed the existence of the enzyme-bound 
succinyl-phosphate intermediate. The requirement for ATP 
is consistent with the model, which indicates that the 
formation of succinyl-phosphate and ultimately succinyl- 
CoA, at one active site requires binding of ATP at the
other site. The replacement of ATP with a
non-hydrolysable ATP analogue demonstrated that 
phosphorylation at the second site was responsible for 
the co-operative effect (Vogel & Bridger, 1982). The 
model would also suggest that the rate of 
dephosphorylation of the enzyme by succinate and CoA 
should be stimulated by ATP, since the formation of 
succinyl-phosphate appears to be dependent upon the 
interaction of ATP with the neighbouring site. To study 
this turnover a thiophosphorylated tetrameric enzyme was 
prepared (Wolodko et al . , 1983). Stimulation of PSO^ 
release, in the presence of succinate and CoA, occurred on 
addition of ATP exactly as predicted by the model.
Alternating site co-operativity is believed to be a unique
phenomenon dependent upon the subunit organization of the 
E. coli STK as an <*2^2 tetramer, so that the mammalian 
enzyme, which is a simple non-associating a|3 dimer 
(Wolodko et al ., 1986), would not be expected to display
3_
such stimulation. However, similar stimulation of PSO^ 
release, by GTP, has been observed in the pig heart enzyme 
(Nishimura & Mitchell, 1985). This surprising result has 
been attributed either to a second binding site for GTP on
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the enzyme or to a mechanism involving the incoming 
phosphoryl group of GTP displacing the phosphate already 
attached to the enzyme. It is therefore apparent that the 
precise molecular mechanisms involved in the STK reaction 
have yet to be finally established.
1•5 Synthesis of STK
The majority of researchers have concentrated their 
attention upon the mechanism of the STK reaction, so that 
little knowledge of the control of STK biosynthesis exists. 
Recent work in E . coli has identified the genes specifying 
the a and 3 subunits, locating them to the distal segment 
of a cluster of nine citric acid cycle enzymes (Buck 
et al., 1985). Studies have also begun with the rat liver 
enzyme. Already the a subunit has been partly sequenced 
and established as having a cytoplasmic origin, complete 
with a cleavable signal sequence responsible for 
targetting its mitochondrial location (Bridger et al . ,
1986) .
1 •6 Possible in vivo associations of STK
Multienzyme complexes appear to be present in most 
metabolic pathways. A number of studies have indicated 
specific interactions between various enzymes of the 
citric acid cycle, in both eukaryotic (Srere, 1985) and 
prokaryotic organisms (Barnes & Weitzman, 1986). Purified 
STK has been shown specifically to interact with purified
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2-oxoglutarate dehydrogenase (Porpaczy et al., 1983) and 
some loose association of STK with the inner mitochondrial 
membrane has been reported (Nishimura, 1986).
1•7 Possible physiological roles of STK
"Succinate thiokinase is one of the most neglected 
enzymes of intermediary metabolism" (Ottaway et al . , 1981). 
Such sentiment is well founded. STK, probably due to the 
freely reversible reaction it catalyses, has for a long 
time been regarded as a necessary but uninteresting link 
between the 2-oxoglutarate and succinate dehydrogenases.
So much so that it is often excluded from flow diagrams of 
the cycle (Walsh et al., 1986). As can be appreciated 
from Section 1*4, most devotees of STK have concentrated 
their efforts on understanding the molecular mechanisms of 
the reaction, rather than establishing any metabolic or 
physiological involvement.
Succinyl-CoA, besides its involvement in the citric 
acid cycle, is known to be required for the utilization of 
ketone bodies in extra-hepatic tissues. Ottaway and co­
workers (Ottaway et a l ., 1981) have suggested that only a 
guanine-linked STK (G-STK) and not an adenine-linked STK 
(A-STK) is found in tissues actively using ketone bodies.
On the basis of computer stimulation studies and the 
predicted internal mitochondrial GTP/GDP ratios, they have 
predicted that, in such tissues, G-STK must be inhibited 
by the product GTP, before ketone body activation can
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occur (McClellan & Ottaway, 1980). However, no
experimental evidence has been presented to substantiate
this proposal.
Another role for succinyl-CoA occurs is the
biosynthetic pathway of porphyrins. This pathway is
initiated by the condensation of succinyl-CoA and
glycine by the enzyme 6-aminolevulinic acid synthase
(ALA-S), to produce 6-aminolevulinic acid (ALA) (Shemin,
1979) which is then subsequently converted in several
steps to haem. A number of genetically inherited diseases,
known as "porphyrias", have been identified, in which
dysfunction of an enzyme of the pathway leads to a
compensatory increase in ALA-S activity (Elder, 1983*0;
porphyria may also be induced by a range of chemicals.
Elevation of ALA-S may lead to a drain on succinyl-CoA and
glycine. Most attention has focused on the regulation of
ALA-S and subsequent enzymes, except for one report over
,et al,
20 years ago (Labbe^ 1965) which describes the increase of 
STK activity in porphyric liver. This finding has largely 
been overlooked.
It is clear that, unlike the molecular aspects of 
STK, the possible metabolic associations of STK requires 
further investigation.
1 •8 Aims and scope of thesis
After the establishment of distinct nucleotide 
specificity and molecular weight patterns among bacterial
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STKs, it was decided that a careful study of STKs from 
eukaryotic organisms was necessary and timely. The 
interesting, if inconclusive, studies by Ottaway and co­
workers (McClellan & Ottaway, 1980; Ottaway et a l ., 1981) 
on the physiological significance of STK nucleotide 
specificity, together with the other metabolic roles of 
succinyl-CoA within mitochondria, have prompted further 
examination of various systems.
In this thesis, a broad range of organisms has been 
used to explore the diversity and physiology of the STK 
system. The studies encompass bacteria, eukaryotic 
unicellular organisms such as yeast and parasitic protozoa, 
plants, insects and mammals. The deliberate choice of 
these disparate organisms was designed to clarify the 
metabolic roles of STK. Studies have included comparative 
measurement of enzyme levels, enzyme fractionation and 
molecular and kinetic characterization.
Due to the wide diversity of organisms and metabolic 
conditions studied, the thesis is divided into separate 
chapters. Each chapter contains a short introduction to, 
and interpretations of, the results presented. The final 
chapter contains an integrated discussion of the 
discoveries that have been made and attempts to build them 









The following bacterial strains were used: 
Acinetobacter calcoaceticus - 4B, Arthrobacter simplex - 
C73, Bacillus megaterium - D101, Bacillus subtilis - 168, 
Brevibacterium linens, Brochothrix thermosphacta,
Corynebacterium fascians, Corynebacterium rubrum* 
Deinococcus radiodurans* Escherichia coli - K12D500, 
Kurthia zopfii and Staphylcoccus aureus - 12600. All 
strains were obtained from the culture collection of 
Prof. P.D.J. Weitzman, University of Bath.
Saccharomyces cerevisiae (Baker's yeast) from the 
Microbiology Group, University of Bath.
Trypanosoma brucei bloodstream strain - MITatl’l and 
procyclic strain - EATRO - 427, were originally obtained 
from Dr H.P. Voorheis, Trinity College, Dublin and 
Dr W. Gibson, Tsetse fly centre, Langford, Bristol, 
respectively, being subsequently prepared and kindly 
supplied by Dr R. Eisenthal, University of Bath.
Mouse lymphoma - L1210 and hamster kidney (BHK) cell 
lines were obtained from Dr W.J.D Whish, University of 
Bath.
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Locusta schistocerca gregaria (desert locust) were 
obtained from Dr G.G. Lunt, University of Bath.
Wistar rats and white C .F .L .P .-mice were obtained 
from the maintained stocks at the University of Bath.
Other animal tissues, eg. bovine, porcine and ovine, 
were obtained from a local abattoir after slaughter.
Zea maize (jubilee), etiolated and non-e~tiolated , 
were obtained from the Horticulture Group, University of 
Bath. Pigeon (racing) breast muscle was obtained from 
University of Bristol.
2 r 2 Chemicals & Enzymes
All inorganic chemicals were obtained at highest 
purity from BDH Chemicals Ltd., Poole, Dorset, U.K. and 
Fisons Scientific Apparatus, Loughborough, Leics., CoA, 
OAA, NADP and NADPH were from Boehringer Mannheim, Lewes, 
Sussex, U.K., adenosine, guanosine and inosine 
nucleotides, acetoacety1-CoA, bovine thyroglobulin, 
lithium acetoacetate, mesoporphyrin, sodium $- 
hydroxybutyrate, streptozotocin, succinic anhydride and 
all other fine chemicals were from Sigma Chemical Co., 
Poole, Dorset, U.K.
Nutrient agar and broth were from Oxoid Ltd., London, 
U.K., Clinistix and Ketostix came from Ames Division,
Miles Laboratories Ltd. (supplied through Arnold R.
Harwell Ltd., London). Insulin (Neulente-zinc suspension,
100 I.U./ml, Wellcome) was kindly supplied by
Dr J.P.D. Reckless, Royal United Hospital, Bath. Bio-Rad
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protein assay solution and hydroxylapatite (Bio-gel HTP) 
were obtained from Bio-Rad Laboratories Ltd., Watford, 
U.K., Percoll, PD-10 columns, Sephadex G-10, Sephacryl 
S-200 and Sepharose 4-B were from Pharmacia, Milton 
Keynes, U.K., Zorbex-ODS (4*6 x 250 mm) and Zorbex-NH^ 
(4*6 x 250) HPLC columns (Du Pont) were obtained through 
Anachem, Luton, U.K.. The triazine dyes were kindly 
supplied by Dr S. Syed. 3,5-diethoxycarbony1-1,4- 
dihydrocollidine (DDC) was kindly supplied by Dr F. De 
Matteis, MRC Toxicology Unit, Carshalton.
Enzymes
Glucose 6-P dehydrogenase (yeast), lactate 
dehydrogenase (rabbit muscle), malate dehydrogenase (pig 
heart), phosphoglycerate kinase (yeast) were from 
Boehringer Mannheim. $-hydroxybutyrate dehydrogenase 
(Rhodopseudomonas spheroides) and succinate thiokinase 
(pig heart) were obtained from Sigma Chemical Co.
2•3 Polarography
Due to the unusual use of this electroanalytical 
technique for the assay of enzymic activity, a short 
introduction to the subject and the practical procedures 
involved has been included.
2*3*1 General principles & theory 
Introduction
Polarography is an electrochemical method of
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analysis, devised by Heyrovsky (1922). It involves the 
production of a current at a polarizable micro-electrode, 
as a function of the applied potential. The polarizable 
micro-electrode, usually a dropping mercury electrode, is 
immersed in the test solution, while a non-polarizable 
reference electrode, connected via a salt bridge to the 
test solution, completes the circuit. Reduction or 
oxidation of an electroactive species, at the 
microelectrode, produces a cathodic or anodic current, 
respectively.
The relationship between current and voltage is 
shown in Figure 8 . As the potential difference is 
increased from zero, very little current will flow until 
the potential is such that the electroactive species can 
be reduced or oxidized at the surface of the micro­
electrode. This causes a large increase in current from 
a relatively small increase in potential. The mid-point 
(Ei) of the wave is characteristic of the particular 
species examined. As the potential difference is further 
increased, a situation is reached where the electroactive 
species is reduced or oxidized as fast as it reaches the 
microelectrode. The current is then said to be the 
"limiting current” and is determined by the rate of 
diffusion of the electroactive species, which is directly 
proportional to its concentration. Therefore the 
activity of enzymes that utilize or produce an 
electroactive substrate or product can be measured in a
- 35 -
Figure 8 Half-wave potential of an electroactive
species







Considerations of current & diffusion
Any electrolytic process involves first the bringing 
of the electroactive species to the electrode surface and 
secondly the electrochemical process. The first step is 
associated with the diffusion of the electroactive 
species to the electrode, and therefore is temperature 
and concentration dependent. The electrochemical step, 
involving electron transfer between the electrode and 
species in solution, often requires adsorption followed 
by atomic or molecular rearrangements of the 
electroactive species into a form suitable for electron 
exchange. These rearrangements may be rapid or slow and 
therefore could be rate limiting. However, polarography 
has traditionally been concerned with rapid 
electrochemical processes, such that the rate-limiting 
step in the whole procedure is the diffusion of the 
electroactive species to the electrode.
With the dropping mercury electrode (d.m.e.) a near 
spherical drop of mercury, which slowly forms and then 
falls from the end of a very fine capillary, acts as the 
polarizable electrode. A sophisticated mathematical 
solution was required to solve the problem of quantifying 
the current produced, by the diffusion of an 
elecProactive species to a spherical drop which is 
increasing in volume uniformly with time. This was
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achieved by Ilkovic (1934). 
Ilkovic equation:
1 I I
i = 607 n D2 C • M 3 t6
(A) (B)
where i = current (yA)
607 = a numerical constant
n = number of electrons transfered per mol 
electroactive species 
D = diffusion coefficient (cm2/s)
C = concentration (mM)
M = mass of mercury flowing (mg/s) 
t = formation time of one mercury drop
From the equation it is apparent that section (A) is 
dependent upon the solution, whereas section (B) is 
dependent upon the electrode. Therefore if the electrode 
and nature of solution are constant, the current is 
proportional to concentration.
2*3*2 The d.m.e., reaction vessel and reference electrode 
A d.m.e. consists of a reservoir of pure mercury, 
of variable height, from which mercury escapes via a fine 
glass capillary (20-30um diameter). The mercury issues 
from the capillary in regular and identical drops at a 
rate dependent upon the height of the reservoir .(required 
drop time = 4-9S). The reaction vessel consists of a
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glass cell, suitable for a 1 ml test solution, with a 
standard ground glass neck. This is attached to a 
matching stopper of hard polythene, which is held in a 
fixed vertical position and ensures a gas-tight seal for 
the system. Through the stopper are a number of drilled 
holes to carry: the d.m.e. capillary, a salt bridge (20% 
agar in saturated KC1) and inlet and outlet tubes for 
nitrogen. A small capped hole also exists to allow 
introduction of extract solution (see Figure 9). The 
applied potential is measured against a saturated calomel 
non-polarizable electrode. This reference electrode 
consists of a paste mixture of mercury (Hg) and mercurous 
chloride (Hg^C^) in a saturated KC1 solution, so that an 
equilibrium is established:
Hg2Cl2 + 2e~  Hg + 2 Cl"
2*3*3 The CoA assay procedure
Enzymes responsible for the hydrolysis of acyl-CoA 
derivatives produce free CoA-SH which can be measured 
readily at a potential of -0*3 V (Weitzman, 1976).
CoA-SH, but not its acyl-CoA derivatives, produces an 
anodic polarographic wave, as the CoA-SH is oxidised 
forming a mercaptan with the mercury:
Hg + 2 CoA-SH % Hg(CoA ) 2 + 2 H+ + 2 e
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1 ml test 
solution
A dropping mercury electrode
g  salt bridge (2% agar in saturated
KC1 )
C. small capped hole (to enable
material to be added to
vessel)
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The assay mixture is placed in the reaction vessel
which is then attached to the polythene stopper, so that
the d.m.e., salt bridge and nitrogen inlet tube all 
reach into the solution. Oxygen-free nitrogen is then 
flushed through the solution for 2 min to remove oxygen 
from the system. This is necessary because oxygen has
two redox potentials at + 0*8 and + 0*3 V (Morris, 1974),
so that throughout the working potential of the d.m.e. 
molecular oxygen is reducible and would thus produce a 
polarographic wave that would mask other polarograms. 
After oxygen removal, extract is introduced into the 
assay mixture using a very fine pipette. The nitrogen 
tap is then quickly adjusted to allow nitrogen to flow 
over the surface of the solution so that turbulence 
ceases. Immediately a fixed potential is applied and the 
current recorded automatically with a Radiometer P04 
recording polarograph.
The trace obtained has a characteristic oscillatory 
pattern (see Figure 10). The advantage of using a d.m.e. 
over other types of electrode is that each drop that 
forms is unaffected by the reaction which occurred at the 
surface of the earlier drops. This ensures that the 
d.m.e. is never poisoned because the surface is 
continually renewed.
2*3*4 Calibration of the d.m.e.
As can be deduced from the Ilkovic equation, each 
mercury electrode requires calibration for a particular
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electroactive species. This is achieved by preparing a
1 mM solution of CoA-SH, the exact free thiol
concentration being determined using DTNB
3 -1 -1
(e^l2 = 13*6 x 10 l.mol .cm ). Known amounts of CoA 
are added to a solution of 0*1 M sodium/potassium 
phosphate buffer, pH 8 *0 , containing 10 mM MgCl^ to give 
a final volume of 1 ml. A potential of -0*3 V is applied 
to each sample and the height of the anodic wave produced 
is recorded. A simple linear calibration plot is then 
constructed. Once calibrated the electrode is used at a 
fixed mercury column height. The electrode used for all 
enzyme assays had a conversion factor of 0*613 so that 
yA ml ^min  ^ x 0*613 = ymoles ml ^min
2*3*5 Care of the d.m.e.
The use of pure, double or triple distilled 
mercury is essential for the uniform formation of each 
mercury drop. As each drop falls, the mercury thread 
momentarily retracts slightly into the capillary lumen 
before the succeeding drop begins to form. This pumping 
of solution in and out of the lumen, can over time foul 
the capillary and lead to erratic and slower mercury flow. 
Periodic immersion of the electrode, with the mercury 
flowing, into 50% (v/v) nitric acid, acetone and 
finally double distilled water will maintain a clean 
lumen.
2*3*6 Advantages & general applications
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Polarographic measurement of STK activity is a 
particularly suitable assay procedure for examining 
nucleotide specificity and dependence of the enzyme.
Other assays that have been employed are the hydroxamate 
method (Kaufman, 1955) which is discontinuous and rather 
insensitive (Weitzman & Kinghorn, 1980) and the 
spectrophotoraetric method at 235 nm (Cha, 1969). This 
continuous assay suffers from interference absorbance of 
the nucleotide substrates and is unsuitable for crude 
cell extracts of high turbidity. Similarly, measurement 
of STK activity by free CoA-SH detection, with the 
reagent DTNB, as used for citrate synthase assays (Srere 
et al.> 1963), may also be unsuitable. This method, 
although widely used is known to expose enzymes to the 
possibility of inactivation by the chromogen (DTNB) 
(Weitzman & Danson, 1976) and this is especially so with 
eukaryotic STK enzymes. However, all these possible 
disadvantages in traditional assay methods are eliminated 
by use of the polarographic procedure.
Many enzyme reactions involve substrates or products 
which are electroactive. Besides CoA-SH and other 
sulphur-containing compounds, recently reviewed by Adler 
& Westely (1987), the carbonyl group of pyruvate produces 
a cathodic wave at -1*4 V so allowing pyruvate kinase to 
be assayed. Lipoamide dehydrogenase activity may be 
measured by detection of either the cathodic or anodic 
waves produced by lipoamide and dihydrolipoamide 
respectively (at -0*75 V and -0*2 V), while NAD(P)-linked
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dehydrogenase reactions may be assayed by following the
reduction of NAD+ or NADP+ , to produce a cathodic wave at
-1*1 V (Weitzman, 1976).
In conclusion, the polarographic method of enzyme 
assay is a technique which has a wide and useful 
application in a variety of enzyme systems. It has been 
found to be particularly applicable and advantageous in 
the measurement of STK activities.
2•4 Enzyme assays
Polarographic assays were carried out using a 
Radiometer P04 recording polarograph. Spectrophotometric 
assays were carried out with either a Perkin Elmer 504 or 
a Pye Unicam SP1800 spectrophotometer.
All assays were carried out at 25°C. A unit of 
enzyme activity is defined as that amount of enzyme which 
catalyses the conversion of 1 ymole of substrate to 
product per min. Where appropriate, non-specific 
reactions were taken into account. All assays involving
the measurement of NAD/NADH/NADP/NADPH were calculated
3 -1 -1
using £^C) = x ^  l.mol .cm . Results are
expressed in activity^min ^(mg of protein)  ^ or in activity 
min (ml of extract)
Acetoacety1-CoA thiolase [EC 2*3*1*9]
ACT was assayed by following the decrease in
absorbance at 303 nm due to the hydrolysis of acetoacetyl-
3 -1 -1
CoA (e3Q3 = 20*5 x 10 x l.mol .cm ). The assay mixture
contained 0*1 mM acetoacety1-CoA, 0*11 mM CoA and 50 mM
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MgCl^ in 50 mM Tris-HCl buffer, pH 7*5. The reaction was 
initiated by the addition of the CoA.
Citrate synthase [EC 4.1.3.7]
CS was assayed by the method of Srere et al. (1963)
using Ellman’s reagent 5,5’-dithiobis (2-nitrobenzoic
acid) (DTNB), which is cleaved by CoA-SH. The increase
in absorbance at 412 nm, due to the production of the
yellow thio-nitrobenzoate anion, was followed
3 -1 -1
spectrophotometrically = *3*6 x 10 l.mol .cm ).
The assay mixture contained 0*2 mM acetyl-CoA, 0*2 mM OAA 
and 0*1 mM DTNB in 20 mM Tris-HCl + 1 mM EDTA buffer, 
pH 8*0. CS was also measured polarographically (Weitzman, 
1969) with the same assay mixture except for the omission 
of DTNB. The formation of CoA-SH was monitored with a 
dropping mercury electrode at a potential of -0*3 V 
relative to a saturated calomel electrode, with a full 
scale deflection of 0*2 jjA (vimoles ml ^min  ^ = 0*613 x 
yA ml“ ^min~^).
Glutamate dehydrogenase [EC 1.4.1.3]
GDH was assayed by following the oxidation of NADH 
at 340 nm. The assay mixture contained 3 mM
2-oxoglutarate, 25 mM NH^Cl and 50 uM NADH in 0*1 M 
sodium/potassium phosphate + 2 mM EDTA buffer, pH 7*5.
Hexokinase [EC 2 . 7 .1.1 ]
HK was assayed by linking to glucose 6-P
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dehydrogenase (G6PDH) and following the reduction of 
NADP + at 340 nm. The assay mixture contained 222 mM 
glucose, 8 mM MgCl2> 0*91 mM NADP+ , 0*64 mM ATP and 
0*155 U/ml G6PDH in 40 mM TEA buffer, pH 7*6.
8-Hydroxybutyrate dehydrogenase [EC 1*1*1*30]
HBDH was assayed by following the oxidation of NADH 
at 340 nm. The assay mixture contained 100 yM lithium 
acetoacetate and 0*2 mM NADH in 50 mM sodium/potassium 
phosphate buffer, pH 6 *8 .
Isocitrate dehydrogenase [ECNAD 1*1*1*41] [ECNADp 1*1*1*42] 
IDH was assayed by following the increase in 
absorbance at 340 nm. The assay mixture contained 4 mM 
isocitrate, 0*2 mM NAD+ or NADP+ in MET -8 buffer. 1 mM 
ADP was included in the assay for the NAD-linked enzyme.
Lactate dehydrogenase [EC 1*1*1*27]
LDH was assayed by following the oxidation of NADH, 
as a decrease in absorbance at 340 nm. The assay mixture 
contained 0*2 mM pyruvate and 0*2 mM NADH in 20 mM 
Tris-HCl buffer, pH 8*0.
Malate dehydrogenase [EC 1.1.1.37]
MDH was assayed by following the decrease in 
absorbance at 340 nm. The assay mixture contained 0*2 mM 
0AA and 0*2 mM NADH in MET-8 buffer.
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3-Oxo-acid CoA-transferase [EC 2.8 .3.5]
OAT was assayed by following the decrease in
absorbance at 303 nm due to the cleavage of acetoacety1-CoA.
3 -1 -1(£303 = 20*5 x 10 l.mol .cm ). The assay mixture
contained 80 uM acetoacety1-CoA, 10 mM iodoacetamide,
10 mM MgCl^ and 50 mM succinate in 50 mM Tris-HCl buffer,
pH 8*5. The reaction was initiated by the addition of
the succinate.
2-0xoglutarate dehydrogenase [EC 1 • 2 • 4 • 2 ]
0GDH was assayed by following the increase in
absorbance at 340 nm due to the reduction of NAD+ . The
assay mixture contained 2 mM 2-oxoglutarate, 2*5 mM NAD+ ,
0*2 mM TPP, 0*13 mM CoA, 2*6 mM cysteine-HCl and 1 mM
MgCl^ in 50 mM potassium phosphate buffer, pH 8*0.
Phosphoenolpyruvate carboxykinase (EC 4.1.1.32]
PEPCK was assayed by linking to MDH and following 
the decrease in absorbance at 340 nm, due to the 
oxidation of NADH. The assay mixture contained 1*25 mM 
phosphoenolpyruvate, 1*25 mM GDP, 50 mM KHCO^, 1 mM 
MnCl^i 0*15 mM NADH and 5 U/ml MDH in 100 mM imidazole- 
HC1 + 2 mM DTT buffer, pH 6 -6 .
Phosphoglucose isomerase [EC 5.3.1.9]
PGI was assayed by linking to G6P-DH. The reduction 
of NADP+ was followed at 340 nm. The assay mixture 
contained 1*4 mM fructose-6-phosphate, 6*8 mM MgCl^,
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0*39 mM NADP+ and 0-46 U/ml G6P-DH in 85 mM TEA buffer, 
pH 7-6.
3-Phosphoglyceraldehyde dehydrogenase-NADP+ [EC 1 . 2 . 1 . 9 ] 
PGADH was assayed by following the oxidation of 
NADPH at 340 nm. The substrate 3-phosphoglycerate 
phosphate was produced in the assay from phosphoglycerate 
kinase. The assay mixture contained 1 mM
3-phosphoglycerate, 3*3 mM ATP, 1*5 U/ml phosphoglycerate 
kinase, 10 mM MgCl^, 4 mM EDTA, 0*14 mM NADPH and 1 mM 
DTT in 67 mM MOPS buffer, pH 7*3. The assay mixture was 
incubated at room temperature for 1 min to allow 
activation, before initiation of the reaction by addition 
of the 3-phosphoglycerate.
Pyruvate kinase [EC 2.7.1.40]
PK was assayed by linking to LDH. The oxidation of 
NADH was followed at 340 nm. The assay mixture contained 
0*54 mM phosphoenolpyruvate, 2*5 mM MgSO^, 10 mM KC1,
4*7 mM ADP, 0*2 mM NADH and 9*2 U/ml LDH in 20 mM Tris- 
HCl buffer, pH 8*0. The reaction was initiated by the 
addition of the phosphoenolpyruvate.
Succinate thiokinase ADP [EC 6.2.1.5] GDP [EC 6 .2.1.6]
STK was assayed polarographically in the forward 
direction (succinyl-CoA breakdown). CoA-SH formation was 
monitored with a dropping mercury electrode at a 
potential of -0*3 V, relative to a saturated calomel
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electrode, with a full scale deflection of 0*2 \ik
(ymoles = 0*613 x uA). The assay mixture contained 0*17
mM succiny1-CoA, 0*5 mM NDP and 10 mM MgCl^ in 100 mM
sodium/potassium phosphate buffer, pH 8*0.
STK was measured spectrophotometrically in the
reverse direction (succiny1-CoA formation) by following
the increase in absorbance at 235 nm due to the thio-
3 — 1 — 1
ester bond of succinyl-CoA (e23  ^ = x 10 l.mol cm ).
The assay mixture contained 10 mM sodium succinate,
10 mM MgCl^i 0*4 mM NTP and 0*l7mM CoA in 50 mM Tris-HCl 
buffer, pH 7*5.
2•5 Estimation of Protein
Protein concentrations were estimated by the method 
of Bradford (1976). To 800 ul of test solution were 
added 200 ul of Bio-Rad reagent; after gently mixing the 
absorbance was read at 595 nm after 5 min. Bovine
thyroglobulin was used as standard.
2 •6 Preparation of reagents 
2*6*1 Preparation of acetyl-CoA
Acetyl-CoA was prepared by the method of Stadtman 
(1957). To 10 mg of CoA, dissolved in 1 ml of double­
distilled was added 0*2 ml of lMKHCO^ to ensure a
neutral pH. 0*2 ml of 0*1 M acetic anhydride was then 
added and the mixture incubated for 10 min on ice. 
Completion of acetylation was checked using DTNB.
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2*6*2 Preparation of succiny1-CoA
Succinyl-CoA was prepared by the method of Simon & 
Shemin (1953). 5 mg of CoA were dissolved in 0*5 ml of 
double-distilled H^O. A neutral pH was ensured by 
addition of 100 jjl of lMKHCO^. 20 mg of succinic 
anhydride were added and the solution frequently and 
thoroughly mixed for 5 min. The excess succinic 
anhydride was then removed by filtration and the 
succinyl-CoA solution stored on ice.
2*6*3 Stability & estimation of succinyl-CoA
All acyl-CoA derivatives are notoriously unstable, 
with succinyl-CoA having a half-life of between 1-2 h at 
room temperature (Dawson et al . , 1986). The stability of 
succinyl-CoA, stored on ice, was therefore determined 
over a period of 24 h. Hydroxylamine is known to react 
with acyl-CoA derivatives to yield an acy1-hydroxamate
and CoA; DTNB can then be added to quantify the CoA
liberated.
To the succinyl-CoA sample, in 100 mM sodium/
potassium phosphate buffer, pH 7*5, was added 50 ul of a
2*4 M neutralized hydroxylamine stock solution (3 ml of
4 M NH20H-HC1 + 2 ml of 7 M K0H). After 15 min, 20 ul
of 10 mM DTNB was added and the absorbance read at 412 nm
3 - 1 - 1
(e / 10 = 13*6 x 10 l.mol cm ). The free CoA-SH content 
. 4 1 2
was determined by addition of DTNB to succinyl-CoA 
samples in the absence of hydroxylamine.
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CoA (grade 1) obtained from Boehringer Mannheim is 
reported to be 85% pure. Therefore the maximum amount 
of succinyl-CoA possible from 5 mg CoA/600 yl would be 
9 mM (Mwt CoA = 785*4). The concentration of 
succinyl-CoA measured by the hydroxylamine/DTNB 
method was found to be 8*7 mM, which indicates 97% 
succinylation of the original CoA. The stability of 
succinyl-CoA stored on ice was determined (see Table 
1). Even after 5^ h only 12% of succinyl-CoA had 
been hydrolysed, as determined by the hydroxylamine/ 
DTNB method. During the succinylation of CoA, succinic 
anhydride may also react with water to produce 
succinate.
As succinate is a product of the STK reaction, 
separation of succinyl-CoA from succinate 
contamination was required to ensure that product 
inhibition did not produce interference. This was 
achieved on a column of Sephadex G-10 (2*5 x 400 ram) 
(see Figure 11).
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Table 1 Stability of succinyl-CoA
T ime - hydroxylamine + hydroxylamine succiny1
(h : min) (A412) (A412> (mM)
0 0-01 1-2 8-75
1 : 50 0-013 1-2 8-7
2 : 40 0-077 1-2 8-25
5 : 30 0-15 1-2 7-7
*24 : 00 0-2 1-2 7-35
















Figure 11 Separation of succinyl-CoA from succinate on Sephadex G-10
(2*5 x 400 mm) in 50 mM MOPS buffer, pH 6*5, at 4°C
(300 Ul of 19 mM succinyl-CoA solution was loaded)
10 mM sodium succinate





























Succinyl-CoA was measured using the hydroxylamine/DTNB 
assay, whereas succinate was detected by using the 
reverse directional STK assay, by following the increased 
absorbance, due to succinyl-CoA formation, at 235 nm.
This partially purified succinyl-CoA was shown to produce 
no significant increase in STK activities. However, for 
all kinetic studies partially purified succinyl-CoA was 
used. No such potential problem exists with the citrate 
synthase assay, where the acetyl-CoA also contains 
acetate, because acetate is not a product of the reaction.
2•7 Determination of the purity of adenosine, guanosine 
and inosine dinucleotides by HPLC 
ADP, GDP and IDP were obtained from Sigma at the 
highest purity. To remove any possibility of there being 
cross-contamination between the nucleotides, HPLC 
analysis was carried out on a LDC/Milton Roy HPLC system. 
Initial studies using a Zorbex-ODS column (4*6 x 250 mm), 
with an isocratic elution of 10 mM sodium/potassium 
phosphate buffer, pH 6*5, appeared to confirm the 
individual purities (ADP = 94*7%, GDP = 96% & IDP = 97%) 
but failed to separate a mixture of all three nucleotide's. 
Separation was achieved using a Zorbex-NH^ column (4*6 x 
250 mm) with an isocratic elution of 1*4% acetic acid,
2*8% methanol, 1% acetonitrile and 70 mM NaCl, pH 2*5 
(see Figures 1 2, 13, 14 & 15). These results 
conclusively demonstrated the purity of the nucleotides 
used, and eliminate the possibility of erroneous STK
HPLC analysis of ADP on Zorbex-NH^ column
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0 1 2 3 4 5 6 7 8
min
sample = 10 yl (lOmM) ADP 
flow rate = 2 ml/min 
scale = 0-2*0  
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Figure 13 HPLC analysis of GDP on Zorbex-NH^, column
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Figure 14 HPLC analysis of IDP on Zorbex-NH^ column
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Figure 15 HPLC analysis of a mixture of nucleotides
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activity due to cross-contamination.
2 •8 Bacterial & yeast cultures
2*8*1 Maintenance & growth of organisms
Bacterial strains and S. cerevisiae were maintained 
on nutrient-agar plates at 4°C and sub-cultured every two 
weeks. The culture of organisms occurred in nutrient 
broth media at 30°C or 37°C with shaking. Growth curves 
were followed by estimation of cell density by 
measurement of absorbance at 680 n m .
2*8*2 Culture media
Nutrient broth was used for the routine growth of
organisms. When a specific carbon source was required,
growth was carried out in a medium of basal salts : 50 mM
NH^Cl, 0*18 mM CaCl2 , 0*33 mM MgSO^, 0*018 mM MnS04>
0*014 mM FeSO. in 50 mM sodium/potassium phosphate buffer, 
4
pH 7*2, with addition of the carbon source.
2*8*3 Gram stain
The Gram stain was performed by the method of 
Gillies & Dodds (1973). A small loop of bacteria to be 
examined was added to a drop of sterile saline on a 
microscope slide. After allowing the mixture to dry, the 
material-was fixed by passing the slide three times 
through a bunsen burner flame. The slide was flooded 
with methyl violet (0*5% (w/v) in H^O), left for 5 min, 
and then rinsed with Gram’s iodine (0*3% iodine/0*6%
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potassium iodide (w/v in H^O). After a further 2 min 
the slide was drained and the cells decolourized by 
exposure to acetone for 5 s, before washing in H^O. The 
counter-stain Neutral Red (1% Neutral Red + 1% acetic 
acid in H^O) was then applied and after 30 s the slide 
was again rinsed with H^O and gently blotted dry.
2•9 Isolation & culture of Trypanosoma brucei 
2*9*1 Bloodstream cell form (strain MITat 1*1)
These were isolated from the blood of 250 g Wistar 
rats, 71 h after intraperitoneal injection with a dosage 
of 107 viable trypanosomes. The cells were separated 
from blood components by centrifugation (600 x g) for 
10 min at 4°C and further purified on a short DEAE- 
Sephacel column (5 ml bed volume) in isotonic P.B.S., 
pH 8*0, containing 10 mM glucose as described by Lanham 
& Godfrey (1970). At pH 8*0 blood cells absorb to the 
column, whereas the less negatively charged T. brucei 
cells are eluted. Cell number and viability were 
monitored by phase contrast microscopy. Active 
trypanosomes were counted using a haemocytometer and x40 
objective of a Zeiss microscope.
2*9*2 Procyclic cell form (strain EATRO-427)
These were cultured at 26°C on the very complex 
SDM-79 medium (Brun & Schonenberger, 1979) supplemented 
with 10% (v/v) fetal calf serum. Cultures were initiated 
by adding a volume of an established procyclic culture to
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5 ml of complete SDM-78 medium, so that the final cell 
density was 10^ cells/ml^. Cultures may also be initiated 
using stabilates (procyclic cells in 20% glycerol stored 
in liquid nitrogen). Within 4 days the cultured cells 
reached a density of 1-5 x 107 cells/ml. At this point, 
to prevent exhaustion of available nutrients, cells may 
be diluted into fresh medium or harvested. Cells were 
harvested, by centrifugation (600 x g) for 5 min at room 
temperature and then washed in 100 mM HEPES buffer, 
pH 7*5, containing 25 mM NaHCO^, 50 mM NaCl, 5 mM KH^PO^,
5 mM L-proline, 5 mM KC1 and 5 mM glucose; the cells were 
then stored on ice.
2*10 Induction of physiological dysfunction and 
metabolite measurements 
2*10*1 Induction of diabetic ketoacidosis
Female Wistar rats (150-160 g), following 24 h 
starvation, were used. Diabetes was induced by 
intravenous administration (tail vein), under ether 
anaesthesia, of streptozotocin (150 mg / Kg body weight) 
dissolved in 50 mM sodium citrate buffer, pH 4*2, at 
60 mg/ml. Control and treated animals were fed (C.R.M- 
labsure) ad libitum and given 5% (w/v) glucose in the 
drinking water for the initial 12 h.
2*10*2 Estimation of diabetic condition
24 and 48 h after treatment, animals were 
assessed as to the severity of diabetes by estimation of
- 62 -
urinary glucose and acetoacetate with Clinistix and 
Ketostix strips, respectively. Treated animals that 
failed to give a positive glucose test at 24 h and a 
positive acetoacetate test at 48 h, were removed from the 
experiment.
2*10*3 Insulin controlled diabetes
Commencing 24 h after treatment, diabetic animals 
received subcutaneous administrations of insulin (5 units 
/animal/day) until body weights approached control values. 
Individual animals that failed to increase in body weight 
in a given 24 h period, were given an additional 2 units 
of insulin for that day.
2*10*4 Determination of plasma glucose
Immediately after decapitation, 0*1 ml of whole 
blood was added to 1*5 ml of H^O and deproteinated by the 
addition of 0*2 ml of 0*3 M Ba(OH)^ and 0*2 ml of 5%
(w/v) ZnSO^. Following centrifugation (3000 x g) for 15 
min at 4°C the glucose concentration of the supernatant 
was determined by the method of Asatoor & King (1956).
To 1 ml of the deproteinated sample was added 1 ml' of 
copper reagent (0*6% (w/v) CuSO^.5H^0) and 1 ml of 
Harding's reagent (see Appendix I). The samples were 
thoroughly mixed and boiled for 20 min. After cooling,
1 ml of Nelson’s reagent (see AppendixII) was added 
followed by 6 ml H^O. After mixing, absorbances were 
recorded at 600 nm. A standard glucose curve (0-100 ug)
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was prepared for each determination (see Figure 16). For 
diabetic animals an initial x 20 dilution was required.
2*10*5 Determination of plasma ketone bodies
Immediately after decapitation, 0*5 ml of whole 
blood was deproteinated by addition of 0*5 ml ice-cold 
10% (w/v) perchloric acid. After thorough mixing and 
centrifugation (3000 x g) for 15 min at 4°C, the 
supernatant was collected and its volume recorded. 
Neutralization was quickly achieved by addition of 5 yl 
B .D .H .-universal indicator and slow addition of 4 M K0H 
until the indicator became green/blue (pH7-8). After 
30 min on ice, samples were centrifuged (3000 x g) for 
10 min at 4°C. Supernatant volumes were again recorded 
before enzymic determination of acetoacetate and 
B-hydroxybutyrate by the methods of Williamson &
Mellanby (1974). The acetoacetate assay mixture 
contained: 0*2 mM NADH, 50 mU/ral $-HBDH and 300 yl test 
sample in 50 mM potassium phosphate buffer, pH 6 *8 , in a 
total volume of 1 ml. The decrease in absorbance at 
340 nm was recorded after 10 and 20 min. The
3-hydroxybutyrate assay mixture contained: 0*4 mM NAD+ ,
50 mU/ml 3~HBDH and 300 yl test sample in Tris-HCl/ 
hydrazine buffer, pH 8*5 (see AppendixIIl) . The increase 
in absorbance at 340 nm was recorded at 40 and 60 min. 




Figure 16 (Jlucosp standard curve
0 8-
0 - 6 -
0 - 4-
90 10060 8070502010 40
Ug glucose
- 65 -
2*10*6 Induction of hepatic porphyria
Hepatic porphyria was induced by the drug 
3 , 5-diethoxycarbonyl-l,4-dihydrocollidine (DDC). Female 
mice (strain C.F.L.P.)* each about 30 g and individually 
housed, were given drinking water ad libitum and starved 
for 24 h. Each mouse of the treatment group then 
received 5 g of lab chow (C.R .M .-Labsure) containing 
10 mg DDC, the control group each received only 5 g of 
lab chow. Mice were sacrificed 24 h later and the livers 
were immediately removed. Aliquots (0*5 g) of control 
and treated livers were retained for total liver 
porphyrin determination, while the remainder of the 
livers were pooled into control and treated groups for 
the preparation of mitochondria.
2*10*7 Estimation of total liver porphyrins
Total liver porphyrins were estimated by the 
method of Abbritti & De Matteis (1972). The 0*5 g 
aliquots were homogenized with an Ultra-Turrax tissue 
homogenizer in 5 ml of H^O. 0*5 ml of the homogenate was 
then added to 4*5 ml H^O, followed by 0*5 ml of 10*2 M 
perchloric acid and 5 ml of absolute ethanol. After 
mixing and storage on ice, in the dark, for 15 min the 
mixture was centrifuged (3000 x g) for 15 min at 4°C.
The supernatant was then allowed to warm up to room 
temperature, in the dark. The porphyrin content was 
determined fluorimetrically (excitation X = 400 nm, 
fluorescence X = 550-650 nm) in an Amico-Bowman
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Spectrophotofluorimeter, using an internal mesoporphyrin 
standard. Results are expressed in nmol/g wet liver.
2*11 Preparation of mitochrondria
All procedures were carried out at 4°C, the sucrose 
/Tris extraction buffer contained: 0*25 M sucrose + 1 mM 
EDTA + 0*2 mM EGTA + 0*1% BSA (fatty acid free) in 50 mM 
Tris-HCl buffer, pH 7*5. Tissue : buffer ratio was 1 : 4.
2•11 • 1 Bovine heart mitochondria
Mitochondria were prepared by the method of 
Azzone et al. (1979), with slight modifications. Fresh 
heart tissue was diced into cubes and homogenized (1 g 
tissue : 2 ml extraction buffer) in a Waring blender,
10 s at low power, with ice-cold sucrose/Tris extraction 
buffer. 1 M Tris was used to maintain pH 7*5. A second 
homogenization, 15 s at medium power, was followed by 
centrifugation (1,600 x g) for 15 min. The supernatant 
was filtered through double-cheesecloth and centrifuged 
(20,000 x g) for 30 min at 4°C. The mitochondrial pellet 
was resuspended in sucrose/Tris buffer containing no BSA 
and centrifuged (20,000 x g) for 30 min. The resultant 
pellet was stored on ice.
2*11*2 Mouse liver or rat brain mitochondria
Fresh tissue was washed and diced into ice-cold 
sucrose/Tris extraction buffer. This was then gently 
hand-homogenized using a Potter/Dounce homogenizer with a
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teflon plunger (gap = 0*31 mm) for 5 complete strokes.
The homogenate was then centrifuged (1600 x g) for 
10 min. After filtration through double-cheesecloth, the 
supernatant was centrifuged (30,000 x g) for 30 min. The 
mitochondrial pellet was then gently resuspended in 
sucrose/Tris buffer, containing no BSA, centrifuged 
(30,000 x g) for 30 min and stored on ice.
2*11*3 Locust flight muscle mitochondria
150 adult locusts were dissected and their flight 
muscles placed in 20 ml of sucrose/Tris extraction buffer. 
This was then hand-homogenized using a Potter-Dounce 
homogenizer with a glass plunger (gap = 0*25 mm) for 10 
complete strokes. The homogenate was centrifuged (1000 
x g) for 10 min and then passed through a fine nylon 
filter to remove fat granules, before centrifugation 
(30,000 x g) for 30 min. The small ’halo1 of membrane 
material was removed from the main pellet, which was 
gently suspended in sucrose/Tris buffer, containing no 
BSA and centrifuged (30,000 x g) 30 min and stored on ice.
2*11*4 Zea Maize mitochondria
Etiolated and non-etiolated plant tissue was cut 
into 2 cm sections and suspended in Mannitol extraction 
buffer containing 0*3 M mannitol, 1 mM EDTA, 0*1% (w/v)
BSA (fatty acid free) in 100 mM MOPS buffer, pH 7*5, and 
homogenized with an Ultra-Turrax homogenizer for 3 s on 
ice. The supernatant was squeezed through 4-layers of
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double-cheesecloth and then centrifuged (1600 x g) for 
15 min. The supernatant was centrifuged (30,000 x g) for 
30 min. The resultant mitochondrial pellet was gently 
resuspended in Mannitol/MOPS extraction buffer containing 
no BSA, centrifuged (30,000 x g) for 30 min and stored on 
ice.
2*11*5 Preparation and isolation of intact mitochondria
u s i n g  P e r  c o l  1 (bovine heart)
Percoll was made isotonic by diluting with 2*5 M 
sucrose (9 : 1). Discontinuous gradients were composed 
of 13*5, 28 and 55% (15 ml each) Percoll, carefully 
prepared in thin-walled 50 ml polyallomer (Sorvall) 
centrifugation tubes. The gradients were stored at 4°C 
until required. Crude mitochondrial preparations (20 mg 
protein/centrifugation tube) were gently layered onto the 
gradients, which were then centrifuged (12,000 x g) for
1 h at 4°C. Intact mitochondria were found to band at 
the 28/55% interface. Fractionation was achieved using 
an MSE gradient fractionator. After establishing an air­
tight seal, a hollow.needle was inserted through the 
bottom of the tube and by means of a finely controlled 
air valve slowly fractionated the gradient. Mitochondrial 
integrity was assessed by the latency of citrate synthase 
actively with and without 0*05% Triton X-100 in the assay 
mixture.
2*12 Methods of cellular & mitochondrial disruption
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2 *12-1 French press
Yeast cells at 1 g/ml of 100 mM Tris-HCl + 1 mM 
EDTA buffer, pH 7*5 were disrupted by passage twice 
through a pre-cooled French press cell at a pressure of 
62 MPa (9000 lb/in2)
2*12*2 Ultra sonication
Ultrasonication of bacteria or mitochondria was 
achieved using a MSE 100 W sonicator, with a 5 mm probe, 
operated at 40 W for 6 x 15 s with cooling.
2*12*3 Tissue homogenization
Tissue homogenization was achieved using an 
Ultra-Turrax tissue homogenizer (5 x 15 s bursts 
interspersed with cooling). Ossified tissues, such as 
bone marrow, were homogenized using a Sorvall Omni-mixer 
(4 x 15 s bursts interspersed with cooling, at full 
power ) .
2*12*4 Osmotic lysis
Pelleted mitochondria were gently resuspended in 
ice-cold 20 mM Tris-HCl buffer, pH 7*5, containing 20% 
(v/v) glycerol and incubated for 30 min at 4°C.
2*12*5 Triton X-100
Pelleted mitochondria were resuspended in 20 mM 
Tris-HCl buffer, pH 7*5, containing 0*05% (v/v) Triton 
X-100 and incubated for 10 min at 4°C.
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2*12*6 Toluenization
Yeast cells were made permeable to low molecular 
weight substances by the method of Weitzman (1973).
Cells were washed with 100 mM Tris-HCl buffer, pH 8*0, 
resuspended at 0*1 g cell/ml buffer and prewarmed to 37°C. 
50 yl of toluene/ethanol mixture (1 : 4 (v/v)) was added 
per ml of extract which was then shaken vigorously for 5 
min at 37°C. After cooling on ice, the cells were 
centrifuged (600 x g) for 2 min at 4°C and resuspended in 
fresh 100 ml Tris-HCl buffer, pH 8*0. This washing 
procedure, to remove toluene, was repeated 6 times.
Finally the cells were resuspended at 0*1 g cell/ml 
buffer and stored on ice.
2*13 Centrifugation
Differential centrifugations were performed in a 
Sorvall RC 5B super-speed centrifuge (Du Pont Instruments), 
Beckman L5-50B Ultracentrifuge and Eppendorf microfuge. 
Maximum relative centrifugal force (g max) was calculated 
from r.p.m. values as follows:
RCF = 1*12 x 10" 5 . R . N2
where R = radius (cm) from the centre of 
the rotor shaft to the tip of 
the centrifuge tube 
N = r.p.m.
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2*14 Polyacrylamide gel electrophoresis (PAGE)
2*14*1 Non-denaturins PAGE
Non-denaturing gels (7% (w/v) acrylamide) were 
prepared according to the method of Davis (1964). The 
resolving gel buffer was 0*37 M Tris-HCl, pH 8*9, the 
stacking gel (3% acrylamide); the buffer was 0*12 mM 
Tris-HCl + 0*19 M glycine, pH 8*0. Ammonium persulphate 
was used as the initiator of the aerylamide/bis-acrylamide 
polymerization, with TEMED as the catalyst. Depending 
upon the staining to be employed, 2-20 yg protein 
samples were applied to each gel in 50 yl of reservoir 
buffer containing 10% (w/v) sucrose + 0 *001% (w/v) 
bromophenol blue. The samples were run at 0*5 mA/gel 
until the dye bands had traversed the stacking gel; the 
current was then increased to 2 mA/gel for the remainder 
of the run.
2*14*2 SDS - PAGE
SDS-gels (5% (w/v) acrylamide) used for 
estimation of sub-unit molecular weight, were prepared 
according to the method of Weber & Osborn (1969). The 
reservoir and gel buffer were 0*1 M sodium phosphate 
buffer, pH 6*7, + 0*1% (w/v) SDS. Polymerization was 
achieved using ammonium persulphate and TEMED. 2-20 yg 
protein samples were dissolved in 40 ul of 0*1 M sodium 
phosphate buffer, pH 6*7, 0*1% (w/v) SDS, 10% (v/v) 
glycerol, 0*2 M 2-mercaptoethanol and 0*001% (w/v) 
bromophenol blue, boiled for 2 min and then loaded.
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Samples were run into the gel at 2 mA/gel and then at 
8 mA/gel for the remainder of the run.
2*14*3 Staining of polyacrylamide gels
Samples containing more than 5 yg protein were 
stained with Coomassie Brilliant Blue (CBB). Gels were 
fixed overnight in 50% (v/v) methanol + 10% (v/v) acetic 
acid, followed by staining for 45 min at 37°C in 0*1%
(w/v) CBB + 50% (v/v) methanol + 10% (v/v) acetic acid. 
Gels were then destained in 5% (v/v) methanol + 7*5%
(v/v) acetic acid at 37°C.
Samples containing 1-5 yg protein were stained using 
the silver staining method of Morrisey (1981), all 
procedures being carried out at 37°C. Gels were incubated 
for successive 30 min incubations in 50% (v/v) methanol 
+ 10% (v/v) acetic acid, then 5% (v/v) methanol + 7%
(v/v) acetic acid and finally 10% (v/v) glutaraldehyde.
The gels were then washed overnight in distilled 1^0 
(500 ml/gel). The following day the gels were incubated 
for 30 min in 5 yg/ml DTT. This was then removed (no 
rinsing) and 0 *1% (w/v) AgNo^ added. After 30 min the 
gels were rapidly rinsed with distilled H^O and covered 
with 15 ml of developer (50 yl of 37% (v/v) formaldehyde > 
in 100 ml of 3% ^ 200^). Staining was terminated by 
adding 0*75 ml of 2*3 M citric acid to each gel. The 
gels were washed (x 5) with distilled 1^0 and soaked in 
0*3% Na2C0  ^ for 10 min. Finally the gels were washed in 
distilled water and stored in the dark.
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2*15 Gel chromatography
2*15*1 Preparation and use of Gel f iltrat ion Matrices 
A column (2*5 x 35 cm) of Sephacryl S-200 
(supplied preswollen) was used to determine the 
approximate size of STKs (ie large or small type) from 
animal and bacterial extracts. The column was 
equilibrated in 0*1 M sodium/potassium phosphate, pH 8*0, 
at 4°C (with the inclusion of 20% (v/v) glycerol for the 
bacterial extracts). 50 yl of LDH (0*25 mg) was added 
as a marker to the test sample, to distinguish between 
large and small STKs. Before application, the sample was 
made 10% (w/v) with respect to sucrose, to increase the 
density. 2-ml fractions were then collected.
Sephadex G-10 (swollen for 3 h at room temperature) 
was used for desalting samples and separation of 
succinate from succiny1-CoA.
Prepacked P-10 columns (Sephadex G-25) were also 
used to desalt samples up to 2 ml in volume. Sepharose 
4B, as used in affinity and dye chromatography, was 
supplied preswollen.
2*15*2 Hydroxylapatite Columns —
Hydroxylapatite (Bio-Rad HTP) was reauspended 
(1 : 6 v/v) in 10 mM sodium/potassium phosphate buffer, 
pH 7*5. The matrix was repeatedly resuspended and fined. 
Columns were poured and allowed to settle under gravity. 
The loading capacity was 5 mg protein/ml bed volume, with 
a maximum flow rate of 12 ml/h. Elution was achieved by
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a linear phosphate gradient. The void volume was
calculated to be - 70% of the bed volume.
2*15*3 Affinity chromatography 
2*15*3*1 CNBr activation of Sepharose 4B
This was achieved by the method of Marsh et al. 
(1974). To a slurry of Sepharose 4B (4 ml of packed gel
+ 4 ml H^O) was added 8 ml of 2 M Na2C0  ^ and the mixture
slowly stirred. The stirring rate was increased and 
1 ml CNBr/acetonitrile solution (0*8 g CNBr/ml) was 
added dropwise. After 2 min vigorous stirring the slurry 
was washed on a coarse sintered-glass filter with 50 ml 
of 0*1 M Na2C0  ^ pH 9*5, followed by 50 ml of H2O.
2*15*3*2 Preparation of a dial-2 *t3 f-nucleoside 
diphosphate affinity column 
This was achieved by the method of Ball & Nishimura 
(1980). 16 ml of packed CNBr-Sepharose 4B were washed
with 1 1 of 1 mM HC1. A spacer arm (C8 ) was then 
covalently attached by stirring the gel very gently with 
17*5 ml of 0*1 M Na2C0^» pH 9*5, containing 1*57 g of 
adipic acid overnight at 4°C. The following day the 
nucleoside diphosphate (ADP, GDP or IDP) was peroxidated 
by adding 2*5 ml of NDP (10 mg/ml) to 2*5 ml of sodium 
meta periodate (4*3 mg/ml) and stirring for 1 h in the 
dark at 4°C. The adipic acid-linked Sepharose 4B was 
washed with 1 1 of water and 1 1 of 0*2 M NaCl and then 
stored in 10 ml of 0*1 M sodium acetate, pH 5*0, at 4°C.
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5 ml of the NDP/periodate mixture were then added to the 
gel, followed by 25 ml of 0*1 M sodium acetate, pH 5*0, 
and stirred gently for 3 h at 4°C. 75 ml of 2 M NaCl
were then added to the mixture which, after a further 
30 min, was washed with 1 1 of water, and stored at 4°C. 
For best results the gel was used within 2 days of 
synthesis.
2*15*4 Preparation of triazine dye columns
6 ml columns were prepared from 15 supplied 
triazine dyes:
1. Red MX-50 2. Red HE-3B 3. Ramazol Red
4. Red R3BN 5. Scarlet MXG 6 . Brown H2G
7. Brown MX-5BR 8 . Blue MX-3G 9. Blue HE-RD
10. Blue PGR 11. Turquoise H-A 12. Turquoise H-7G
13. Green HE4BD 14. Yellow MX G8 15. Orange MX 2R. 
All coupling procedures were carried out at room 
temperature. To 6 ml aliquot of Sepharose 4B (thick 
slurry) were added 17*5 ml of water followed by 60 mg of 
dye dissolved in 5 ml of water. The mixtures were 
stirred for 10 min before the addition of 2*5 ml of 20% 
(w/v) NaCl, and then stirred for 30 min. 0*31 ml of 5 M 
NaOH was then added and the mixtures stirred gently for 
3-4 days. The gels were then washed, to remove unbound 
dye, with successive 50 ml-washes of water, 1 M NaCl and 
6 M urea. The gels were then stored at 4°C in 20 mM 
Tris-HCl + 2 mM M g C ^  buffer, pH 7*2 containing 0*01% 
sodium azide until required.
- 76 -
2*15*5 Fast Protein Liquid Chromatography (FPLC)
The Pharmacia FPLC system was used. The system 
comprised a GP-250 gradient programmer, two P-500 pumps, 
gradient mixer, V-7 valve, single path UV-1 monitor and 
control unit, Frac-100 fraction collector and chart 
recorder. Samples (up to 10 ml) were loaded through a 
superloop onto a Mono Q (anion exchanger) column which 
had previously been equilibrated with 10 column volumes 
of 20 mM Tris-HCl + 2 mM MgCl^ buffer, pH 7*5. The 
column was eluted with a KC1 gradient and protein was 
monitored at 280 nm with a UV source connected to a 
microprocessor-controlled fraction collector. Absorbance 
sensitivities of 0*2-2*0 were used. Figure 17 shows the 
FPLC gradient programme used in the purification of 
pigeon A-STK. The FPLC system was also used with a 
Superose-12 (gel filtration) column for estimation of Mr. 
The column was equilibrated with 0*1 M Tris-HCl buffer, 
pH 8*0, containing 20% (v/v) glycerol and was run at 0*3 
ml/min.
2*16 Ul trafiltr ation .
The concentration of column fractions was achieved 
by using an Amicon Ultrafiltration cell (50 ml) (Amicon 
Corporation, U.S.A.) operated at 64 psi with oxygen-free 
nitrogen. The procedure was carried out at 4°C with a 
P10 membrane (mwt cutoff 10,000).
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Figure 17 FPLC Programme method
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CHAPTER 3 
EUKARYOTIC SUCCINATE THIOKINASES
3 * 1 STK activities from mammalian & non-mammalian sources 
The eukaryotic STK enzyme that has received most 
attention is the pig heart enzyme. Originally, when the 
succinate thiokinase reaction was first proposed and 
identified in pig heart extracts (Kaufman, 1951), the 
enzyme was considered to be linked to adenine nucleotides. 
However, it was later reported (Sanadi et al . , 1956) that
after removal of nucleoside diphosphokinase activity, pig 
heart STK showed strict specificity for guanine and 
inosine nucleotides (G-STK). These, and>similar findings 
of other guanine-linked animal STKs, led to the view that 
all animal STKs were guanine nucleotide-specific enzymes 
(Bridger, 1974), a situation generally presented in most 
biochemistry textbooks. Some years ago, however, an 
adenine nucleotide-linked enzyme (A-STK) was reported to 
occur in blowfly flight muscle (Hansford, 1973) and, more 
recently, A-STK activities have been found in a wide range 
of animals (McClellan & Ottaway, 1980), though not in 
mammalian tissues. Interestingly, Steiner & Smith (1981) 
presented immunological evidence for the existence of an 
A-STK in rat brain mitochondria. Antibody raised to pig 
heart G-STK was shown to cross-react with a brain G-STK 
and what appeared to be a brain A-STK. However, no enzyme 
activities were demonstrated and the authors were unable
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positively to identify the ATP-dependent phosphorylation 
they observed as due to autophosphorylation of an A-STK 
rather than an endogenous protein kinase.
Recently, work in Professor P.D.J. Weitzman’s 
laboratory has shown that considerable variation occurs 
in the nucleotide specificity of a wide range of bacteria 
(Weitzman & Jaskowska-Hodges, 1982). Each organism 
appears to follow a taxonomic pattern in the nucleotide 
specificity of its STK. In the light of these results, 
and those previously mentioned, it seemed pertinent to 
re-examine carefully the nucleotide specificity of animal 
STKs (mammalian & non-mammalian) for the possible 
occurence of both G-STK and A-STK enzymes.
Rat tissues were homogenized with an Ultra-Turrax 
homogenizer as described. The resultant supernatants were 
used to assay for both guanine & adenine nucleotide-linked 
STK activities. The results in Table 2 indicated the 
existence of both G-STK and A-STK in rat tissues. 
Significantly, the ratio of G-STK to A-STK activities 
varied between tissues. A spectrum of ratios was found, 
G-STK being the predominant enzyme in kidney and liver, 
more nearly matching the A-STK in heart, and being 
exceeded by A-STK activity in brain and skeletal muscle.
It is difficult to reconcile the approximate 10-fold 
change in the G-STK/A-STK ratio with the presence of a 
single STK enzyme of ’loose* specificity; one would have 
to postulate that the ’looseness’ of specificity itself 
varied between tissues. A simpler explanation is that
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Table 2 STK activities in extracts of various 
rat tissues
Tissue G-STK A-STK Ratio
activity G-STK/A-STK
(nmol.min  ^. mg ^)
kidney 6*9 2*0 3*5
liver 4*5 1*5 3*0
heart 3*6 2*5 1*4
brain 0*95 1*5 0*63
skeletal
muscle 0*42 1*1 0*38
Tissues from 5 animals were pooled, homogenized (Ultra- 
Turrax) in 0*1 M sodium/potassium phosphate buffer, 
containing 1 mM EDTA, pH 8*0 and centrifuged (30,000 x g 
for 30 min at 4°C). Supernatants were then used without 
further treatment.
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there are two, nucleotide-specific, STKs whose relative 
proportions differ between tissues. Interestingly, from 
Table 2, it is apparent that it is the G-STK which varies 
considerably in specific activity, whereas A-STK remains 
fairly constant throughout the tissues. McClellan & 
Ottaway (1980), who reported A-STK and G-STK in a number 
of non-mammalian animal tissues, also observed divergence 
in the G-STK/A-STK ratios and commented that this may be 
an indication of the presence of two enzymes, but no 
further experimental evidence was presented.
Subsequent studies on STK activities from other 
mammalian sources (Table 3) also indicated the presence 
of both G-STK and A-STK activities. It is conceivable 
'that the apparent A-STK activity, in Tables 2 & 3, was due 
to a guanine nucleotide-specific STK coupled to the 
activity of nucleotide diphosphokinase (NDPK) and the 
presence of sufficient substrate (i.e. GTP). However, the 
apparent A-STK activity could only equal and never exceed 
the tissue's G-STK activity. Therefore, the fact that 
A-STK is the major activity in brain and skeletal muscle 
excludes the possibility that A-STK results from the 
action of NDPK.
G-STK and A-STK activities were also observed in 
other animal tissues (Table 4). Two mammalian cell lines 
contained both activities and in the case of the Baby 
hamster kidney cell line (BHK) the ratios of G-STK / A-STK 
was similar to that found in kidney tissue extracts. For























Extracts were prepared as in Table 2, page 80.
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Table 4 STK activities from various animal sources
Sample G-STK A-STK Ratio
activity G-.STK/A-STK
(nmol.min  ^.mg ^)
Cell lines
BHK 2*0 0*8 2-5
(Baby hamster kidney)
L1210 1-6 1-6 1-0
(mouse lymphoma)
animal tissues
pigeon breast muscle 0*7 13*0 0*05
(40-60%(NH4 )2S04
locust thorax 1*2 5*6 0*21
Cultured cells were disrupted by U1trasonication and 
centrifuged (30,000 x g for 30 min at 4°C). Tissue 
extracts were prepared as in Table 2, page 80.
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the first time G-STK activity was detected in pigeon
breast muscle and locust thorax. Previously, both were
thought to contain only A-STK activity (McClellan &
Ottaway, 1980). The G-STK activity from pigeon breast
muscle could not be detected in crude extracts and was
only measurable in the 40-60% (NH,)_S0. cut.
4 I 4
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3•2 Evidence for distinct G-STK & A-STK enzymes 
3*2*1 Additivity of STK activities
Apart from observing a wide variation in the 
G-STK/A-STK ratio in tissues (Tables 2 & 3), another 
indication for the existence of two distinct enzymes, as 
opposed to a single STK with broad specificity, is 
provided by a comparison of the activities measured in 
the presence of ADP and GDP singly with that measured in 
their joint presence. A single enzyme saturated with the 
’preferred’ nucleotide would not show increased activity 
on addition of the second nucleotide. On the other hand, 
if two enzymes were present, saturation of one of them 
with its specific nucleotide should still permit the 
other enzyme to display activity on the addition of the 
other nucleotide; hence some additivity of activities 
should be observed. McClellan & Ottaway (1980) used 
additivity of the activities of STK with GTP and ATP, as 
a criterion for genuine utilization of both nucleotides 
(rather than an artefactual display of A-STK activity due 
to NDPK activity), though not for the existence of 
distinct STKs. Table 5 displays results that indicate 
additivity of A-STK and G-STK enzymes in extracts from 
porcine brain and bovine heart tissue, as well as 
mitochondrial extracts from locust flight muscle and 
bovine heart. The additivities observed were not strictly 
the sum of the two activities, but partial additivities 
(typically between 80-90%) were seen. A possible 
explanation for partial additivity is that, although each
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Table 5 Additivity of STK activities for animal extracts




(tissue extract) 98-2 49* 1 120 81*5
locust flight muscle 
(mitochondrial 
extract) 553 166 617 85*8
bovine heart
(tissue extract) 51 68 • 9 103 85*9
(mitochondrial 
extract) 330 736 920 86*3
Mitochondrial extracts were prepared by Ultrasonication 
and centrifugation (30,000 x g for 30 min at 4°C). 
Tissue extracts were prepared as in Table 2 , page 80.
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STK may be specific for one nucleotide as substrate, the 
other nucleotide may be able to act as a competitive 
inhibitor.
3*2*2 Thermal inactivation of STK activities
Additional evidence for two STKs was obtained from
thermal inactivation studies. In rat heart extracts, and
to a lesser extent in pig heart extracts, A-STK was shown
to be more rapidly inactivated at 48°C, than G-STK (Figs.
18 & 19). Further stability studies were carried out on
STK activities from bovine heart mitochondria. The
mitochondria were resuspended i n !20 mM Tris-HCl buffer,
pH 7*5, containing 1 mM EDTA, sonicated and centrifuged
(30,000 x g) for 30 min at 4°C. The .supernatants were
>
assayed for STK activities and then stored for 24 h at 
4°C. G-STK only lost 4-5% over the 24 h period, whereas 
A-STK lost between 50-60% activity.
3*2*3 Separation of G-STK and A-STK enzymes
Conclusive evidence for distinct enzymes was 
obtained by separation of the two activities using 
affinity chromatography. This was carried out using 
derivatized GDP immobilized on Sepharose 4B, as described 
in Methods section 2*15*3*2. The separation of G-STK and 
A-STK activities was achieved with bovine heart mitochond­
rial extracts and locust flight muscle mitochondrial 
extracts (see Figs. 20 & 21). After loading with mito­
chondrial extract ( 0*5 ml) the column, equilibrated with 







Extracts were prepared as in Table 2, page 80. 2*7 ml of 0*1 M sodium/
potassium phosphate buffer, containing 1 mM EDTA, pH 8*0 was 
equilibrated at A8 °C. At zero time, 0*3 ml of tissue extract was added 
and aliquotes (0*3 ml) were removed at various time intervals and assayed






































































Figure 20 Separation of G-STK and A-STK activities from bovine heart
mitochondria, on a 2 1 ,3 *-dialdehyde-GDP affinity column, at 4°C
(15 x 150 mm)
















Figure 21 Separation of G-STK and A-STK activities from locust flight muscle
mitochondria, on a 2 1 ,31-dialdehyde GDP affinity column, at 4°C
(15 x 160 mm)
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equilibrating buffer and 1-ml fractions were collected. 
When the protein content of the eluted fractions had 
fallen to zero, the elution buffer was changed to 20 mM 
sodium/potassium phosphate buffer, pH 7*5, containing 
2 mM GDP + 2 mM MgCl^. Removal of GDP from the subsequent 
fractions, apparently containing STK activities, was 
achieved by gel filtration on a prepacked PD-10 column. 
Significantly, neither of the separated enzymes showed 
any activity whatsoever for the other nucleotide.
Table 6 shows that, in the case of the separated STKs 
from bovine heart, the non-substrate nucleotide acts as 
an inhibitor of the ’other' activity; this inhibition 
therefore supports the explanation given above for partial 
additivity in Table 5, when activity measurements were 
made in the joint presence of both nucleotides.
The Ki of the bovine heart mitochondrial G-STK for 
ADP was determined from a secondary replot of the slopes 
of Lineweaver-Burk plots for various ADP concentrations.
A Ki value of 233 yM ADP was obtained, this displayed a 





Specificity of separated bovine heart STKs, 
and inhibition by the non-substrate nucleotide











Fig. 22a Lineweaver-Burk plot:
ADP inhibitor concentrations; 
O- zero, •- 100 UM,
□ - 200 yM, ■- 300 yM.
Fig. 22b The intercept on the
abscissa gives a Ki value
of 233 yM ADP for the G-STK
enzyme from bovine heart mitochondria
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Figure 22a Linweaver-Burk plot: V versus [GDP]
for G-STK from bovine heart mitochondria with
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Figure 22b Determination of Ki for ADP of G-STK,








3•3 Characterization of animal STKs 
3*3*1 Molecular size
The mammalian G-STK is known to be an aft dimer of 
molecular weight around 75,000 (Bridger, 1974). A 
comparison of the G-STK and newly identified A-STK from 
mammalian tissues was therefore sought. This was achieved 
with a simple gel filtration procedure, similar to that 
used by Weitzman & Kinghorn (1978). As described in 
section 1*3, the latter authors examined a range of 
prokaryotic and eukaryotic sources. LDH (Mr - 140,000) 
acted as the marker enzyme, with STKs eluting from the 
Sephadex G-200 column before LDH termed ’large’ (Mr>
140.000) and those eluting after LDH termed ’small* (Mr<
140.000). They clearly showed that Gram-negative bacteria 
possessed ’large’ STKs, similar to the E . coli STK (an
tetramer)» while Gram-positive bacteria and 
eukaryotic STKs were ’small', similar to the pig heart 
G-STK (an aB dimer). Fig. 23 shows the gel filtration of 
rat heart STK activities. Both G-STK and A-STK display 
very similar elution profiles in respect to their elution 
after LDH, thus indicating their ’small’, possibly dimeric, 
character. Further studies, on bovine heart mitochondrial 
G-STK and A-STK, using a calibrated FPLC Superose-12 
column, yielded an approximate Mr value of 81,000 for both 
enzymes.
3*3*2 Nucleotide dependence










Figure 23 Gel filtration of rat heart STKs on a
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well established (Nishimura & Grinnell, 1972). It was 
therefore interesting to compare the NDP and succinyl-CoA 
dependences of both G-STK and A-STK from the same source. 
Figs. 24, 25 & 26 present Hanes-Woolf plots (S/V versus S) 
of GDP, ADP and IDP, respectively, for the STKs from 
bovine heart mitochondrial extracts. Figs. 27 & 28 show 
similar plots for succinyl-CoA dependence. Similar 
studies were undertaken on the dependence of the STKs of 
locust flight muscle on ADP & GDP (Figs. 29 & 30). All 
apparent Km & Vmax values i.S.D. were calculated using a 





















Figure 24 Hanes-Woolf plot: [GDP]/V versus [GDP] for G-STK
from bovine heart mitochondria
Km


























Figure 25 Hanes-Woolf plot: [IDP]/V versus [IDP] for G-STK





Figure 26 Hanes-Woolf plot: [ADP]/V versus [ADP] for A-STK 
from bovine heart mitochondria 
Km = 57 ± 7 yM
Vmax = 0*19 ± 0*03 jjjnol.ml .min
500300
Figure 27 Hanes-Woolf plot: [succinyl-CoA]/V versus [succiny1-CoA ] for
G-STK from bovine heart
Km = 68*5 ± 20 uM
i

































Figure 28 Hanes-Woolf plot: [succinyl-CoA]V versus [succiny1-CoA ] for
A-STK from bovine heart mitochondria
Km = 48*2 ± 14 yM




























Figure 29 Hanes-Woolf plot: [ADP]/V versus [ADP] for A-STK
8-5 from locust flight muscle mitochondria
Km




F igure 30 Hanes-Woolf plot: [GDP1/V versus fGDP ] for G-STK
from locust flight muscle mitochondria 
Km = 32*8 ± 8 uM
0*36 ± 0*04 umol.mlVmax . m m
100 500300
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3•4 STK activities in unicellular eukaryotes
Initially, when Saccharomyces cerevisiae (baker’s 
yeast) was examined for STK activity, only A-STK activity 
could be detected. This result appeared to confirm 
earlier findings by other investigators (Heerde & Radler, 
1978; Schwartz et al.* 1983). However, prompted by the 
results from the mammalian and other animal tissues, 
permeabilization of yeast cells, instead of the convent­
ional cellular disruption (French press) was carried out. 
Permeabilization with toluene, of cell or organelle 
membranes, was first developed by Bridgeland and Jones 
(1965) and later by Serrano & co-workers (Serrano et al .» 
1973). It enables small molecular weight substances 
(e.g. substrates and products) to diffuse freely into and 
out of the cell or organelle. This technique, unlike the 
French press which leads to massive dilution of cell 
constituents, appears to maintain enzymes at their 
physiological concentrations and probably does not cause 
extensive disruption of intra-cellular protein-protein 
interactions. It was previously demonstrated that such 
in situ examinations of enzyme activity in yeast is 
possible by toluenization (Weitzman & Hewson, 1973).
Table 7 presents the results of examining STK activities 
from S . cerevisiae processed by French press or by 
toluenization. The activities are expressed in 
umol.ml ^.min ^.gcell  ^ to enable direct comparison of 
both procedures. Only A-STK activity was detectable in
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French press extracts, whereas both A-STK and G-STK were 
detected in toluenized cells. It appeared that 
permeabilization of yeast cells allowed detection for the 
first time of G-STK activity. It is worth noting that 
A-STK in permeabilized cells displayed a higher activity 
compared with that of the French press extract. Also 
included in Table 7 are the STK activities found in the 
eukaryotic parasite Trypanosoma brucei.
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Table 7 STK activities in unicellular eukaryotes
Organism + ADP + GDP + IDP Ratio
activity G-STK/A-STK





51-4 0 0 —
Toluenized
cells
86-0 7*6 7*0 0-09
Trypanosoma + ADP + GDP Ratio
brucei activity G-STK/A-STK
(nmol.min ^.mg ^)




3 * 5 STK activities from zea maize
For many years it was assumed that £-aminolaevulinic 
acid, required for chlorophyll biosynthesis, originated 
from succinyl-CoA. This lead to the prediction that 
either large amounts of mitochondrial succinyl-CoA would
have to be transferred to plastids in greening tissues or
\
that plastids contained their own STK activity (Kirk, 
1970). The location of STK in photosynthesizing plants 
was therefore of much interest. Successive attempts, 
however, failed to find any plastidic STK activity (Fluhr 
& Harel, 1975). The low levels of apparently chloro-p 
plastic STK activities were shown to be entirely due to 
mitochondrial contamination (Kirk & Pyliotis, 1970).
Beale & Castelfranco (1973) demonstrated that '>
glutamate (C5), rather than succinyl-CoA (C4), was the 
precursor of chlorophyll. This result removed the 
necessity for transfer of mitochondrial succinyl-CoA, or 
a plastidic STK activity.
The discovery of A-STK & G-STK enzymes in other 
eukaryotic systems prompted a re-examination of STK 
activities in plant tissues. Table 8 presents the 
activities of a chloroplastic marker enzyme NADP- 
phosphoglycerate dehydrogenase (PGADH), together with 
citrate synthase and STK activities, in etiolated and non­
etiolated chloroplasts and mitochondria from zea maize.
The first interesting result was that both A-STK and G-STK 
activities were detected in mitochondria. Citrate 
synthase and A-STK activities were also found in
-  1 1 0  -
Table 8 Enzyme activities from zea maize chloroplast 
& mitochondrial preparations (etiolated & 
non-e tiolated)




NADP-PGADH 98*6 0 2^-6 0
citrate
synthase 0 70*6 2*4 10*5
A-STK 0 12-4 4*7 l 7*5
G-STK 0 1-5 0 0
After extraction, chloroplasts or etioplasts were 
separated from mitochondria'by rapid centrifugation 
(8,000 x g for 10 s at 4°C). Mitochondria were pelleted 
at 30,000 x g for 30 min at 4°C.
-  I l l  -
etioplasts, but not in chloroplasts. The finding of both 
STK activities in plant mitochondria, mirrors the results 
obtained with other eukaryotic systems. The fact that no 
STK activity could be found in chloroplasts, complements 
previous studies and is consistent with glutamate, not 
succiny1-CoA, acting as the chlorophyll precursor. The 
surprising finding of citrate synthase and A-STK activity 
in etioplasts is less easily explained. If it is due to 
contamination with mitochondria, then similar contamination 
would be expected to occur in the chloroplastic fraction. 
In fact, etioplast contamination of mitochondria would be 
far more likely to occur because etioplasts are known to 
be considerably smaller than chloroplasts (Kirk & Tilney- 
Bassett, 1978). The metabolism>of the etioplast is not 
well established and it may be that during etioplast 
development, respiration is occurring within it.
-  1 1 2  -
3•6 Purification of pig liver G-STK and pigeon breast
muscle A-STK
G-STK enzymes have previously been purified from 
mammalian heart & liver tissues (Cha & Parks, 1964; Ball 
& Nishimura, 1980), but no A-STK enzyme has been purified 
from any animal source since Hansford (1973) first 
identified an A-STK in blowfly flight muscle. After our 
discovery of distinct STKs in animal tissues, each 
possessing strict nucleotide specificity, it became 
apparent that purification of these enzymes from a single 
source may yiej-d information concerning subunit function. 
The purified enzymes would be dissociated into their 
respective a and 8 subunits and an attempt would be made 
to construct catalytically active hybrid (aB) molecules, 
by recombination of heterologous a and 3 subunits. The 
procedure of dissociation and recombination of modified 
subunits of the E.coli tetrameric ((*282) enzyme has 
already successfully been demonstrated (Pearson & Bridger, 
1975a). Such a procedure applied to the eukaryotic system 
may determine the subunit governing nucleotide recognition. 
It is possible that one subunit is conserved between the 
two dimeric enzymes, e.g. the 8 subunit may be common to 
both STKs, as it appears to possess the succinate and CoA 
binding sites, whereas the a subunit, which is 
phosphorylated during catalysis, may vary, contributing 
the strict nucleotide specificity of each STK. Before the 
purification of G-STK and A-STK enzymes from the same 
source was undertaken, it was proposed that purification
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procedures should be established using convenient sources 
of, each enzyme. Pig liver (G-STK) and pigeon breast 
muscle (A-STK) were chosen as rich sources of each enzyme.
3*6*1 Purification procedures for both enzymes
Both purifications followed similar procedures up
\
to, and including, affinity chromatography (Tables 9 &
10). All procedures were carried out at 4°C, except for 
the affinity and fast protein liquid chromatographic 
steps which were done at room temperature.
Each tissue was homogenized with a Waring blender in 
extraction buffer (0*1 M sodium/potassium phosphate 
buffer, pH 7*5, containing 1 mM EDTA, 0*1 mM EGTA and 
25 mM ascorbate). After centrifugation (30,000 x g for 
30 min), (^H^^SO^ fractionation of the supernatants and 
dialysis (2 x 2 h against 2 1 of 10 mM sodium/potassium 
phosphate buffer, pH 7*5, containing 1 mM EDTA, 25 mM 
ascorbate and 0*5% (v/v) glycerol) the samples were 
loaded onto hydroxylapatite columns-, equilibrated with 
30 mM Tris-acetate buffer, pH 8*0, containing 1 mM EDTA,
25 mM ascorbate and 0*5% (v/v) glycerol. After washing 
with one column volume of the Tris-acetate buffer, linear 
phosphate gradients were established (10 mM-350 mM 
potassium phosphate buffer, pH 7*5, containing 1 mM EDTA, 
25 mM ascorbate and 0*5% (v/v) glycerol) and ^  3 ml 
fractions were collected overnight. Pig liver G-STK was 
eluted at ~  250 mM phosphate, whereas pigeon breast A-STK 
was eluted at ~ 200 mM phosphate. Fractions with the
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Table 9 Purification of pig liver G-STK
Sample Volume Total Total activity Specific Purification Yiel
(ml) protein (ymol.ml *.min *) activity (-fold) (%)
(mg) (ymol.min ^mg )^
Crude 192 8830 117*8 0*01 - 100
(NH4) 2S° 4 
40-55% 30 1690 38*2 0*023 1*77 32
hydroxylapatite 
column 25 105 32*9 0*38 29*0 28
dial-GDP affinity 
column 2 0*95 7*9 8*32 639 6*7
0-40 % (NH4 )S04 = 0*243 g/ml at 4°C
40-60% " = 0 • C97 g/ml at 4°C.
FI ow rate of hydroxylapatite and affinity columns = 12 ml h
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Table 10 Purification of pigeon breast A-STK
Sample Volume Total Total activity Specific Purification Yieli
(ml) protein (ymol.ml 1.min_1) activity (-fold) (%)
(mg) (ymol.min ^.mg )^
Crude 210 7350 20*6 0*0028 100
(nh4)2so4
40-60% 13*5 945 12*5 0*0132 4*7 60*7
hydroxylapatite
column 8*5 59*5 6*8 0*114 40*7 33
dial-ADP affinity
column 2 4*6 4*2 0*913 326 20*4
FPLC
(monoQ) 2 1*2 2*2 1*833 655 10*6
0-40 % (NH.)oS0, = 0*243 g/ml at 4°C 
4 2 4
40-60 % " = 0*132 g/ml at 4°C
Flow rate of hydroxylapatite and affinity columns = 12 ml h 
Flow rate of FPLC column = 1 ml min
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highest specific activity were pooled and concentrated 
using an Amicon ultrafiltration concentrator and 
subsequently stored at -80°C overnight. Concentrated 
fractions were desalted using prepacked PD-10 columns into 
25 mM Tris-HCl buffer, pH 7*5, containing 2 mM MgCl^ and 
25 mM ascorbate. Pig liver and pigeon breast samples were 
loaded onto their respective dial 3 ' , 5 T-NDP-adipic acid 
hydrazide Sepharose 4B columns, which were then washed 
until no more protein was eluted. The STKs were then 
eluted with their nucleotide buffer - 20 mM sodium/ 
potassium phosphate buffer, pH 7*5, containing 2 mM MgCl^ 
and 2 mM GDP or ADP. Fractions apparently containing STK 
activity were then desalted on PD-10 columns to remove 
the nucleotide buffer. The pigeon A-STK was then loaded, 
in 20 mM Tris-HCl buffer, pH 7*5, containing 2 mM MgCl^, 
onto a FPLC Mono Q column (see section 2*15*6) and eluted 
with a 0-200 mM KC1 gradient (Fig. 17). All attempts to 
bind pig G-STK to Mono Q (anion exchanger) or Mono S 
(cation exchanger) proved unsuccessful, with no increase 
in specific activity.
Both enzymes were shown to be electrophoretically 
homogeneous by polyacrylamide gel electrophoresis (PAGE!) 
under non-denaturing conditions, with silver or Coomassie 
brilliant blue staining. Subunit molecular weight 
determinations were achieved on SDS-PAGE gels using 
standard molecular weight proteins. Pigeon breast A-STK 
gave subunit Mr of 33,150 (a subunit) and 45,000 (8 sub­
unit) (Figs. 31 & 32), while pig liver G-STK gave Mr of
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Figure 31 Photographs of native and SDS-PAGE of 
purified pigeon breast A-STK










45 ,5 0 0 ( 6 ) 
0 3 ^ 5 0  ( c t )
5 yg purified pigeon Track 1 - standard Mr subunits
breast A-STK loaded; (10 yg each);
protein was detected by Track 2 - purified pigeon
silver staining. breast A-STK (15 yg);
protein was detected by 
Coomassie brilliant blue 
staining.
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Figure 32
Standard Mr subunits: (A), hen egg - Ovotransferrin
(Mr 78,000); (B)f bovine serum
- Albumin (Mr 66,250); (C)fJien egg
- Ovalbumin (Mr 45,000);;
(D), bovine erythrocyte - Carbonic 
anhydrase (Mr 30,000); (E), equine
- Myoglobin (Mr 17,200) and (F), 
equine - Cytochrome c (Mr 12,300). 
Pigeon breast muscle A-STK 
dissociated in SDS to yield an 
a-subunit (Mr 33,150) and a 8 
subunit (Mr 45,500).
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Figure 32 SDS-polyacrylamide gel electrophoresis
of pigeon breast muscle A-STK, with 
standard Mr proteins, at pH 8*9 - 
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34,100 (ot subunit) and 46,300 (3 subunit) (data not shown). 
Brownie & Bridger (1972) have already characterized an 
animal G-STK (pig heart) and shown it to be a dimer with 
an a subunit (Mr = 34,500) and 3 subunit (Mr = 42,500).
Ball & Nishimura (1980) obtained very similar subunit 
molecular weights for rat liver G-STK (Mr a = 33,500 & Mr 
3 = 46,500). Confirmation of the dimeric nature of both 
the pig liver G-STK and pigeon breast A-STK, was obtained 
by using a calibrated FPLC Superose-12 column (Fig. 33).
During the establishment of a purification procedure 
for pigeon breast A-STK, Allan & Ottaway (1986) published 
information concerning a partially purified A-STK fraction
from pigeon breast muscle. They obtained a native enzyme
>
molecular weight of -v 100,000 by gel filtration and sub­
unit molecular weights of ~  40,000 (a) and ~  48,000 (3) 
by SDS-PAGE. These values are slightly higher than those 
obtained from Figs. 32 & 33 for the purified pigeon 
breast A-STK, and from the other animal STKs so far 
investigated.
3*6*2 Characterization of pigeon breast A-STK
As mentioned above, Allen & Ottaway (1986) recently 
published molecular and kinetic information on partially 
purified pigeon breast A-STK. They obtained a Km for CoA 
of approx. 20 viM, which is comparable with the value 
reported for pig heart G-STK (Cha, 1969). However, from 
a Lineweaver-Burk plot, they obtained a Km for ATP of 0*8 





Kd = (Ve - Vx)/(Vy - Vx)
where Ve = elution vol. of protein 
Vx = exclusion vol. of Blue
Dextran 2000 (Mr ^  3 x 10^) 
Vy = elution vol. of dnp- 
lysine (Mr = 367) 
Exclusion vol. = 6*0 ml 
Inclusion vol. = 29*8 ml
(G), bovine liver - catalase (Mr 240,000);
(H), rabbit muscle - aldolase
(Mr 158,000); (I)f bovine serum - 
albumin (Mr 68,000); (J), bovine
pancreas - chymotrypsinogen (Mr 25,000); 
(K), equine heart - cytochrome c 
(Mr 12,500).
1 - Pig liver G-STK Mr 85,100
2 - Pigeon breast A-STK Mr 79,400
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Figure 33 ' FPLC gel filtration (Superose-12 column)
Mr determination of purified pig liver G-STK
and pigeon breast A-STK enzymes
5 0 -
4 5 -
4 0 0*50 40 30 2
Standard Mr proteins (0*5 mg each) loaded in 
200 ul on to column equilibrated with 0*1 M 
Tris-HCl + 20% glycerol buffer, pH 8*0. 200 yl 
fractions collected. Flow rate = 0*3 ml/min.
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intercept on the abscissa yields a Km value of - 1*6 mM! 
In contrast, Km values for GTP from mammalian G-STK 
enzymes are of the order of 10-30 pM (Cha, 1969; Ball & 
Nishimura, 1980). Hansford (1973), in studies of A-STK 
from blowfly flight muscle, obtained Km values of 0*29 mM 
for both ATP and ADP. The present studies on the 
purified pigeon breast A-STK yielded a Km value of 
155 ± 28 pM for ADP (Fig. 34), which is similar to the 
results of Hansford (1973). However, these Km values for 
ADF with the pigeon breast and blowfly A-STKs are 
substantially higher than those for bovine heart and 
locust flight muscle A-STKs. Here, Km values for ADP are 
of the order of 20-40 pM, more nearly matching the Km 
values for guanine nucleotides with the animal G-STKs.
Although Allen & Ottaway (1986) could not detect 
G-STK activity in pigeon breast muscle, the present study 
consistently detected G-STK activity in the (NH^)^SO^ 
40-60% fractions during the purification of A-STK (Table 
4). Purification of a G-STK from pigeon breast muscle 
has been reported (Meshkova & Matveeva, 1970). However, 
such a discrepancy has been commented upon (Allen & 




















Figure 34 Hanes-Woolf nlot: TADPl/v versus fAD P 1 for A-STK from piSeon breast muscle
Km






3•7 Preliminary purification of A-STK and G-STK from
a single source
From examining a wide range of animal tissues it 
became apparent that the best source of both STKs was 
bovine heart. Unfortunately, initial purification 
attempts using the procedures previously described were 
unsuccessful, especially in the case of A-STK, which 
displayed instability. Attempts to stabilize the enzyme 
over the 3-4 day procedure with protease inhibitors, 
glycerol and reducing agents were only partially 
successful. It was therefore concluded that an additional 
rapid separation procedure was required. Dye-ligand 
Chromatography was chosen as a possible further 
purification step.
Dye-ligand chromatography developed after it was 
noticed that occasionally, during gel filtration, certain 
proteins co-eluted with the void volume marker dextran 
blue (a dextran conjugate of cibacron blue-F3GA). It was 
soon established that these proteins were binding 
selectively to the dye (Kopperschlager et al.$ 1968).
After these initial observations the possibility of 
triazine dye chromatography was studied and shown to be 
effective for a wide range of proteins (Dean & Watson, 
1979) and especially nucleotide-requiring enzymes (Turner, 
1981). Triazine dyes were originally developed by ICI 
Chemicals, primarily for. use in the textile industry.




1,3,5, trichlorotriazine, the basic element of triazine dyes 
The procion range of dyes, which contain the reactive
j
chlorotriazine moiety, consists of various aromatic
chromophores linked to the triazine ring via NH-bridges.
Procion MX dyes contain one substitution, whereas the
>
Procion HE range contain two substitutions to the triazine 
ring. The dyes are readily coupled, by direct 
substitution of the chlorine atom(s) in the ring, with 
hydroxyl groups on the supporting matrix.
For successful binding of a protein/enzyme the pH, 
temperature and ionic strengths are important variables. 
Elution can be achieved either by pH/ionic gradient 
elution or by bio-specific elution. Bio-specific elution 
utilizes the affinity of an enzyme for its substrate(s), 
product(s) or substrate(s) and product(s) to produce a 
dead-end complex.
Preliminary studies for identification of a suitable 
triazine dye column, for both A-STK and G-STK, are shown 
in Tables 11 and 1 2, respectively. (The dye 
identification list occurs in section 2*15*4). The 5 ml
Protein Total Protein Total Specific
)lumn buffer wash activity 1 M KC1 wash activity activity
No (mg/ml) (umol.min”*) (mg/ml) (Mmol.min-^) (nmol.min-^.mg
1 1-5 ‘ 0 1 *65 0*23 27*8
2 0-5 0 2*5 0*22 17*8
3 2*13 0*037 1*3 0*27 41*5
4 1 • 1 0 2 • 7 0*14 10*5
5 1-4 0*027 2 *35 0*27 23*0
6 1*5 0 2-2 0*23 21*2
7 0-95 0 3 • 1 0*21 13*7
8 0-83 0 3*0 0*15 1 0* 1
9 0*5 0 2 • 1* 0*17* 50*35*
10 0*8 0*017 2*35 0*13 11*5
11 1 *95 0 2 • 1 0*26 24*7
12 2-2 0*088 1 *65 0*14 16*8
13 0*75 0 2*7 0*08 6*2
14 3*6 0 0*95 0*31 64*6



















(0*5 units loaded per column, with a specific activity of 18*5 nmol.min ^.mg ^). 
5 ml buffer wash and 5 ml salt wash fractions collected.












































Protein Total Protein Total Specific %
Column buffer wash activity 1 M KC1 wash activity activity Recovery
No (mg/ml) (ymol.min-^) (mg/ml) (ymol.min-!) (nmol.min- ! .mg-!)
1 1 5 0 1 65 0 0A3 5 2 A3
2 0 5 0 2 5 0 051 A 0 51
3 2 13 0 1 3 0 051 7 8 51
A 1 1 0*017 2 7 0 051 3 7 51
5 1 A 0 2 35 0 0 0
6 1 5 0 2 2 0 057 5 2 57
7 0 95 0 3 1 —  o 02 1 3 20
8 0 83 0*02 3 0 0 037 \ 2 5 37
9 0 5 0-03A 2 1 0 0 0
10 0 8 0-03A 2 35 0 03A 2 9 3 A
11 1 95 0*03 2 1 0 027 2 6 27
12 2 2 0 1 65 0 0 0
13 0 75 0 2 7 0 02 1 5 20
1A 3 6 0 0 95 0 06A 13 5 6 A
15 1 3 0 2 7 0 0 0
(0*1 units loaded per column, with a specific activity of 3*7 nmoles min ^mg !). 





































(bed volume) columns were equilibrated at 4°C with 20 mM
Tris-HCl buffer, pH 7*5, containing 0*5 mM EDTA, 2 mM
MgCl^ and 25 mM ascorbate. After loading samples
(desalted (NH.) SO. 40-65% fractions of bovine heart crude 
4 2 4
tissue extracts) and washing with equilibrating buffer, 
the columns were eluted with 1 M KC1 in equilibrating 
buffer. Both G-STK and A-STK bound to all columns to 
various extents. However, for both enzymes, column 14 
(yellow MXG8 ) yielded the greatest increase in specific 
activity and the highest percentage recovery. Earlier 
work ,in this laboratory had demonstrated that a range of 
citrate synthase and STK enzymes were able to bind to 
procion Red HE3B (column 2) and then be eluted with KC1 
(Weitzman Ridley, 1983). The results displayed in
Table 11 for bovine heart G-STK on column 2 were
comparable, with respect to percentage recovery, with the 
result for pig liver G-STK in that earlier study.
After identification of yellow MXG8 as a suitable dye 
ligand, biospecific elution was attempted. Tables 13 & 14
present the results for G-STK and A-STK respectively. The
eluants for each column were as follows: 1 - 0*2 mM
succiny1-CoA; 2 - 2 mM succinate; 3 - 0*2 mM CoA; 4 - 1 mM 
GTP; 5 - 1 mM GDP; 6 - 1 mM ATP; 7 - 1 mM ADP; 8 - 2 mM 
succinate + 1 mM GTP; 9 - 2 mM succinate + 1 mM ATP;
10 - 0*2 mM succinyl-CoA + 0*5 mM potassium phosphate;
11 - 0*2 mM succinyl-CoA + 1 mM GTP; 12 - 0*2 mM succinyl- 
CoA + 1 mM ATP; 13 - 0*2 mM CoA + 2 mM succinate + 1 mM 
GDP; 14 - 0*2 mM CoA + 2 mM succinate + 1 mM ADP;
15 - 0-1 M KC1.
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Table 13 Bio-specific elution of G-STK (bovine heart) 
from triazine dye column yellow MXG8
Total Specific %
Column No. Protein activity activity Recovery
(mg/ml) (ymol.min *) (nmcl.min *.mg *)
1 0 11 0*41 375 82
2 0 05 0-14 270 28
3 0 15 0-31 207 62
4 0 09 0 • 2 215 40
5 0 06 0*15 245 30
6 0 09 0-175 199 35
7 0 066 0-136 206 27
8 0 09 0-27 207 54
9 0 11 0-069 63 14
10 0 09 0-175 77 35
11 0 09 0-35 383 70
12 0 09 0-337 199 67
13 0 19 0-37 195 74
14 0 15 0-365 243 73
15 0 15 0-243 162 47
0*5 units loaded per column, with a specific activity of 
16*1 nmol.min ^.mg
10 ml buffer wash & bio-specific wash fractions were collected.
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Table 14 Bio-specific elution of A-STK (bovine heart)
from triazine dye column yellow MXG8












1 0*11 0-24 218 80
2 0*05 0-10 200 33
3 0-15 0-135 90 45
4 0-09 0-175 195 58
5 0-06 0-095 157 31
6 0-09 0-13 r 140 43
7 0-066 0-148 225 50
8 0-09 0-121 135. 40
9 0-11 0-162 147 54
10 0-09 0-108 120 36
11 0-09 0-135 150 45
12 0-09 0-162 181 54
13 0-19 0-16 84 53
14 0-15 0-24 162 80




. -1 -1min mg
with a specific activity of
10 ml buffer wash & bio-specific wash fractions were collected.
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Succinyl-CoA (0*2 mM) appeared to be the most 
successful for both enzymes, with respect to percentage 
recovery and specific activity. In Table 13 (G-STK) a 
combination of succinyl-CoA + GTP appears to give a 
higher specific activity but lower percentage recovery, 
whereas in Table 14 (A-STK) ADP gives a higher specific 
but lower percentage recovery. Interestingly, in Table 
13, it is apparent that adenine nucleotides, although 
inhibitors of the G7STK enzyme, are able to effect elution 
of G-STK from the column.
These preliminary screening studies indicate that 
inclusion of triazine dye chromatography in the purifi­
cation of G-STK and A-STK from bovine heart should 
provide a rapid purification step. It is envisaged that, 
in the future, a mitochondrial preparation followed by 
dye-ligand chromatography, affinity chromatography and/ 
or FPLC may allow rapid purification of the two enzymes 







4 • 1 Novel STK nucleotide specificity
As previously described in the Introduction, 
bacterial STKs possess a diversity of nucleotide 
specificity and molecular size which displays a strong 
correlation with the taxonomic status of the source 
organism (Weitzman, 1986). As yet, the biochemical and 
physiological significance of such diversity is unknown.
Adenine and guanine nucleotides have mainly been 
used in assaying bacterial STKs, although a few reports 
have identified that inosine nucleotides can be utilize^, 
along with the former nucleotides, by certain Gram- 
negative bacterial STKs (Burnham, 1963; Murakami et al. » 
1972; Kelly & Cha, 1977). Early work on the pig heart 
G-STK established that it, too, was able to utilize 
inosine nucleotides (Cha & Parks, 1964). From a report 
on STK nucleotide specificity in a number of avian 
tissues (Hamilton & Ottaway, 1981) it was noted that 
tissues possessing G-STK activity could utilize inosine 
nucleotides, whereas those tissues with apparently only 
A-STK activity could not utilize inosine nucleotides.
The enzyme phosphoglycerate kinase from baker’s yeast has 
been shown to be able to utilize guanine and inosine 
nucleotides, whereas the same enzyme from blue-green 
algae demonstrated absolute specificity for adenine
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nucleotides (Soling, 1982). This information, together 
with the results from the avian tissues (Hamilton & 
Ottaway, 1981), appeared to indicate a general pattern 
amongst nucleotide-utilizing enzymes. In the light of 
the above observations and in connection with the pattern 
of nucleotide utilization observed amongst bacteria 
(Weitzman & Jaskowska-Hodges, 1982), it was interesting 
to re-examine the pattern with inosine nucleotides.
Table 15 presents the results of ADP, GDP and IDP 
utilization in representative organisms of the four main 
bacterial groups identified by Weitzman & Jaskowska- 
Hodges (1982). The NDP concentration was set at the Km 
value of the preferred nucleotide in each case. First, 
it was seen that IDP and GDP utilization appeared to be 
closely associated. Secondly, these results were 
supported by studies on IDP utilization by the separated 
bovine heart G-STK and A-STK enzymes, purified pig liver 
G-STK and purified pigeon breast A-STK (Table 16). In 
every case G-STK enzymes were able to utilize IDP, whereas 
with A-STK enzymes no activity was observed with IDP. 
Comparisons of the molecular structures of the nucleotides 
(Fig.35) suggest that the substituent groups on C - 6 of the 
purine ring »may be important in the recognition and 
binding of the nucleotides to the particular STK enzymes.
However, perhaps the most surprising result displayed 
in Table 15 was obtained with the Gram-positive bacterium 
Bacillus megaterium. Here, IDP-dependent activity was 
observed even though no G-STK activity was detectable.
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Table 15 IDP utilization by bacterial STKs
Organism + ADP + GDP + IDP
activity 
(ymol.ml ^.min ^)
A . calcoaceticus 0*012 0*135 0*135
(0*05 mM NDP)
E . coli 0*128 0*03 0*02
(0*01 mM NDP)
Ps. aeruginosa 0*47 0*49 0*48
(0*05 mM NDP)
B, megaterium 1*38 0 0*33
(0*1 mM NDP)
NDP concentrations for each organism 
were set at the Km value for the 
preferred nucleotide (Weitzman &
Jaskowska-Hodges, 1982).
Cells were harvested (13,000 x g for 10 min at 4°C), 
resuspended in 0*1 M sodium/potassium phosphate buffer, 
containing 20 % (v/v) glycerol + 1 mM EDTA, pH 8*5, 
disrupted by Ultrasonication and centrifuged (30,000 x g 
for 20 min at 4°C)
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Table 16 IDP utilization by animal STKs
Source + ADP + GDP
activity
(jjmol .ml  ^. min  ^)
Purified

















Assay NDP concentrations were 0*5 mM. 
Extracts were prepared as in Table 5, page 8 6 .
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This result indicates either that this particular A-STK, 
unlike all others, is able to utilize ADP & IDP but not 
GDP, or that a second STK specific for IDP is present.
«
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N %
H C r /






Guanosine 5 1-diphosphate 
(GDP)
Adenosine 5 ’-diphosphate 
(ADP)
Inosine 5 ’-diphosphate 
(IDP)
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4•2 Evidence for two STKs in Gram-positive bacteria 
4*2*1 Additivity and differential inhibition of 
STK activities
The new IDP-dependent STK activity was found to be 
dependent upon the presence of succiny1-CoA, inorganic 
phosphate, MgCl^ and IDP in the assay mixture. Table 17 
displays results from B . megaterium and B. subtilis.
Partial additivity of A-STK and I-STK activities was 
clearly seen, similar to the situation with the eukaryotic 
STKs of Table 5. Significantly, GDP was shown to inhibit 
I-STK activity (55-64% inhibition), whereas A-STK activity 
was inhibited to a lesser extent (22-26%). This 
difference in inhibition by GDP may be due to the 
structural similarity between GDP and IDP (Fig.35).
«
4*2*2 pH profile of STK activities
Fig. 36 demonstrates a difference between A-STK and 
I-STK activities. The pH optimum for A-STK wa s ~ p H  9*2, 
whereas that for I-STK was~pH 8*5. This result contrasted 
with mammalian STKs which both displayed pH optima around 
pH 8*0. Also, unlike the mammalian STKs, no differential 
thermal inactivation was observed.
4*2*3 Variation of STK activities on different growth 
media
The relative specific activities of the two STKs 
from B. megaterium were found to vary depending on the 
stage of growth and on the carbon source used (Table 18).
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Table 17 Additivity and inhibition of Gram-positive
STK activities
Organism
Assay conditions B. megaterium B. subtilis
activity 
(nmol.min  ^. mg  ^)
+ ADP 61*3 59
+ GDP 0 0
+ IDP 10*4 12*6
+ (ADP + IDP) 65*3 61*0
% Additivity 91 85
+ (ADP + GDP) 47*8 43*7
% Inhibition 22 26
+ (IDP + GDP) 5*3 6 • 0
% Inhibition 49 52
0*5 mM NDP used; cells were 
grown on nutrient broth at 
37°C and harvested in early 
stationary phase.
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Early - logarithmic 31*0 0-35 88-6
Mid - logarithmic 73*3 4 • 8 15*3
Late - stationary 48-7 5 • 6 8*7
25 mM succinate
Late - stationary 41 • 1 6- 8 6*0
25 mM glucose
Late - stationary 57-9 1-0 57-9
25 mM glutamate
Late - stationary 28* 1 0-43 65*3
grown on various media
Growth media A-STK I-STK
activity 
(nmol.min  ^.mg ^)
Extracts were prepared as in Table 15, page 135.
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On nutrient broth a 10-fold variation in the ratio of 
A-STK/I-STK occurred between early-logarithmic and late- 
stationary growth phases, and between different growth 
media at the same stage of growth. These results, along 
with those presented in Table 17 and Fig. 36, strongly 
suggest the presence of two distinct nucleotide-specific 
STKs, whose relative proportions vary according to 
physiological conditions. The elevation in I-STK activity 
during growth on succinate may reflect increased formation 
of succinyl-CoA from succinate.
B . megaterium, in common with other bacteria, has the 
ability to store and then utilize poly 3-hydroxybutyrate 
(Dawes & Senior, 1973). The activation of acetoacetate 
(derived from hydroxybutyrate) by the enzyme 3-oxo-acid 
CoA transferase requires a supply of succinyl-CoA.
B. megaterium was therefore grown on acetoacetate and the 
enzymes of ketone body utilization were measured along 
with A-STK and I-STK activities (Table 19). Significantly, 
not only was there a rise in ketone body utilizing enzymes 
(3-oxo-acid CoA transferase and acetoacety1-CoA thiolase) 
but also in I-STK activity. The value of 2*8 for the 
A-STK/I-STK ratio was the lowest observed from 
B. megaterium grown on any media.
4*2*4 Nucleotide dependence of the STK activities
Figures 37 & 38 display the Hanes-Woolf plots for 
the STK activities from B. megaterium with ADP and IDP 
respectively. Km and apparent Vmax values ± S*D were
Table 19 Variation in STK, 3-oxo-acid CoA transferase and acetoacety1-CoA
thiolase activities from B. megaterium grown on nutrient broth 
and acetoacetate




(nmol.min  ^. mg ^)
Nutrient broth
(Late-stationary) 228 123 44*3 3*8 11*6
25 mM-acetoacetate
(Late-stationary) 665 207 39 13*8 2*8
A-STK I-STK Ratio
A-STK/I-STK



















Figure 37 Hanes-Woolf plot: [ADP]/v versus [ADP] for A-STK from
































Figure 38 Hanes-Woolf plot: [IDP]/V versus [IDP] for I-STK from
B, megaterium at pH 8*5
Km








determined using a computer programme of the direct linear 
plot (Eisenthal & Cornish-Bowdon, 1974).
In contrast to the two distinct STKs found in 
mammalian tissues, the STICs from B. megaterium have 
different Km values for their respective nucleotides.
Km (IDP) = 28*1 ± 4*7 yM, whereas Km (ADP) = 89*4 ±
11*9 yM. This result again indicates the presence of two 
distinct STKs. Were IDP to be converted into ADP and 
then react with A-STK, it would be expected that the Km 
for IDP would be similar to, if not higher than, the Km 
for ADP. However, the Km for IDP is over 3-fold lower 
than that for ADP.
«
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4 • 3 STK activities from a range of Gram-positive bacteria 
After observing A-STK and I-STK activities in
B. megaterium and B. subtilis, it was decided to carry 
out a limited screening of a number of Gram-positive 
bacteria, to establish the extent of this phenomenon.
It has been suggested that Gram-positive bacteria 
can be divided into two main groups: group 1 , possessing 
a low G + C DNA e.g. Bacilli» Lactobacilli & Brochothrix 
and group 2, possessing a high G + C DNA, e.g.
Corynebacterium, Kurthia & Arthrobacter (Woese et al., 
1985). In Table 20, representatives of the sub-grouping 
were investigated, with respect to their STK activities: 
Gram-positive cocci - Staphylococci and Deinococci; 
endospore forming rods & cocci - Bacilli ; non-sporing
<
rods - Lactobacilli and Brochothrix; coryneform Gram- 
positive bacteria - Brevibacterium and Corynebacterium 
and the related eubacteria - Kurthia and Arthrobacter.
The original pattern of only A-STK and I-STK activity, 
as seen in Bacilli, was shown to be incomplete.
Brochothrix and Deinococci utilized all three nucleotides, 
while Brevibacterium linens utilized ADP and GDP but not 
IDP.
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Table 20 Nucleotide dependence of STK activities 
from Gram-positive bacteria
Organism + ADP + IDP + GDP
activity 
(nmol.ml ^.min 1)
Low G + C DNA
Bacillus megaterium 328 36 0
Bacillus subtilis 295 25-8 0
Lactobacillus plantarum 0 0 0
Brochothrix thermosphacta 305 ■p- • CD 43
Deinococcus radiodurans 79*6 6 • 0 3
Staphylococcus aureus 289 20 0
High G + C DNA
Arthrobacter simplex 228 16 0
Brevibacterium linens 312 0 156
Corynebacterium fascians' 184 147 150
Corynebacterium rubrum 147 80*4 75
Kurthia zopfii 36 16*2 0
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4•4 Nucleotide dependences and molecular sizes of STKs
from Gram-positive bacteria
The Km and apparent Vmax values for ADP, IDP and GDP 
were determined for the bacteria Bacillus megaterium t 
Brevibacterium linens and Corynebacterium rubrum (Table 
21) .
Estimation of the molecular sizes of the STKs from 
B, megaterium and C. rubrum were carried out using a 
calibrated FPLC Superose-12 column, with the addition of 
LDH (rabbit muscle Mr — 140,000) (Figs. 39 & 40). Both 
Gram-positive bacteria appeared to possess ’small* STK 
enzymes. In the case of C. rubrum, the A-STK gave a Mr 
value of- 87,000, whereas the G/I-STK gave a Mr value of 
— 89,000 (Fig. 39). B, megaterium A-STK and I-STK
t
activities gave a similar Mr value o f — 83,000 (Fig. 40).
These results fall into line with the previously 
identified pattern of Gram-positive bacteria possessing 
’small* STKs (Weitzman, 1981).
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Table 21 Km and apparent Vmax values of NDP, for STKs
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Figure 39 Gel filtration of STKs from C. r u br um on FPLC
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Figure 40 Gel filtration of STKs from B. m e g a t e r i u m


























Following our discovery of two distinct STKs in 
eukaryotic organisms, one (G-STK) specific for GDP/GTP 
and the other (A-STK) for ADP/ATP, we addressed the 
possibility that they serve differing metabolic roles. 
Succinyl-CoA is known to be involved in three important 
cellular processes: the citric acid cycle, the activation 
of ketone bodies and as a precursor for porphyrin 
biosynthesis. This chapter reports investigations of 
these three areas with respect to STK activity.
<
5•1 Ketone body activation
Originally, ketone bodies (acetoacetate and 
3-hydroxybutyrate) were thought to be the normal inter­
mediates in the degradation of fatty acids. However, 
after the discovery of Coenzyme A by Lipmann (1945) and 
subsequent studies (Lynen & Ochoa, 1953) it was 
established that the CoA-derivatives, not free ketone 
bodies, were the normal intermediates of fatty acid 
metabolism. The situation was further complicated when 
it was shown that L-3-hydroxybutyrate was formed from 
long-chain fatty acids, whereas the 3-hydroxybutyrate that 
appeared in body fluids was of the D-configuration 
(Lehninger & Greville, 1953).
Although it was known that circulating ketone bodies
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could act as fuel for respiring tissues, they were, in the 
light of the discoveries in 1953, relegated to an inferior 
position in metabolism and regarded as waste products.
The elevation in plasma ketone bodies, often associated 
with diabetes, further compounded the view that ketone 
bodies were undesirable metabolic products.
Even twenty years ago, confusion over the reasons for 
their occurrence was expressed: ’’Clearly it is not
obvious in what ways ketogenesis in fasting is a good 
thing for the whole animal” (Greville & Tubbs, 1968).
However, in the late 1960s and early 1970s, the 
significance of the presence of ketone bodies and their 
physiological roles were elucidated. Today ketone bodies 
are viewed as having an integral position in the
«
regulation and transport of lipid fuels. They are known 
to provide alternative fuel to body tissues when 
carbohydrate is in short supply and this is especially 
critical for essential muscles such as the heart, 
diaphragm and digestive tract smooth muscles (Beis et al. f 
1980). Ketone bodies have even been shown to replace 
glucose as the major fuel of respiration in the brain, 
during starvation (Owen et al., 1967) and diabetes 
(Hawkins et al.. 1986). They have also been shown to 
minimize breakdown of muscle protein, required for 
gluconeogenesis, during prolonged starvation (McGarry & 
Foster, 1980) and to act as important precursors for the 
biosynthesis of neonatal cerebral lipid (Robinson & 
Williamson, 1980).
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Ketone bodies arise from the oxidation of fatty acids 
and certain amino acids in the liver and can be used by 
most if not all aerobic tissues (e.g. muscle, brain, 
kidney, mammary gland and small intestine) with the 
exception of the liver itself (see Fig. 41). The enzyme 
hydroxymethylglutary1-CoA synthase (HMG-CoA synthase), 
regarded as the rate-limiting enzyme of ketone body 
production, occurs in large amounts only in the liver.
The ketone bodies produced by the liver readily diffuse 
into the blood and then into extrahepatic tissues. They 
probably cross the plasma and mitochondrial membranes by 
diffusion as undissociated acids or enter mitochondria as 
anions, with a carrier similar to or identical with that 
used by pyruvate (Robinson & Williamson, 1980). The
«
potential to utilize ketone bodies by extrahepatic tissues 
(see Fig. 41) is marked by the occurrence of the enzyme 
3oxo-acid CoA-transferase (OAT), which is not found in 
significant levels in liver tissue. This enzyme utilizes 
succinyl-CoA during the activation of acetoacetate to 
acetoacety1-CoA. The occurrence of two STKs in mammalian 
tissues lead us to study their possible associations with 
this area of metabolism.
Ketone body metabolism can be perturbed in diabetes 
and thus offers a means of investigating the participation 
of the STKs. Diabetes was induced by administration of 
streptozotocin (Schein et al.♦ 1971).
- 157 -
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is an antibiotic derived from Streptomyces achromogenes♦ 
which has been demonstrated to possess diabetogenic, 
antitumoral and carcinogenic properties. It is now the
<
compound of choice for producing experimental insulin- 
dependent diabetes. Streptozotocin induces diabetes by 
selectively destroying the insulin-secreting 3-cells of 
the Islets of Langerhans. The glucose moiety facilitates 
entry of the drug into the 3-cells, while the N- 
MethyInitrosourea moiety provides the cytotoxic effect 
(Fischer, 1985). The mode of action after a single large 
dose involves alkylation of critical cell components 
coupled with a more complex damage mechanism. Treatment 
of pancreatic cells with streptozotocin has been shown to 
increase the activity of poly (ADP-ribose) synthetase and 
therefore reduce cellular NAD+ levels (Okamoto, 1981); 
such increase in poly (ADP-ribose) synthetase activity is 
known to be associated with DNA damage. Streptozotocin-
- 159 -
induced DNA damage has been reported in isolated pancreatic 
cells (Uchigata et al., 1952).
c
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5*1*1 Specific association of STK activity with ketone
body utilization
Procedures for the induction and monitoring of
experimental diabetes were given in the Methods section
2*10. Both G-STK and A-STK activities were assayed in
various tissues from diabetic and control rats (Table 22).
The first significant finding is that the G-STK of liver
fell in diabetes, but that of brain was markedly elevated.
As a consequence, the ratio of G-STK/A-STK in these
tissues was greatly changed. Neither heart nor skeletal
muscle displayed such marked changes, although a slight
depression of both STK activities occurred in the diabetic
tissues. As discussed previously, diabetes is accompanied
by enhancement of ketone body production by the liver and
c
utilization by the brain (Robinson & Williamson, 1980).
The ability of the brain to metabolise ketone bodies had 
not been believed to be an enzymic adaption, because the 
enzymes responsible for ketone body utilization - 
3-hydroxybutyrate dehydrogenase, 3oxo-acid CoA-transferase 
and acetoacety1-CoA thiolase - are all present in 
sufficient activities in the brain and are unchanged by 
starvation or diabetes (Williamson et al.♦ 1971; Page et 
al .» 1971). It was therefore proposed that only the 
availability of succinyl-CoA limits the brain's potential 
to use ketone bodies (Lopes-Cardozo & Klein, 1982). The 
finding that G-STK increases in diabetic brain suggests 
that it may produce the succinyl-CoA required for ketone 
body activation. As mentioned above, diabetes leads to
- 161 -
Table 22 STK activities in rat tissues from diabetic
and control animals
Treatment Tissue G-STK A-STK Ratio
activity G-STK/A-STK
(nmol.min ^.mg ^)
Control brain 0*33 1*1 0*3
" heart 4*3 3*0 1*4
" skeletal
muscle 0*6 1*1 0*54
liver 4•5 1-5 2-5
Streptozotocin brain 5*0 2*0 2*5
" heart 3*7 2*3 1*6
" skeletal
muscle 0*4 1*0 0*4
" liver 1-3 3*0 0*43
Tissues from 5 control and 5 treated animals were pooled 
and prepared as in Table 2, page 80.
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increased ketogenesis in the liver. The reduction of 
G-STK in diabetic liver may be related to the recent 
report (Lowe & Tubbs, 1985) of specific succinylation and 
inhibition of the enzyme HMG-CoA synthase. This enzyme is 
crucial in ketone body formation (Fig. 41); its specific 
inactivation by succinyl-CoA may therefore be a control 
mechanism in ketogenesis. Stimulation of ketogenesis, 
e.g. by glucagon, is accompanied by reduction in the 
concentration of hepatic succinyl-CoA (Seis et al. » 1980); 
this reduction might lead to re-activation of HMG-CoA 
synthase and hence to increased ketogenesis (Lowe & Tubbs,
1985). The observation of a decreased level in liver 
G-STK was therefore consistent with a reduction in 
succinyl-CoA formation and may be related to these other
«
processes. A-STK activity was raised in both diabetic 
brain and liver (Table 22). In the brain, this may be 
associated with increased ketone body oxidation via the 
citric acid cycle, whereas, in the liver, enhanced 
respiration has been reported to accompany ketogenesis 
(Seis & Wieland, 1978) and increased hepatic citrate 
synthase activity is known to occur during starvation and 
diabetes (Srere, 1968).
Interestingly, it has recently been reported (Boquist & 
Ericsson, 1986), that streptozotocin has a direct 
inhibitory action on mouse liver G-STK in vitro (50% 
inhibition at 10 nM streptozotocin), though no in vivo 
alteration in the activity of this enzyme was observed.
The effect of streptozotocin was therefore tested on the
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activities of G-STK from rat liver and brain. However, no 
inhibition could be detected even at 100 nM streptozotocin 
and it may therefore be concluded that the reduction seen 
in liver G-STK, following streptozotocin administration, 
was unlikely to be due to any direct inhibition but rather 
to a reduction in the level of the enzyme.
Table 23 shows the specific activities of a number of 
enzymes in brain and heart tissues from control and 
diabetic rats. It is clear that in the diabetic brain 
there was a general increase in the specific activities, 
although only G-STK displayed marked elevation. In 
diabetic heart, 48 h after induction of diabetes, there 
was a general decrease in the enzyme activities. In the 
fed state the activities of the ketone body-utilizing
c
enzymes of heart are known to be the highest of all 
tissues (Beis et al. i 1980). However, it has recently 
been reported (Grinblat et al., 1986) that decreased 
utilization occurred gradually over the initial period of 
diabetes ( 0 - 2  months). This decrease is known to be 
associated with decreased 8-hydroxybutyrate dehydrogenase 
activity in the inner mitochondrial membrane of diabetic 
heart.
Ketone bodies are also thought to play an important 
role in neonatal brain development. At about 8 days after 
birth, rat neurones are actively extending neuronal 
processes and forming synapses (a procedure requiring 
energy and lipid synthesis), while at 15 days most 
connections have been made and the necessity for utilizing
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Table 23 Specific activities of enzymes from control 
& diabetic rat brain and heart
Enzyme Control Diabetic Control Diabetic
brain brain heart heart
activity 
(nmol.min  ^. mg ^)












4*2 4 • 2 3*8
12*7 26*2 21-4
32*8 12-8 12-9
Tissues were pooled and extracted as in Table 22, page 161.
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ketone bodies may have declined (Chechik et al. • 1987). 
Changes in the specific activity of OAT have also been 
reported (Haney & Patel, 1985), during this period of 
brain development. This area was investigated with 
respect to 3oxo-acid CoA-transferase, acetoacetyl-CoA 
thiolase, citrate synthase and STK enzymes in the 
developing rat brain. Table 24 presents the specific 
enzyme activities from rat brain (day 2 - 16). 
Unfortunately, no convincing trends in OAT or G-STK 
activities could be identified.
5*1*3 Insulin controlled diabetes
After demonstration of elevated G-STK activity in 
diabetic brain, further investigations into G-STK
«
association with ketone body metabolism were carried out 
using insulin administration to diabetic animals and with­
drawal of insulin from insulin-controlled animals.
Insulin and glucagon (secreted by the a-cells of the 
pancreas) are mutually antagonistic hormones. Normally, 
in the controlled state, a fine balance exists between the 
ratio of the two hormones, which varies depending upon the 
prevailing circumstances, so that e.g. after a large 
carbohydrate- or lipid-rich meal, the insulin/glucagon 
ratio will rise as more insulin is secreted. The main 
target sites for these hormones are the liver, muscle and 
adipose tissue. Insulin appears to be responsible for 
inhibiting ketogenesis, fatty acid oxidation and 
gluconeogenesis, while activating glycogen formation,
Table 24 Specific activities of enzymes in developing rat brain (day 2 - 16)
Day 3oxo-acid acetoacetyl-CoA citrate Ratio
CoA-transferase thiolase synthase A-STK G-STK
G-STK/A-STK
activity 
(nmol.rain ^.mg  ^)
2 25 13-1 5 0-82 0-44 0-54
7 19*7 10*3 5-7 0*88 1*12 1-3
8 20*3 14 4*2 0-92 0*74 0-8
9 19*4 9 4-5 0*96 0-9 0*94
16 29-8 8*9 9*2 1*3 0*64 0-64
Tissues were pooled and extracted as in Table 22, page 161.
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lipogenesis and glycolysis (Agius et al., 1986) whereas 
glucagon stimulates hepatic gluconeogenesis and 
ketogenesis, and lipolysisin adipose tissue.
Table 25 presents the body weights and plasma 
concentrations of 8-hydroxybutyrate , acetoacetate and 
glucose from diabetic animals after administration of 
insulin. 48 h after induction of diabetes, treated 
animals presented total ketone body concentrations of 2*55 
± 0*45 mM, whereas the corresponding control values were 
0*127 ± 0*04 mM; plasma glucose concentrations were also 
elevated. Administration of 10 International units of 
insulin to each rat brought a rapid response in ketone 
body concentrations in the initial 8 h. However, it took 
24 h for glucose concentrations to decrease to control
«
levels. Lipolysis and ketogenesis are known to be much 
more sensitive to insulin than carbohydrate metabolism 
(Robinson & Williamson, 1980); therefore ketone body 
concentrations decrease faster than glucose concentrations. 
The mild hypoglycaemia seen after 24 h is probably due to 
administration of excess insulin. These dramatic changes 
in carbohydrate and lipid metabolism are instigated by 
discrete enzymic changes. During diabetes the specific 
activities of the lipogenic enzymes fatty acid synthetase 
(FAS) and glycerolphosphate acy1-transferase (GPAT) 
decrease in adipose tissue. Restoration of these 
activities is observed after insulin administration 
(Saggerson & Carpenter, 1987). Similar marked enzymic 
changes occur in carbohydrate metabolism. Normally,
Table 25 Body weight and plasma ketone body and glucose concentrations after insulin
administration to diabetic rats
Time after Body 3-hydroxybutyrate acetoacetate glucose
administration weight (mM) (mM) (mM)
of insulin (g)
(h) control diabetic control diabetic control diabetic control diabetic
0 157*3 133*4 0*057 1*65 0*07 0*09 6*58 24*1
±4*2 ±9*9 ±0*01 ±0*35 ±0*03 ±0*1 ±0*3 ±1*1
8 161*1 132*0 0*048 0*044 0*054 0*04 7*14 22*8
±6*0 ±8*0 ±0*004 ±0*007 ±0*007 ±0*001 ±0*8 ±0*3
24 166*0 136*1 0*058 0*049 0*06 0*04 6*8 3*9
±5*5 ±4*0 ±0*014 ±0*02 ±0*001 ±0*06 ±0*56 ±0*8
168
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skeletal muscle contains mostly hexokinase isoenzyme II, 
whereas the brain contains predominantly isoenzyme I. 
However, a marked decrease in isoenzyme II activity occurs 
in skeletal muscle when insulin is in short supply. This 
is due to an increased degradation (up to 3-fold) of the 
enzyme (Frank & Fromm, 1986). Administration of insulin 
restores hexokinase II activity by reducing the rate of 
its degradation. During diabetes these changes in the 
activity of such a key enzyme leads to marked 
hyperglycaemia because skeletal muscle is quantitatively 
the most important site for insulin-dependent glucose 
disposal (Defronzo et al.» 1983).
Fig. 42 displays the changes in STK activity in 
diabetic brain and heart tissues, compared with control
<
values, in connection with the changes in circulating 
ketone bodies and glucose, after insulin administration. 
Only diabetic brain G-STK, and not A-STK, shows increased 
activity concurrent with elevated ketone body utilization. 
In Fig. 42 this elevation in diabetic brain G-STK was 
already apparent at the time of insulin administration and 
persisted for at least 8 h. However, at 24 h, G-STK had 
returned to the control value. No such changes were 
observed in diabetic heart tissue, where a slight decrease 
in both STK activities was observed in the diabetic state 
(this is similar to results obtained in Tables 22 & 23).
After observing the decrease in STK activities 
following administration of insulin it was decided to 
examine the consequences of withdrawal of insulin from
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Figure 42 Changes in STK activities, glucose and ketone

























700-i to diabetic animals
co































4->0) _   Control
glucose level
Time (h)
Tissues were pooled and extracted as in Table 22, page 161.
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insulin-controlled diabetic animals. Fig. 43 displays the 
changes in body weights associated with induction, insulin 
-controlled diabetes and then removal of insulin. After 
receiving streptozotocin on day 1 , diabetic animals were 
then given insulin daily from day 2 onwards. After 
treated animal body weight values had begun to approach 
control values, insulin treatment was withdrawn (day 13). 
The insulin used in the experiment, Neulente-zinc 
suspension, was active over a 24 h period after 
administration; therefore no decrease in body weights was 
observed 24 h after insulin withdrawal. However, after 
48 h a marked decrease in body weight was seen. In the 
subsequent days, body weights continued to decrease but 
not at such a marked rate. The changes seen in body
*
weights, after insulin withdrawal, were mirrored by 
changes in ketone body levels (Table 26). A sharp 
increase in plasma ketone body concentrations occurred 
concomitant with the marked decrease in body weights 
(Fig. 43). After 48 h the levels of ketone bodies 
gradually decreased until, 120 h after insulin withdrawal, 
their levels were only slightly higher than control values. 
These changes in ketone body concentrations, at the later 
part of the experiment, appeared to coincide well with the 
gradual decrease observed in body weights.
Fig. 44 displays the changes in STK activities that 
occurred in diabetic brain, after insulin withdrawal, 
together with the total plasma ketone bodies. 24 h after 
insulin withdrawal, both G-STK and ketone body concentrations
-  172  -
Figure A3 Body weight changes with and without insulin 
administration to diabetic animals
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Table 26 Changes in plasma ketone body concentrations 
after insulin withdrawal from controlled 
diabetic animals
B-hydroxybutyrate acetoacetate total ketone
(mM) (mM) bodies
(mM)
control diabetic control diabetic control diabetic
24 0 *042 0 •057 0 076 0-074 0 -12 0 13
±0 •001 ±0 •007 ±0 002 ±0*003 ±0 *003 ±0 01
48 0 048 1 .6 0 068 1*12 0 *12 2 7
±0 002 ±0 •2 ±0 004 ±0-3 ±0 -006 ±0 5
72 0 047 1 •2 0 057 0-85 0 -1 2 1
±0 001 ±0 •2 ±0 006 ±0-06 ±0 -007 ±0 2
96 0 05 0 •33 0 062 0* 135 0 -11 0 47
±0 007 ±0 •03 ±0 003 ±0*02 ±0 -01 ±0 05
120 0 045 0 •08 0 -059 0*057 0 -1 0 14
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Figure 44 Changes in STK activities and ketone body 
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Tissues were pooled and extracted as in Table 22, page 161
- 175 -
were still at control levels. However, elevation of 
ketone bodies after 48 h was complemented by a similar 
elevation of G-STK. The levels of G-STK and the available 
plasma ketone bodies then decreased gradually together 
until both approached control levels after 5-days.
The results presented in this section support the
suggestion that the succinyl-CoA required for ketone body
activation is produced directly by the action of G-STK.
Fig. 45 shows a scheme of ketone body activation and
subsequent oxidative metabolism via the citric acid cycle
which is based on the results from this section and from
the previously proven presence of a distinct A-STK (see
section 3*2). At two points, in the scheme, succinyl-CoA
is converted to succinate, by the reaction with acetoace-
<
tate (catalysed by OAT) and by reaction with nucleoside 
diphosphate and inorganic phosphate (catalysed by STK). In 
the latter case, succinate is further oxidized by the 
later steps of the citric acid cycle to reform oxaloace- 
tate for condensation with the acetyl-CoA produced from 
the ketone bodies. In the former case, by contrast, the 
succinate must be reconverted to succinyl-CoA in order to 
maintain the flow of acetoacetate to acetoacety1-CoA.
This re-cycling could be achieved either by metabolism of 
succinate round the citric acid cycle, via oxaloacetate 
and citrate, or by the action of an STK operating in the 
reverse direction. It appears from the investigations 
into STK activities during elevated ketone body 
utilization that the re-cycling of succinate to succinyl-
- 176 -











NTP + CoA NDP + P.
NDP and NTP represent nucleoside diphosphate and 
triphosphate respectively. A and B are two points
at which the succinate thiokinase reaction occurs.
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CoA is achieved directly by the action of G-STK. It is 
therefore possible that the second STK (A-STK) may be 
associated with the other requirement for the succinate 




Porphyrins are known to consist of four pyrrole rings
(Fig. 46). Early studies, based on structural
similarities, suggested proline and the indole ring of
tryptophan as possible precursors of the pyrroles (Shemin,
1979). However, following a series of now classical
14 15
isotope experiments using C and N, Shemin and co­
workers demonstrated that glycine was a precursor of 
porphyrin (Radin et al., 1950; Wittenburg & Shemin, 1950). 
Subsequent work revealed that the other carbon atoms of 
porphyrin were supplied by a succinyl derivative, later 
identified as succinyl-CoA. Significantly, their work 
identified that the succinyl-CoA utilized in porphyrin 
biosynthesis originated directly from succinate, as well 
as from 2-oxoglutarate dehydrogenase (Shemin & Kumin, 
1952). These results therefore demonstrated the existence 
and reversibility of the succinate thiokinase reaction 
even before the reaction or enzyme were identified and 
characterized (Kaufman, 1955; and Sanadi et al . , 1956).
Once succinyl-CoA and glycine were shown to be 
precursors of the pyrrole structure, an intermediate was 
sought. 6-Aminolaevulinic acid (ALA) was quickly 
established as the intermediate from which the complete 
porphyrin structure was synthesised (Shemin et al.♦ 1955). 
Since that time ALA has been shown to be the first 
intermediate in the biosynthesis of all naturally 
occurring porphyrins (Porra & Meisch , 1984).
In animals, ALA is formed by the pyridoxal phosphate-
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Figure 46 The biosynthesis of porphyrin
2 x 6-Aminolaevulinic acid ■ »  Porphobilinogen (PBG) 






















dependent enzyme, 6-aminolaevulinic acid synthase (ALA-S). 
The synthesis of ALA-S has been found to be under strict 
negative feed-back control from haem and is regarded as 
the first and rate-limiting enzyme e-f haem biosynthesis.
In higher plants, algae and cyanobacteria, ALA is not 
synthesised from glycine and succiny1-CoA, but from 
glutamate (Castelfranco & Beale, 1983; Oh-homa et al. »
1986). The mechanism of this reaction has recently been 
demonstrated to involve a novel requirement for t-RNA 
(Schon et al . , 1986; Kannangara et al., 1988).
All mammalian cells contain haemoproteins and possess 
the capability to synthesise haem (May et al., 1986). 
However, the highest rates of haem biosynthesis are 
located in the bone marrow of the vertebrae, sternum and 
pelvis, where erythrogenesis occurs. The liver also 
actively synthesises haem, which is utilized in the 
cytochrome P-450 detoxification systems (Ortiz de 
Montellano & Correia, 1983).
The Porphyrias
A number of disease states of haem biosynthesis occur 
and are collectively known as the porphyrias (Elder, 1983 
]d ) . These perturbations in the normally closely regulated 
biosynthesis of haem originate from partial deficiency in, 
or inhibition of, an intermediate enzyme(s) of the pathway. 
Such conditions have now been identified for each of the 
steps in the conversion of ALA to haem (Elder, 1983_b) .
These defects do not lead to a deficiency in haem, due to
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a compensatory rise in the concentration of the intermed­
iates before the affected enzyme. Each enzyme deficiency 
produces a characteristic pattern of accumulation and 
excretion of haem precursors which can cause a variety of 
clinical symptoms. Porphyrins can be classified into two 
categories: those in which erythrocyte porphyrin is 
elevated, and those in which only hepatic porphyrin 
content is increased. Such increases in the concentrations 
of the porphyrin intermediates are achieved by elevation of 
ALA-S activity. Besides genetically inherited porphyria, 
a wide range of chemicals can induce porphyria (Ortiz de 
Montellano & Correia, 1983). These drugs and chemicals 
fall into two main groups. One group, exemplified by the 
barbiturates, increase haem demand and stimulate the 
production of microsomal haemoproteins of the cytochrome 
P-450 series. The second group contains compounds which 
elevate ALA-S synthesis by inhibiting haem synthesis or by 
accelerating its degradation. The drug 3,5 ,-diethoxycar- 
bony1-1,4-dihydrocollidine (DDC) has been shown to inhibit 
the final enzyme in the haem biosynthetic pathway, 
ferrochelatase, which catalyses the insertion of ferrous 




In the liver of DDC-treated animals, transfer occurs of 
the 4-methyl group of DDC to one of the pyrrole nitrogens 
of protoporphyrin IX, converting it to N-methy1-protopor­
phyrin (De Matteis et al.t 1981); this is a potent 
irreversible inhibitor of ferrochelatase. Probably in the 
mammalian liver, as in avian liver, decrease in haem 
production causes derepression of ALA-S synthesis (Elder, 
1983 Jb) . This leads to over production of subsequent haem 
precursors, which can give rise to various clinical 
manifestations. Such elevation in ALA-S activity must 
therefore place an increased demand upon succinyl-CoA and 
glycine within the porphyric liver. Over twenty years ago 
Labbe et al. (1965) demonstrated that induction of
porphyria was accompanied by an increase in liver STK
- 183 -
activity.
5*2-1 Specific association of STK activity with
porphyrin metabolism
The discovery of two distinct STKs in mammalian 
tissues prompted a re-investigation of STK activities in 
porphyric animals. Initially the drug AIA (2-allyl-2- 
isopropylacetamide) was used in attempts to induce 
porphyria in rats but this proved unsuccessful. DDC was 
then used, successfully, to induce porphyria in mice.
Porphyric mouse liver, gall bladder contents and 
prepared liver mitochondria were all characteristically 
dark red in appearance. In a typical experiment, total 
liver porphyrin contents of DDC-treated mice were 
increased 100-fold from a control value o f ~ 4  nmol g  ^
liver to a DDC-treated value of ^ 400 nmol g  ^ liver, 
clearly indicating the porphyric condition. Table 27 
displays the results from three separate experiments. It 
is clear that the increase in demand for succinyl-CoA is 
met by an increase in the activity of G-STK, and not A-STK. 
Citrate synthase and A-STK activities show no significant 
changes in activities, whereas G-STK demonstrated a 98% 
rise in specific activity in the porphyric state compared 
with control values. In addition to the induction of 
hepatic porphyria, bovine sternum bone marrow was also 
investigated, in view of its important role as a site for 
erythrogenesis. Significantly, sternum bone marrow 
exhibited the highest G-STK/A-STK ratio of any mammalian
- 18 A -
Table 27 Effect of porphyria on citrate synthase and 
STK activities in mouse liver mitochondria
Ratio
G-STK/A-STK
Control liver 8*9 3*7 1*5 2*5
mitochondria ±0*8 ±0*4 ±0*5
DDC-treated 8-7 7-4 1-6 4-6






Mitochondrial extracts were prepared as in Table 5, page 86. 
The results presented here represent the mean (x) of 3 
separate experiments ± S.D., with 5 animals per group.
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tissue so far examined. The specific activities of G-STK 
and A-STK were found to be 2*5 & 0*33 nmol.min ^.mg \  
respectively, giving a ratio of 7*6. This value is 
considerably greater than the highes-t ratio reported for 
any other tissue e.g. 3*5 from rat kidney (Table 2). This 
result, taken together with the sharp rise in mouse liver 
G-STK in the porphyric state, implicates G-STK, and not 
A-STK, as the STK responsible for supplying succinyl-CoA 
for haem biosynthesis.
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5 * 3 Life cycle of Trypanosoma brucei
Trypanosomes are parasitic protozoa that cause 
several important human and animal diseases. They are 
sub-divided into twomain groups, the South American 
Stercoraria (characterized by faecal transmission, e.g. 
Trypanosoma cruzi) and African Salivaria (characterized by 
salivary transmission, e.g. Trypanosoma brucei ) (Vickerman,
1985). Trypanosomes possess several unique features, 
which include microbody-like organelles (glycosomes), 
which contain the first nine enzymes of glycolysis 
(Opperdoes & Borst, 1977), a single highly branched 
mitochondria, and a huge organised network of mitochondrial 
DNA known as the kinetoplast (Borst & Hoeijmakers, 1979).
The African Trypanosomes, which cause sleeping 
sickness, have a very remarkable life cycle which includes 
the ability to evade the host immune system by antigenic 
variation of surface glycoproteins (Kolata, 1984). 
Trypanosoma brucei, responsible for nagana in cattle, is 
widely used as the biochemical model for its human 
pathogenic sub-species (T. rhodesiense and T. gambiense) 
(Opperdoes, 1985). During the life cycle of T. brucei 
from mammalian host to insect vector (the tsetse fly), 
dramatic changes occur in morphology and metabolism 
(Fairlamb, 1982). In the mammalian bloodstream, T. brucei 
appear to be exclusively dependent upon glucose for energy, 
being unable to metabolise fatty acids or amino acids due 
to the absence of a functional citric acid cycle or 
respiratory chain (Bowman & Flyn, 1976). In the insect
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gut, the situation is reversed. Here glucose is scarce 
and amino acids, such as proline, constitute the main 
energy source for the procyclic form of T. brucei (Broman 
et al., -4982), proline being oxidized and eventually 
entering a functional citric acid cycle as oxoglutarate 
(Ford & Bowman, 1973).
5*3*1 Specific association of STK activity with the
citric acid cycle
The bloodstream and procyclic (insect gut) cell 
forms of T. brucei provide an excellent example of a 
eukaryotic system in which the enzymes of either glycolysis 
or the citric acid cycle are repressed or derepressed.
Both A-STK and G-STK activities had been detected in the 
bloodstream form of T. brucei (see Table 8). We therefore 
compared the levels of the STKs in both bloodstream and 
procyclic forms of T. brucei , together with key enzymes of 
the glycolytic and citric acid cycle pathways. The 
results in Table 28 demonstrate the enzymic changes 
associated with the differing metabolic requirements of 
the bloodstream and procyclic cell forms. The specific 
activities of hexokinase and phosphoglucose isomerase 
(both glycosomal) and pyruvate kinase (cytosolic) are 
repressed in the procyclic cell form. Similar changes 
have also been reported by Hart et al. (1984). As 
predicted, the specific activities of citric acid cycle 
enzymes increased in the procyclic cell form. Interest­
ingly, citrate synthase activity was detected for the
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Table 28 Glycolytic and citric acid cycle enzymes in 
both bloodstream and procyclic cell forms 
of T. brucei
Enzyme Bloodstream(B) Procyclic(P) Ratio P/B
activities 
(nmo1.min ^ .mg ^)
Citrate synthase 0*34 2*7 7*9
A-STK 5*4 65*0 12*0
G-STK 1*0 1*7 1*7
NADP-Isocitrate 
dehydrogenase 3*4 28 8*2
Malate
dehydrogenase 130 1800 13*8
Hexokinase 460 13*5 0*03
Phosphoglucose 
isomerase 500 74 0*15
Pyruvate
kinase 30*5 9*4 0*31
Pellets of both cell forms were resuspended in 0*1 M sodium/ 
potassium phosphate buffer, containing 20 % (v/v) glycerol, 
pH 7*5, disrupted by U1trasonication and centrifuged (5000 
x g for 2 min at room temperature).
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first time in the long slender bloodstream form of 
T, brucei. Succinate dehydrogenase now appears to be the 
only enzyme of the citric acid cycle absent in the blood­
stream form, with the remaining enzymes of the cycle all 
attenuated (Ryley, 1962; Overall et al,» 1986). The 
results in Table 28 indicate that the specific activities 
of the citric acid cycle enzymes increase in concert from 
the bloodstream to procyclic forms. Significantly, it is 
A-STK and not G-STK which displays this marked elevation, 
thus clearly implicating A-STK as a component of the cycle.
5*3*2 Occurrence of ketone body-utilizing enzymes in both
forms of T, brucei
After identification of the associations of G-STK 
with ketone body utilization and porphyrin biosynthesis, 
the occurence of G-STK activity in both forms of T. brucei 
required explanation. Trypanosomes are thought not to be 
able to synthesise haem, so equine haemin has always been 
included in their growth media. Yet this area of their 
metabolism has not been thoroughly investigated and it has 
been suggested that the inclusion of haemin may not be 
essential (W. Gibson, personal communication). In the 
case of ketone body utilization no investigations have
been reported. The presence of ketone body-utilizing
enzymes was therefore sought in both forms of T, brucei.
Table 29 shows the existence of 3-oxoacid CoA-transferase
(OAT) and acetoacety1-CoA thiolase (ACT) activities in 
both forms of T, brucei. This is the first time that the










Bloodstream - total cell Ntt 




1 • 1 
2-3
= 4*3 x 10^ cells 
= 3 x 10^ cells
Extracts were prepared as in Table 28, page 188
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enzymes required for utilizing ketone bodies have been 
reported in T. brucei. These results are relevant to the 
recent identification of citrate synthase activity in the 
bloodstream form of T . brucei . The bloodstream form is 
known not to contain pyruvate dehydrogenase activity. It 
is therefore conceivable that the acetyl-CoA utilized by 
the newly identified citrate synthase may originate from 
the metabolism of ketone bodies.
Further attempts were made to clarify the association 
of G-STK with ketone body utilization in T. brucei. Table 
30 presents the specific activities of a number of citric 
acid cycle enzymes, together with the activities of the 
STKs and ketone body-utilizing enzymes, from procyclic 
cells grown in normal medium and normal medium + 10 mM 
acetoacetate or 3-hydroxybutyrate. Although the results 
are not as convincing, concerning association of G-STK 
with ketone body utilization, as in section 5*1, the only 
enzymes that show a significant elevation are G-STK, 
3-oxoacid CoA-transferase and acetoacety1-CoA thiolase.
The possible reasons for the presence of ketone body- 
utilizing enzymes in both forms of T. brucei will be 
discussed in section 6*4.
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Table 30 Citric acid cycle and ketone body-utilizing 
enzymes from procyclic cells grown in normal 
medium and medium supplemented with 
acetoacetate or (3-hydroxy but yrate




Citrate synthase 3*8 1*9 2*1
NADP-isocitrate
dehydrogenase 27 22 26
2-oxoglutarate
dehydrogenase 11*2 12*1 8*2
malate
dehydrogenase 1180 1000 1000
A-STK 49 35-4 40-1
G-STK 1-3 2*3 2*3
3-oxoacid
CoA-transferase 1*1 1*5 1*6
acetoacetyl-CoA
thiolase 1*3 2*4 2*0
Total cell counts - Normal medium = 2*55 x 10 cells
+ acetoacetate = 1*15 x 1 0 ^  cells
+ 8-hydroxy butyrate = 1*01 x 1 0 ^  cells
NB The ketone body supplements were added to established 
cultures 24 h before harvesting.






6 • 1 Introductory comments
As was emphasised in the Introduction, the vast 
majority of studies on STK have been concerned with the 
mechanistic and molecular aspects of the enzymes from 
E. coli and pig heart. The detailed molecular attributes 
of both these representative STKs continues to be 
elucidated (Wolodko & Bridger, 1987; Nishimura et al ., 
1988; Khan & Nishimura, 1988). However, very little 
attention has been focussed upon the possible metabolic 
significance of the diversity of molecular size and 
nucleotide specificity displayed by STK throughout Nature 
(Weitzman, 1981). Only one publication occurs in the 
literature, a minireview entitled "STK and metabolic 
control" (Ottaway et al.» 1981), which attempts to assess 
and rationalise the STK nucleotide specificity displayed 
by a tissue/organism in relation to the metabolic 
constraints placed upon that tissue/organism. The extent 
to which the observations and predictions of that paper 
correlate with the findings presented in this thesis will 
be discussed fully in sections 6*4 & 6*5.
Finally, in this opening section, it is perhaps 
appropriate to comment upon the possible reasons why the 
discoveries reported here were not observed by earlier 
workers. First, the initial confusion concerning the
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nucleotide specificity of pig heart G-STK (Kaufman, 1951; 
Sanadai et al., 1956) and the subsequent identification of 
G-STK activity in a number of mammalian tissues, may have 
influenced investigators to assay only for G-STK and to 
interpret any STK activity observed with adenine 
nucleotides as arising from the presence of nucleotide 
diphosphokinase (NDPK) activity. Secondly, our findings 
were greatly facilitated by our use of the polarographic 
method of enzyme assay (Weitzman, 1976). As discussed in 
Methods section 2*4*5, the use of the polariter was 
particularly suitable for examining the nucleotide 
specificity and dependency of STKs. The majority of 
investigators employ the discontinuous hydroxamate method 
(Kaufman, 1955) for determination of STK activity, even 
though as early as 1964, hydroxylamine was demonstrated to 
be a competitive inhibitor of STK with respect to CoA-SH 
(Cha et al.t 1964). Finally, the ability to measure 
polarographically the activity of STKs in the most turbid 
of extracts permits the detection of STK activities even 
when the various spectrophotometric methods are unsuitable.
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6 •2 Eukaryotic STKs 
6*2*1 Distinct STKs
The discovery of the existence of two distinct STK 
enzymes, within animal tissues, which possess strict 
specificity for their respective nucleotides is one of 
the most significant findings presented in this thesis.
The subsequent studies concerning prokaryotic STKs and the 
metabolic roles of eukaryotic STKs were prompted by the 
discovery of two distinct enzymes.
The occurrence of A-STK and G/I-STK enzymes appears 
to be a general phenomenon throughout the eukaryotic 
organisms examined. In contrast to Ottaway and co-workers 
(Ottaway et al. * 1981), both enzyme activities were found 
in all mammalian tissues, locust flight muscle and pigeon 
breast muscle. Both activities were also detected in 
toluenized yeast cells, zea maize mitochondrial and 
Trypanosoma brucei cell extracts.
The possibility that the detection of STK activities 
linked to adenine nucleotides (ATP/ADP) may be artifactual, 
due to the presence of NDPK activity, was addressed. 
However, this hypothesis was rejected, first because in a 
number of tissues (i.e. brain & skeletal muscle) A-STK 
activities were greater than G-STK activities and, 
secondly, because of the ability to obtain additivity of 
both the enzyme activities in a single source. Hamilton & 
Ottaway (1981) reported the presence of GTP-dependent and 
ATP-dependent STK activities, yet remained uncertain as to 
whether they were dealing with a system containing two
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enzymes or an enzyme of broad specificity; however they 
emphasised that the presence or absence of NDPK had no 
effect on the ratios of the G-STK/A-STK activities they 
observed. The inclusion of EGTA in mitochondrial 
extraction buffers, known to effect removal of NDPK 
activity from mitochondria (Pedersen, 1973), effectively 
rules out any NDPK involvement. Even in vivo, the 
significance of NDPK on the STK system and equilibrium 
between intramitochondrial nucleotides has been questioned 
(Ottaway et a l .♦ 1981). In our studies no changes in the 
G-STK/A-STK ratios could be seen even between crude tissue 
and washed mitochondrial extracts. The fact that very 
little, if any, NDPK activity occurs within the 
mitochondrial matrix (Pedersen, 1973) makes it difficult 
to understand biochemical text-book assertions that the 
GTP produced by the substrate-level phosphorylation step 
of the citric acid cycle is used to rephosphorylate ADP, 
by the action of NDPK (Stryer, 1988).
The demonstration and then separation of G-STK and 
A-STK enzymes from animal tissues might of course reflect 
cell heterogeneity within the tissues; such a claim has 
been made for hepatic parenchymal cells (Jungermann & 
Sasse, 1978). That this is unlikely to be the explanation 
is supported by our examination of two cell lines - mouse 
lymphoma L1210 and baby hamster kidney (BHK) cells. 
Extracts of both these cell types displayed GDP-dependent 
and ADP-dependent STK activities, indicating the presence 
of both enzymes within single cells. Moreover, the ratio
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of G-STK/A-STK in the BHK cell line was similar to that 
obtained in kidney tissue extracts.
Throughout this investigation no evidence was 
obtained for the occurrence of any extra-mitochondrial STK 
activity in eukaryotic organisms, apart from the traces of 
A-STK and citrate synthase activity detected in zea maize 
etioplasts, a finding that will be commented upon in 
section 6*4.
The distinct nucleotide specific STKs found in all 
animal tissues appear to be very similar, apart from 
tissue distribution and stability variations, with respect 
to molecular size, pH optimum and substrate affinities.
All eukaryotic STKs examined by previous investigators 
were ’small1 (Mr< 100,000) (Weitzman, 1987). In the 
present work, the A-STK and G-STK enzymes from bovine 
heart, pigeon breast muscle and pig liver were all shown 
to possess molecular weights estimated at between 
79,000-85,000.
Upon separation of A-STK and G-STK activities from 
bovine heart mitochondria, it was noticed that neither of 
the separated enzymes displayed any activity whatsoever 
with the other nucleotide. In fact the activities of both 
A-STK and G-S'TK were shown to be inhibited by the 
presence of GDP and ADP respectively. This result 
explained why only partial additivity of both STKs was 
observed when activity measurements were made in extracts 
in the presence of both nucleotides. Interestingly, ADP 
was shown to be a competitive inhibitor, with respect to
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GDP, for the G-STK, possessing a value of-^230 yM. As 
the concentration of ADP within the mitochondrial matrix 
is probably of the order of 1-10 mM (Soboll et al., 1978), 
compartmentation of the STKs and their respective 
nucleotide substrates must be occurring to allow operation 
of G-STK.
6*2*2 Purified STKs
The purifications of pig liver G-STK and pigeon 
breast A-STK, both relatively rich sources of each enzyme, 
were carried out with a view to devising procedures for 
eventually purifying both enzymes from a single source, 
e.g. bovine heart mitochondria. An adenine nucleotide- 
specific STK had not previously been purified to 
homogenicity from any eukaryotic source, despite a recent 
attempt to purify A-STK from baker's yeast (Schwartz et 
al.t 1983). Soon after the establishment of a purification 
procedure for pigeon breast A-STK, Allen & Ottaway (1986) 
published a procedure for partial purification of A-STK 
from pigeon breast muscle. Significantly, their 80% 
purified A-STK (in terms of protein) had a specific 
activity of 1*5 units mg  ^ protein, which is near the 
value of 1*83 units mg  ^ protein that was obtained for the 
electrophoretically homogeneous enzyme. These similar 
results confirm the relative low activity of pigeon 
breast A-STK in comparison with the high oxidative 
capacity of pigeon breast muscle (Allan & Ottaway, 1986). 
The purification of pigeon breast A-STK required
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hydroxylapatite, affinity and fast protein liquid 
chromatographic procedures, whereas the purification of 
pig liver G-STK did not require the final FPLC procedure. 
The specific activity of the pig liver G-STK was close to 
that obtained for the rat liver G-STK (Ball & Nishimura,
1980), although higher specific activities have been 
reported for the pig heart G-STK (Brownie & Bridger, 1972). 
In general, the overall purification yields of homogeneous 
STK enzymes from eukaryotes have been low (Nishimura,
1986), and this was also reflected in the yields obtained 
for the purified enzymes from pig liver and pigeon breast.
As previously discussed (section 3*7), initial 
attempts to purify A-STK and G-STK from a single source 
were unsuccessful. However, the preliminary results from 
the screening of the triazine-dye columns and subsequent 
bio-specific elutions, provides a foundation for future 
purification, which will then allow direct molecular 
comparisons.
With the establishment of clear evidence for two 
distinct STKs in animal tissues, we then addressed the 
intriguing possibility that they may serve differing 
metabolic roles. The results of physiological studies are 
discussed in section 6*4.
~ 2 0 0  "
6•3 Prokaryotic STKs
Novel nucleotide specificity
Gram-negative bacteria, in contrast to Gram-positive 
bacteria, possess a ’large’ citrate synthase (a hexamer of 
identical subunits) and a ’large' STK (an a2^2 tetramer) 
(Weitzman, 1981). During our studies, on a number of 
Gram-negative bacteria, no evidence was found for the 
existence of more than one STK enzyme; rather, under 
whatever growth conditions or media used (e.g. 
Rhodopseudomonas spheroides grown aerobically or anaer­
obically), no changes in the ratio of GDP-dependent or 
ADP-dependent STK activities were detected. These results 
were in line with the pattern that ’large1 STKs are able 
to utilize guanine and adenine nucleotides, whereas the 
’small’ STKs found in eukaryotes and Gram-positive 
bacteria are specific for either adenine or guanine 
nucleotides.
Previously, only A-STK activities have been found in 
Gram-positive bacteria (Weitzman & Jaskowska-Hodges ,. 1982 ) . 
Our discovery of an STK of novel nucleotide specificity 
was therefore most surprising. As previously discussed 
(section 4*1), guanine and inosine nucleotide utilization 
was considered to be characteristic of all G-STKs, with 
only A-STKs being strictly specific for adenine 
nucleotides. However, in a number of Gram-positive 
bacteria, an STK activity strictly specific for IDP 
occurred, which was in fact inhibited by GDP. These 
observations were significant because, prior to this
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discovery, Gram-positive bacteria were the only organisms 
apparently unable to display STK activity with at least 
tv/o nucleotides. It therefore now appears that all 
organisms possess the capability to utilize adenine, 
guanine or inosine nucleotides during STK activity.
6*3*2 Distinct STKs
After the detection of IDP-dependent and ADP- 
dependent STK activities from Bacillus megaterium, 
attempts were made to separate the two STK activities. 
Unfortunately, all such attempts (i.e. using affinity 
chromatography and FPLC procedures) proved unsuccessful 
due to the instability of enzyme activity. The inclusion 
of glycerol, protease inhibitors and reducing agents all 
failed to stabilize the activities. However, indication 
of the existence of distinct STK enzymes was obtained from 
additivity and optimum activity pH profile studies. These 
results were complemented by comparative enzyme activity 
and nucleotide dependence studies. A 10-fold change in 
the A-STK/I-STK ratios was obtained with B . megaterium, 
between early logarithmic and early stationary phases 
during growth on nutrient broth. This change originated 
from a rise in I-STK specific activity rather than a 
marked change in A-STK specific activity. Such wide 
changes in the ratio of A-STK/I-STK activities were also 
observed when B . megaterium was grown on other carbon 
sources, such as succinate and glucose. The arguments 
rehearsed when proposing distinct STKs in animal tissues
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were also valid in this system. The occurrence of two 
distinct STKs, each specific for its own nucleotides, was 
a simpler explanation than that of a single enzyme whose 
nucleotide specificity changed, depending upon the growth 
phase of the bacterium or the carbon source being utilized.
Perhaps the strongest indication of a distinct I-STK 
enzyme was obtained when the Km values for IDP and ADP 
were compared. The lower Km value, obtained for IDP, 
ruled out any possibility that IDP was converted to ADP, 
thus providing a substrate for A-STK.
The occurrence of differences in STK ratios is 
indicative of the STKs playing differing metabolic roles 
within the bacterium. Identification of an STK 
specifically utilizing inosine nucleotides poses questions 
as to the provision of IDP/ITP and the possible 
participation of inosine nucleotides in metabolism. Very 
little is known about inosine nucleotides in general 
metabolism, apart from the involvement of IMP in the 
biosynthesis of adenine and guanine nucleotides and the 
occurrence of inosine in the anticodon triplet of yeast 
alanine t-RNA (Lehninger, 1975). Thus, although inosine 
nucleotides are known to be able to replace guanine 
nucleotides in many enzyme reactions, they are still 
regarded as the ’poor relations’ among nucleotides. It 
may well be that, just as guanine nucleotides play a more 
significant role in cellular metabolism than was once 
thought, inosine nucleotides may also be involved in a 
range of other processes.
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The screening of a variety of Gram-positive bacteria, 
with respect to their STK nucleotide specificities, 
revealed that a number of bacteria displayed similar A-STK 
and I-STK activities to those found originally in 
B. megaterium. However, certain bacteria displayed STK 
activities with only ADP and GDP, or with all three 
nucleotides (ADP, GDP & IDP), e.g. Corynebacterium rubrum. 
Interestingly, C. rubrum appears, on the basis of 
molecular weight, to possess distinct A-STK and G/I-STK 
enzymes. It is therefore apparent that, despite earlier 
assertions, Gram-positive bacteria do indeed possess more 
than one STK enzyme.
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6•4 Physiological studies
"It is not unusual to find that where a chemical 
reaction serves more than one purpose in the cell, the 
enzyme catalysing that reaction is synthesised injnultiple 
forms” (Kornberg, 1970).
The discovery of two distinct enzymes catalysing the 
same basic reaction poses the possibility that the enzymes 
may be responsible for operating the reaction in opposite 
directions. Within many organisms, succinyl-CoA is 
involved in three main metabolic processes: first in the
citric acid cycle, secondly in ketone body activation and 
finally as a precursor of porphyrin. Even though the 
succinate thiokinase reaction is regarded as an 
equilibrium reaction, the operation of the citric acid 
cycle would cause the reaction to operate in the 
direction of succinyl-CoA hydrolysis, whereas during 
ketone body activation or porphyrin biosynthesis, if the
i
succinate thiokinase reaction were involved, it would 
operate in the direction of succinyl-CoA formation.
In the case of porphyrin biosynthesis, evidence for 
the formation of the required succinyl-CoA direct from 
succinate was obtained early in the elucidation of the 
porphyrin biosynthetic pathway (Shemin & Kumin, 1952). 
However, much confusion still exists concerning the role 
of STK, in relation to the activation of acetoacetate and 
operation of the citric acid cycle.
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6*4*1 Ketone body activation
Ottaway and co-workers (McClellan & Ottaway, 1980; 
Hamilton & Ottaway, 1981; Ottaway et al.» 1981) have 
suggested that ketone body utilization requires the 
partitioning of succinyl-CoA (formed by 2-oxoglutarate 
dehydrogenase) between 3-oxoacid CoA-transferase (OAT) and 
STK. The Km for succinyl-CoA is very much lower for STK 
(~30-50 yM) than for OAT ( 4*2 mM) so that they proposed 
that inhibition of STK was necessary to permit ketone body 
activation. Such inhibition they believed might be 
effected by maintaining a high NTP/NDP ratio. In support 
of these proposals they noted that various animal tissues 
able to utilize acetoacetate possessed G-STK activities. 
They first stated that: "The correspondence between 
intensive acetoacetate utilization and guanine nucleotide- 
linked STK is good but not absolute. The corollary that 
acetoacetate activation by muscle is linked to the 
inability to use adenine nucleotides, does not appear to 
hold" (McClellan & Ottaway, 1980). Secondly, in 
connection with the proposed inhibition of STK during 
acetoacetate utilization, they cited (Ottaway et al.,
1981) mitochondrial matrix values of ATP/ADP^l and GTP/ 
GDP~100, thus producing the product inhibition of G-STK 
activity. This proposed inhibition of STK to permit 
ketone body metabolism, when that very metabolism requires 
citric acid cycle flux, presents a difficulty which would 
only be overcome if there were an effective transfer of 
succinate from OAT to succinate dehydrogenase. However,
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our discovery of the existence of two STK enzymes, each 
specific for its nucleotide substrate, offers a solution. 
The two enzymes allow metabolic compartmentation of the 
succinate thiokinase reaction, which enables the supply 
of succinyl-CoA for ketone body activation with concom­
itant operation of the citric acid cycle. The results 
presented in section 5*1 clearly implicate G-STK as being 
linked to ketone body activation. However, unlike 
Ottaway who predicted product inhibition of G-STK 
activity, we discovered elevation in the specific activity 
of G-STK in tissues characterized by ketone body 
utilization. It is significant that in normal well fed 
rat tissues, where the levels of ketone body-utilizing 
enzymes, OAT and ACT, are greatest, e.g. heart & kidney, 
(Middleton, 1973 and Beis et al., 1980), the highest 
levels of G-STK activities were detected. This 
correlation was also found to be evident when looking at 
tissues with relatively low levels of OAT and ACT, e.g. 
brain & skeletal muscle; here, low levels of G-STK were 
detected. No such connections apparently existed with 
A-STK activities within rat tissues. Instead of the 10- 
fold change in G-STK specific activities, A-STK specific 
activities appeared to be surprisingly constant between 
rat tissues. The increase in brain ketone body 
utilization which occurs with elevation of plasma ketone 
body concentrations allowed measurement of a marked rise 
in G-STK specific activity, from a very low level to that 
approaching or surpassing that found in normal heart
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tissue. Such changes were not seen in skeletal muscle. 
Skeletal muscle, although low in OAT, ACT and G-STK 
activities, is still, due to its relative contribution to 
body mass (~40%), an important site of peripheral ketone 
body utilization (Robinson & Williamson, 1980; Beiss et 
al., 1980). However a number of studies (Beatty et al.,
1960, 1964) have shown that ketone body utilization by 
skeletal muscle was reduced in the diabetic state, but 
that on addition of insulin skeletal muscle again utilizes 
ketone bodies and glucose (Balasse & Havel, 1971).
The changes seen in brain G-STK activity upon 
elevation and reduction of plasma ketone body concentrat­
ions induced by diabetes and controlled with insulin, 
implicate G-STK as supplying succinyl-CoA for the 
activation of acetoacetate. When this information is 
correlated with the predicted high mitochondrial GTP/GDP 
ratio (Ottaway et al.* 1981), it would appear that G-STK 
does indeed catalyse the reaction of succinate to 
succinyl-CoA utilizing GTP. Much disagreement exists 
concerning the levels and the ratios of nucleotides within 
mitochondria. Such evidence that exists will be discussed 
in section 6*5. What is clear, however, is that G-STK 
appears to be far from inactive during ketone body 
activation; rather, it displays elevated specific 
activities.
6*4*2 Porphyrin biosynthesis
As has been emphasised in section 5*2, the initial
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studies of Shemin & co-workers revealed the role and 
sources of the succinyl-CoA utilized in porphyrin
biosynthesis. The results of Shemin and Kumin (1952),
14 14
using C-carboxy1-labelled and C-methylene-labelled
succinate in the presence and absence of malonate, 
established that the succinyl-CoA which acted as a pre­
cursor of haem, could originate both from oxoglutarate, 
via normal citric acid cycle activity, and directly from 
succinate. This result therefore revealed the 
reversibility of the succinate thiokinase reaction even 
before the reaction had been fully characterized. 
Previously, over 20 years ago, Labbe and co-workers (Labbe 
et al. , 1965) demonstrated that in porphyrinogenic liver 
an elevation in STK activity (~70%) occurred which 
preceded any increased synthesis of S-aminolaevulinate and 
subsequent intermediates of the porphyrin biosynthetic 
pathway. After our discovery of both G-STK and A-STK 
enzymes in eukaryotes and identification of an association 
between G-STK and acetoacetate activation, we repeated 
Labbe's initial experiment. Examination of hepatic STK 
activities during porphyria revealed a specific elevation 
of G-STK, with no change in citrate synthase or A-STK 
activities. Interestingly, Labbe et al. (1965) presented 
evidence for the existence of two G-STKs in hepatic 
mitochondria, one constitutive enzyme, unchanged by 
induction of porphyria, and one that was inducible (3-fold 
in activity). Labbe & co-workers may have considered the 
constitutive G-STK as enabling the citric acid cycle to
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function. However, a second requirement for succinyl-CoA 
may exist within the hepatic mitochondrion, besides that 
required for porphyrin biosynthesis. As discussed earlier 
in section 5*1*2, specific succinylation and inhibition of 
the enzyme hydroxymethylglutary1-GoA synthase may be a 
regulator for this enzyme (Lowe & Tubbs, 1985) and 
therefore of ketogenesis. The existence of at least two 
distinct STKs appears to allow compartmentation of the 
succinate thiokinase reaction, which in the hepatic and 
extrahepatic mitochondrion seems to be required to 
operate in both directions at the same time (citric acid 
cycle and porphyrin biosynthesis/ketone body activation). 
To achieve and maintain this bidirectionality, two STKs 
appear to be present, possessing mutually exclusive 
nucleotide specificity and control. The G-STK operates in 
the direction of succinyl-CoA formation and is responsible 
for the supply of succinyl-CoA for porphyrin biosynthesis 
and ketone body metabolism, whereas the A-STK enzyme may 
be involved in maintaining the flux through the citric 
acid cycle, operating in the direction of succinyl-CoA 
hydrolysis.
In plant tissue (zea maize) the detection of both 
A-STK and G-STK within mitochondria may indicate that, 
although chlorophyll biosynthesis requires glutamate 
rather than succinyl-CoA as a precursor, the situation may 
be reversed in the mitochondria. The possibility that the 
synthesis of haem, required for cytochromes, may occur via 
succinyl-CoA to form 6-aminolaevulinate, by the action of
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low levels of 6ALA-synthase has been suggested by Fluhr 
and Harel (1975). However, detection of A-STK and citrate 
synthase activity within zea maize etioplasts may either 
result from mitochondrial contamination or represent 
possible dark phase respiration.
6*4*3 Citric acid cycle
After observing the specific association of G-STK 
with ketone body activation and porphyrin biosynthesis it 
was thought that A-STK would be associated with the 
remaining major metabolic process involving succiny1-CoA, 
i.e. the citric acid cycle. The bloodstream and procyclic 
cell forms of Trypanosoma brucei provided an ideal system 
to investigate the involvement of STK within the citric 
acid cycle. The concerted rise in A-STK, and not G-STK, 
with other citric acid cycle enzymes upon transformation 
from bloodstream to procyclic cell forms emphasised again 
the separate roles of each STK. However, the occurrence 
of G-STK in T, brucei would indicate, in the light of 
earlier studies, that either ketone body activation or 
porphyrin biosynthesis was occurring within T. brucei. 
Although the synthesis of porphyrin within the bloodstream 
form is unlikely, due to an absence of cytochromes (Ryley, 
1962), the possibility of such biosynthesis within the 
procyclic cell forms has not been ruled out (W. Gibson, 
personal communication). However, the fact that G-STK 
specific activities were similar in both cell forms 
probably excludes an association with porphyrin
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biosynthesis. In the case of ketone body activation our 
investigations soon established, for the first time, 
ketone body utilizing enzymes. It is significant that the 
natural host for T. brucei is not the laboratory rat but _ 
rather cattle and other ruminants. Ruminants differ from 
more simple stomached animals in that there are large 
rates of alimentary ketone body release into the blood­
stream, due to microbial fermentation in the rumen 
(Heitmann et al.» 1987). This means that ruminants, with
both alimentary and hepatic ketogenesis, have circulating 
concentrations of ketone bodies at least 4-5 times those 
seen in most fed non-ruminants (Williamson & Whitelaw, 
1978). The bloodstream form of T. brucei thus appears to 
possess the enzymes required for utilizing the available 
acetoacetate, probably for biosynthetic purposes. The 
ketone body utilizing enzymes OAT and ACT were also found 
in the procyclic form of T. brucei, which occurs in the 
vector, the tsetse fly. There have been limited studies 
on the importanct of ketone bodies in insects.
Acetoacetate is known to increase in concentration in the 
haemolymph of desert locust (Schistocerca gregaria) during 
flight and starvation. Higher concentrations of ketone 
bodies have been reported in the haemolymph of the 
cockroach (Periplancta americana) (Candy, 1985). Ketone 
body utilizing enzymes have also been detected in the 
nervous tissue of a number of insects (Sugden & Newsholme, 
1973; Beis et al», 1980). Bailey et a l .(1972) have shown 
that acetoacetate is the principal ketone body in
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haemolymph, whereas B-hydroxybutyrate is predominant in 
the fat body of insects. It is apparent that ketone 
bodies have the same glucose sparing role in insects as 
that exhibited in mammals, by supplying energy to nervous 
tissue and muscles when glucose is scarce. Therefore it 
is consistent, in view of the association between G-STK 
and ketone body utilization, to have observed A-STK and 
G-STK in both bloodstream and procyclic cell forms of 
T. brucei. The slight changes observed in G-STK, OAT and 
ACT activities, in procyclic cells supplemented with 
ketone bodies, confirmed this association.
The identification of A-STK as a component of the 
citric acid cycle in the eukaryotic protozoan T. brucei 
may indicate a wider association throughout nature of 
A-STK with the citric acid cycle. In rat tissues it is 
significant that, although A-STK specific activities are 
relatively constant between tissues, the highest activity 
is found in heart, which possesses the highest oxidative 
capacity of all tissues. If A-STK is indeed an integral 
part of the citric acid cycle, the succinate thiokinase 
reaction would provide a direct control point for cycle 
flux that is sensitive to the final product of the cycle, 
i.e. ATP. A-STK would allow a slowing down of the citric 
acid cycle when ATP concentrations were high due to 
product inhibition, yet facilitate citric acid cycle flux 
at higher ADP concentrations. This mechanism may operate 
in collaboration with the other regulatory mechanisms that 
have been proposed for the cycle (Williamson & Cooper, 
1980; Rutter & Denton, 1988).
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6•5 Final conclusions
6*5*1 In vivo enzyme organization
There is growing interest in intracellular enzyme 
organization, i.e. non-or ganeJLle compartmentation of 
metabolism through organized multienzyme systems. Various 
interactions between citric acid cycle enzymes have been 
observed in prokaryotic and eukaryotic organisms (Srere 
et al., 1987; Beeckmans & Kanarek, 1987), as well as a 
loosely associated multienzyme cluster (Barnes & Weitzman, 
1986). The latter consists of five sequential enzymes, 
from fumarase to isocitrate dehydrogenase, which elutes 
from a gel filtration column as a high molecular weight 
cluster. Such a multienzyme cluster, which can catalyse 
the sequence of reactions leading from fumarate to 
oxoglutarate, appears to be capable of catalytic 
enhancement and/or channelling of intermediates compared 
with a mixture of the unassociated enzymes.
Along with the molecular and metabolic studies 
carried out on the eukaryotic STKs, attempts were made to 
identify any possible physical associations between STKs 
and other metabolically related enzymes.
G-STK and 3-oxo-acid CoA transferase are known to 
display limited co-purification (W.A. Bridger, personal 
communication). This information, together with the 
strong association between G-STK and acetoacetate 
activation, prompted the examination of the possible 
physical association between G-STK and OAT. Gentle 
osmotic lysis of mitochondria was carried out using a
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similar procedure to that successfully used in 
identification of the high molecular weight cluster of 
citric acid cycle enzymes (Barnes & Weitzman, 1986). 
Affinity chromatography was used to study the G-STK/OAT 
system from Percoll fractionated bovine heart mitochondria, 
after gentle osmotic lysis. However, no association 
between G-STK and OAT was observed. In the case of the 
ultracentrifugation experiments, centrifugation (150,000 
x g for 3 h) of osmotically lysed mitochondrial 
supernatants, which is sufficient to sediment 
2-oxoglutarate dehydrogenase, lead to a loss of A-STK 
activity from the supernatant, while G-STK specific 
activity increased. However, no A-STK activity could be 
detected in the pellet. Porpaczy et al. (1983) have 
reported specific association between purified pig heart 
G-STK and OGDH enzymes, using co-precipitation studies 
with polyethylene glycol. This may or may not represent 
the true in vivo enzymic organization. The molecular and 
kinetic similarities that exist between G-STK and A-STK, 
may reflect a very close resemblance that may exist 
between the two STKs at the molecular level and confer 
upon G-STK the potential to interact with OGDH, even 
though A-STK may be the true in vivo partner. Apart from 
this report of OGDH and G-STK co-precipitation, STK 
appears to be the only citric acid cycle enzyme which has 
not been clarified as possessing direct or indirect 
membrane association. The reason for the absence of 
association evidence could be that investigators have
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concentrated their studies on G-STK, rather than the 
recently discovered A-STK.
6*5*2 Mitochondrial nucleotides
Due to the absence of a specific GTP/GDP trans­
location system in the inner mitochondrial membrane, 
guanine nucleotides (GTP/GDP), unlike adenine nucleotides 
(ATP/ADP), appear to be trapped within the mitochondrial 
matrix (Klingenberg & Heldt, 1982). This means that 
guanine nucleotides are either ’entrapped’ during 
mitochondriogenesis, generated intramitochondrially from 
adenine nucleotides or transverse the inner mitochondrial 
membrane, but at rates which short-term experiments cannot 
detect. Such translocations of guanine nucleotides have 
been suggested (Soling, 1982) but never demonstrated. In 
comparison with adenine nucleotides, which have been 
thoroughly investigated, guanine nucleotides have 
attracted far less attention. This discrepancy is 
partially due to the apparent absence of a specific trans­
location system and also due to the difficulties 
associated with measurement of guanine nucleotide 
concentrations. When Ottaway et al. (1981) proposed a
link between GTP-product inhibition of G-STK and ketone 
body activation, they claimed that in the mitochondrial 
matrix, although the ATP/ADP ratio was ^ 1, the GTP/GDP was 
as much as 2-orders of magnitude higher. These claims 
were based on reports (Smith et al.* 1974; Williamson et 
al . , 1972) of measurements of GTP/GDP ratios within liver
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and heart mitochondria. However, disagreement exists 
about such a large difference in ratios. There is 
general agreement that the ratio of ATP/ADP within 
mitochondria is close to unity, depending upon whether the 
mitochondria are actively respiring (state 3) or resting 
(state 4), but in the case of the GTP/GDP ratio differ­
ences exist in the estimated values. In the mitochondrial 
matrix, the GTP-AMP phosphotransferase reaction appears to 
be the only means of phosphorylating AMP, produced from 
the activation of short chain fatty acids. From the 
equilibrium constant of this enzyme and the mitochondrial 
ADP/AMP ratios observed, a minimum value of the free 
GTP/GDP ratios can be calculated. When such measurements 
were made, the evaluated GTP/GDP ratios were demonstrated 
to be at least 10-times higher than the ATP/ADP ratios 
(Klingenberg & Heldt, 1982). However GTP/GDP ratios as 
low as 2*2 have been proposed within liver mitochondria 
(Siess & Wieland, 1979). At present no accurate method 
exists for the determination of GDP concentrations within 
the mitochondrial matrix. It is possible that all 
nucleotides may be compartmentalized within the matrix, so 
that the exact ratios (NTP/NDP) in vivo may vary greatly 
from the estimated values.
Ottaway et al. (1981) have rightly emphasised that 
nucleotide diphosphokinase (NDPK), which would be expected 
to normalize any differences between the two ratios, 
exists predominantly in the cytosol, with only 5% of the 
total cellular NDPK activity present in mitochondria.
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Moreover, very little of this activity appears to be 
inside the inner mitochondrial membrane; rather it is 
located in the intermembranal space (Pedersen, 1973). 
However, some controversy exists over the absence or 
presence of NDPK activity within the mitochondrial matrix, 
a situation further complicated by apparent species and 
tissue variations (Soling, 1982). If significant amounts 
of NDPK do indeed occur in the matrix, it would appear 
that the reaction favours transfer of a phosphoryl group 
from ATP to GDP. The enzyme from both liver and heart has 
been shown to be strongly inhibited at ADP concentrations 
above 50 yM (Colomb et al.t 1969, 1972) so that the enzyme 
would favour GTP formation rather than GTP utilization. 
These results have largely been overlooked by most 
biochemical text-books, which confidently predict that the 
GTP produced by the substrate level phosphorylation step 
of the citric acid cycle, is used by NDPK to phosphorylate 
ADP (Stryer, 1988).
6*5*3 Possible origins of GTP & succinate
Our proposal that A-STK is responsible for 
catalysing the conversion of succinyl-CoA to succinate, 
resulting in direct production of ATP from the citric acid 
cycle, poses no problems with respect to the provision of 
succinyl-CoA or ADP as substrates. However, the proposal 
that G-STK catalyses the reverse reaction, producing 
succinyl-CoA from succinate, requires the provision of GTP 
and succinate.
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Intramitochondrial GTP is required for mitochondrial 
protein synthesis, the regeneration of ADP from AMP and 
now, in the light of our hypothesis, as a substrate for 
G-STK^ Previously, substrate level phosphorylation was 
considered to be the main provider of intramitochondrial 
GTP. However, Krebs & Wiggins (1978) recognised that "an 
additional GTP-generating mechanism within the 
mitochondrial matrix must be postulated", to account for 
the rephosphorylation of AMP, generated by the medium- 
chain fatty acid thiokinase (butyrate-CoA ligase AMP- 
forming) enzyme. They suggested that the majority of the 
GTP formed in the matrix, and utilized in AMP phosphory­
lation, would originate from NDPK activity. However, 
another possible source of GTP, would be the enzyme 
phosphoenolpyruvate carboxykinase (PEPCK). This enzyme 
catalyses the following reaction:
phosphoenolpyruvate + C02 + GDP ;— *■ oxaloacetate + GTP
A tissue specific distribution of PEPCK between the 
cytosol and mitochondrial matrix is known to occur (Soling, 
1982). In the mitochondrial matrix, the direction of the 
PEPCK reaction has not been clarified. PEP concentrations 
of ~3  mM have been determined within mitochondria, whereas 
concentrations of oxaloacetate (OAA) have been calculated 
to be as low as 1*5 uM (Srere, 1967; Soling, 1982).
However, even this quoted OAA concentration may not 
represent the free OAA concentration within the matrix,
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since a number of OAA binding sites exist, e.g. citrate 
synthase, pyruvate carboxylase, malate dehydrogenase, 
oxaloacetate decarboxylase, glutamate-oxaloacetate amino­
transferase and PEPCK itself. Furthermore, PEP has been 
found to be a very effective counter ion for citrate 
exchange across the inner mitochondrial membrane 
(Robinson, 1971). The incoming PEP, which originates from 
glycolysis, has therefore been proposed, to be converted 
into OAA by mitochondrial PEPCK. Such a mechanism would 
not only provide GTP for the G-STK reaction but also the 
required precursor (OAA) for succinate formation. After 
the initial identification that the succinyl-CoA utilized 
in porphyrin could originate directly from succinate 
(Shemin & Kumin, 1952) the possible sources of succinate 
were further investigated. Identification of an elevation 
in hepatic G-STK activity, upon induction of porphyria 
(Kurumada & Labbe, 1966), lead to the origin of succinyl- 
CoA being sought. Kurumada and Labbe (1966) were able to 
repeat the work of Shemin & Kumin (1952) and went on to 
identify, through isotope labelling studies, fumarate as 
the source of succinate. They were also able to 
demonstrate detection of an NADH-dependent fumarate 
reductase activity. Thus, there exists the possibility 
that fumarate arises from the reverse operation of the 
citric acid cycle enzymes fumarase and malate 
dehydrogenase, with OAA arising from carboxylation of 
pyruvate or phosphoenolpyruvate.
In brain mitochondria, where elevation of G-STK
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activity accompanies increased ketone body utilization, 
the operation of the GABA-shunt may possibly provide a 
source of succinate. However, during activation of 
acetoacetate by OAT, succinate would be continually 
regenerated (Fig. 45), while CoA would be removed as 
acetoacety1-CoA. Thus for ketone body utilization, the 
supply of CoA, for G-STK activity, may be more important. 
The fact that 90% of total cellular CoA occurs within the 
mitochondria probably would ensure its availability 
(Idell-Wenger et al., 1978).
6*5*4 Possible compartmentation of STK activities 
At present our knowledge of the structural 
complexity of cells and their organelles is limited.
Srere (1981) has indicated that the mitochondrial matrix 
contains a high concentration of closely packed proteins, 
so much so that the matrix of mitochondria may be regarded 
as possessing a semi-solid state with proteins existing 
almost in a crystalline structure. The consequences of 
such a model would be to produce microenvironments between 
the protein/enzyme structures which could contain high 
concentrations of intermediates even if the overall 
concentrations were low within the cell. Separate pools 
of nucleotides and metabolites could also be maintained, 
as well as the channelling of substrates from one enzyme 
to the next, along a specific pathway. It may be that 
such compartmentation of the STKs and/or components of the 
succinate thiokinase reaction occurs, so that the
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succinyl-CoA formed during the operation of the citric 
acid cycle is distinct and separate from the succinyl-CoA 
utilized in ketone body activation and/or porphyrin 
biosynthesis
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6•6 Future work
The STK system provides an excellent model to 
investigate the factors governing molecular recognition of 
nucleotides, which are likely to be relevant to -other 
enzyme systems. Comparison of the molecular structures of 
the nucleotides ADP, GDP and IDP suggests that the 
substituent groups on C-6 of the purine ring may be 
important in binding or recognition of the nucleotide to 
the particular STK. Purification of A-STK and G-STK from 
a single eukaryotic source will allow direct comparisons 
of their subunits by proteolytic fragmentation and peptide 
/amino acid analysis. It may therefore be possible to 
determine whether the STKs possess similarities between 
subunits and eventually probe the molecular basis of their 
nucleotide specificity.
Further work is also required on the kinetic and 
molecular characterization of the induced liver G-STK 
during porphyria, and the elevated G-STK from brain during 
enhanced ketone body utilization. This information 
together with investigations into the means of regulation 
of these enzymes (e.g. de novo protein synthesis and/or 
specific activation) will complement the basic molecular 
comparison studies and may lead, in the long term, to 
molecular biological studies into the organization and 
regulation of the expression of the STKs.
Another area of interest worthy of investigation is 
the possible differential organization and association of 
the STKs with other metabolically related enzyme systems
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within the mitochondria. Techniques which have been used 
successfully in identifying possible enzyme/enzyme 
interactions and associations within cells and their 
organelles, should be employed in respect to both the 
G-STK and A-STK enzymes.
Finally, although some of the metabolic processes 
relating to nucleotide specificity are now apparent, the 
metabolic significance(s) of the molecular size diversity 
observed between Gram-negative bacteria and other 
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-Dissolve in order (w/v):
1 *2% sodium/potassium tartrate 
+ 2% Na2C03 + 2*5% NaHC03 
+ 1*8% potassium oxalate and 
store at 4°C.
II Nelson’s reagent:
Dissolve 10 g NH4M0O4
180 ml of distilled water and 
slowly add 8*4 ml of conc. H2S04 . 
10 ml of 12% (w/v) Na2HA504 • 7H20 
are then added, and the mixture 
made up to 200 ml and stored 
at 37°C.
III Tris/hydrazine buffer:
To 1 ml of hydrazine hydrate 
add 20 mg EDTA + 2*5 ml 2 M HC1. 
Then dilute with 100 mM Tris-HCl 
buffer, pH 8*5 to 20 ml.
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Occurrence of two distinct succinate thiokinases in animal 
• tissues
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Although succinate thiokinase from mammalian sources has hitherto been described as showing substrate 
specificity for guanine nucleotide, a range of mammalian tissues has here been found to display succinate 
thiokinase activity with both guanine and adenine nucleotides as substrates. Evidence is presented for the 
existence of two distinct succinate thiokinases and this is confirmed by their separation by affinity chroma­
tography. Each enzyme is specific for one nucleotide and is inhibited by the non-substrate nucleotide. The 
physiological roles of the two enzymes is yet to be established.
Adenine nucleotide Guanine nucleotide Nucleotide specificity Succinate thiokinase Tissue enzyme variation
1. INTRODUCTION
Succinate thiokinase (succinyl-CoA synthetase) 
(STK) catalyses the following reversible reaction as 
part of the citric acid cycle:
NDP + Pi + succinyl-CoA 5=^
NTP + succinate + CoA-SH
where NDP and NTP represent nucleoside 
diphosphate and triphosphate. The STKs which 
have been most fully studied are those from pig 
heart and Escherichia co li [1,2]. The pig STK was 
found to function with GDP/GTP as substrates, 
while the E. co li enzyme appeared to be specific for 
ADP/ATP. These findings led to the established 
view that animal STKs utilize guanine nucleotides 
whereas bacterial (and plant) STKs operate with 
adenine nucleotides, a situation generally 
presented in textbooks of biochemistry. Some 
years ago, however, an adenine nucleotide-linked 
enzyme (A-STK) was reported to occur in blowfly 
flight muscle [3] and, more recently, A-STK activi­
ty has been found in a wider range of animals 
[4,5], though not in mammals. In some non­
mammalian tissues, both A-STK and G-STK ac­
tivities were detected [4,5] but whether these ac­
tivities result from a single non-specific enzyme or 
from the presence of two specific STKs was not 
resolved.
We have previously reported considerable varia­
tion in the nucleotide specificities of a range of 
bacterial STKs and have shown that some of the 
bacterial enzymes function as well, or even 
preferentially, with GDP rather than ADP [6]. In 
the light of this diversity and the apparent 
breakdown of the earlier view concerning animal 
and bacterial STKs it seemed worthwhile to ex­
amine carefully the STKs of mammalian tissues for 
the possible occurrence of both types of STK ac­
tivity. This communication reports, for the first 
time, the presence of both A-STK and G-STK ac­
tivities in mammals and presents clear evidence for 
their location on two distinct enzyme proteins.
2. EXPERIMENTAL
2.1. Preparation o f  tissue extracts
Fresh beef, pig and sheep tissues were obtained 
from a local slaughterhouse, immediately cooled 
on ice and processed in the laboratory within 1 h 
of slaughter. Rat tissues were taken from freshly
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
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killed male Wistar rats. Tissues were manually 
diced into ice-cold 0.1 M  Na/K phosphate buffer 
(pH 8.0) containing 1 m M  EDTA, and homoge­
nized with an Ultra-Turrax tissue homogenizer 
(5 x15 s bursts interspersed with cooling). After 
centrifugation (30000 x g for 30 min at 4°C) the 
supernatant solutions were used without further 
treatment.
2.2. P re pa ra tion  o f  bee f heart m ito c h o n d r ia l 
ex trac t
Mitochondria were prepared from a whole beef 
heart as in [7] with the slight modification that they 
were washed twice in 50 m M  Tris-HCl (pH 7.5),
0.25 M  sucrose, 1 m M  EDTA. The washed 
mitochondria were resuspended in 20 m M  Tris- 
HCl (pH 7.5), 2 m M  MgCL, and disrupted by 
ultrasonication (MSE 100 W  sonicator operated at 
40 W  for 6 x 15 s with cooling). After centrifuga­
tion (30000 x g for 30 min at 4°C) the supernatant 
solution was used in the experiments reported.
2.3. Assay o f  succinate  th iok inase
STK was assayed polarographically [8,9] as 
described in [6] in the presence of 0.5 m M  A D P  or 
GDP.
2.4. T he rm a l in a c tiv a tio n
2.7 ml of 0.1 M  Na/K phosphate (pH 8.0), 
1 m M  EDTA were equilibrated at 48°C. At zero 
time, 0.3 ml tissue extract was added and aliquots 
(0.3 ml) were removed at various time intervals 
and assayed for both A-STK and G-STK activities.
2.5. A f f in i t y  ch ro m a to g rap hy
Affinity chromatography was carried out on 
derivatized GD P  immobilized on Sepharose [10]. 
A  column (1.5 x 15 cm) of this affinity material 
was equilibrated at 4°C with 20 m M  Tris-HCl (pH 
7.5), 2 m M  MgCb and 0.5 ml of the beef heart 
mitochondrial extract (~12 mg protein) was ap­
plied. Elution was continued with the equilibration 
buffer, 1-ml fractions being collected. When the 
protein content of the eluted fractions had fallen to 
zero, the elution buffer was changed to include 
1 m M  GDP. Removal of GDP from the subse­
quent fractions apparently containing STK was 
achieved by pooling and gel filtration on a pre­
packed Sephadex G-25 column (Pharmacia, 
PD-10).
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3. RESULTS A N D  D ISC U SSIO N
As stated in section 1, all previous studies on 
mammalian STK have emphasised the specificity 
of the enzyme for guanine nucleotide substrates 
(GDP or GTP, depending on the direction of assay 
of the reaction) and no observation of activity with 
ADP/ATP has hitherto been reported.
Our first significant finding then is that all the 
mammalian tissue extracts examined showed STK 
activity with both AD P  and GDP. This was the 
case with bone marrow and heart from beef, brain, 
heart, kidney, liver and retina from pig, brain, 
heart, kidney, liver and skeletal (leg) muscle from 
rat, and brain and liver from sheep. A single sam­
ple of human leg muscle (following hospital am­
putation) was also found to display activity with 
both nucleotides. Measurements of STK activity 
were greatly facilitated by our use of the 
polarographic method of enzyme assay. We have 
previously commented [6,11] on the superiority of 
this assay in comparison with the discontinuous 
colorimetric hydroxamate method [12] or the spec- 
trophotometric method at 235 nm [13] used by 
other investigators. Our discovery of STK in 
cyanobacteria [11], despite its earlier reported 
absence, owed much to the use of the 
polarographic assay and the present observations 
of both A-STK and G-STK activities in mam­
malian tissues may also have eluded other in­
vestigators employing less favourable detection 
procedures.
The next significant finding was that the ratio of 
the A-STK and G-STK activities varies between 
tissues (table 1). A  spectrum of ratios was found,
Table 1
Activities o f G-STK and A-STK in extracts o f various rat 
tissues






Kidney 6.87 1.96 3.5
Liver 4.54 1.5 3.0
Heart 3.58 2.5 1.4
Brain 0.95 1.51 0.6
Skeletal muscle 0.42 1.06 0.4
\
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the G-STK being the predominant enzyme in 
kidney and liver, more nearly matching the A-STK 
in heart, and being exceeded by the A-STK in brain 
and skeletal muscle. It is difficult to reconcile this 
approx. 10-fold change in the G-STK/A-STK ratio 
with the presence of a single STK enzyme of loose 
specificity; one would have to postulate that the 
‘looseness’ of the specificity itself varied between 
tissues. A  simpler explanation is that there are two, 
nucleotide-specific, STKs whose relative propor­
tions differ between tissues. Ottaway and co­
workers [4,5], who first reported A-STK and G- 
st K in a number of non-mammalian animal 
tissues, also observed a divergence in the ratio and 
commented that this may be an indication of the 
presence of two enzymes, but no further ex­
perimental evidence was presented.
The ability of a guanine nucleotide-specific STK 
to show activity with A D P  could result from the 
additional presence of nucleoside-diphosphate 
kinase (NDPK) activity and traces of GTP (see 
[2]). However, the apparent activity of A-STK 
could never exceed that of G-STK. Thus the fact 
that A-STK was the major activity in brain and 
muscle excludes the possibility that A-STK activity 
results from the action of NDPK. Furthermore, 
the inclusion of EDTA in the isolation and 
washing media used in the preparation of beef 
heart mitochondria has the effect of removing 
NDPK [5].
The heart mitochondrial preparation also 
showed the presence of A-STK and G-STK, in­
dicating that both activities are located within the 






T I M E  ( m i n )
F ig .l. Thermal inactivation o f  rat heart succinate 
thiokinases at 48°C . Experimental conditions are 
described in the text.
to be a dimer of M t -70000 [2]. We therefore com­
pared the molecular sizes of the G-STK and A-STK 
identified in mammalian tissues by means of gel 
filtration on Sephadex G-200 as in [14]. The two 
enzyme activities from all the rat tissues listed in 
table 1 co-eluted on gel filtration, indicating no 
detectable difference in molecular size between the 
A-STK and G-STK activities.
One way to test for the presence of two distinct 
enzymes, as opposed to a single STK with broad 
specificity, is to compare the activities measured in 
the presence of A D P  and GDP singly with that 
measured in their joint presence. A  single enzyme 
saturated with the ‘preferred’ nucleotide would not 
show increased activity on addition of the second 
nucleotide. On the other hand, if two enzymes are 
present, saturation of one of them with its specific 
nucleotide should still permit the other enzyme to 
display activity on the addition of the other 
nucleotide; hence some additivity of activities
Table 2
Specificity o f  the separated succinate thiokinases and inhibition by the non­
substrate nucleotide
Enzyme Activity (nm ol/m in  per ml) Inhibition
0.5 mM A D P  0.5 mM G DP 0.5 mM A D P
+










The two STKs from bovine heart m itochondria were separated by affinity  
chromatography as described in the text
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should be observed. In [4], additivity of the ac­
tivities of STK with GTP and ATP was used as a 
criterion for the genuine utilization of both 
nucleotides (rather than an artefactual display of 
A-STK activity due to nucleoside diphosphate 
kinase), though not for the existence of distinct 
STKs. In the present work, the activities of STK in 
several tissue extracts (beef heart, pig brain, rat 
heart) measured in the joint presence of 
A D P  + G D P  (both at 0.5 mM, i.e. above satura­
tion) were greater than either of the activities 
measured in the presence of a single nucleotide. 
The additivity observed was not strictly the sum of 
the two activities, but partial additivity (between 
50 and 100%) was clearly seen and thus offers fur­
ther evidence for the existence of two STKs. A  
possible explanation for the partial additivity is 
that although each STK is specific for one 
nucleotide as substrate, the other nucleotide may 
act as an inhibitor; this point is considered further 
below.
Additional evidence for the two STKs has been 
obtained from thermal inactivation studies. Rat 
heart extract showed the A-STK to be more rapidly 
inactivated at 48°C than the G-STK (fig.l), sup­
porting the non-identity of the A-STK and G-STK 
proteins. Similar results were obtained with pig 
brain.
Finally, conclusive evidence for distinct enzymes 
was obtained by separating the two activities by af­
finity chromatography. When the beef heart 
mitochondrial extract was applied to a column of 
dialdehyde-GDP-Sepharose (see section 2.5) only 
the A-STK activity could be detected in the frac­
tions eluted when the column was washed with the 
equilibration buffer. However, when this buffer 
solution also contained 1 m M  GDP, the G-STK 
activity was sharply eluted. Neither enzyme 
showed any activity whatsoever with the other 
nucleotide. These findings clearly demonstrate the 
existence of two distinct STKs - one specific for 
adenine and the other for guanine nucleotide. 
Table 2 shows that, in each case, the non-substrate 
nucleotide acts as an inhibitor of the ‘other’ activi­
ty; these inhibitions therefore support the explana­
tion offered above for the observation of only par­
tial additivity when activity measurements were 
made with crude extracts in the joint presence of 
both nucleotides.
April 1986
Our results thus demonstrate that h 
textbook assertions, mammalian cells do n PUe 
the enzymic facility to produce ATP h; S6SS 
through citric acid cycle activity. The question 
why mitochondria contain two STKs remains to h 
answered. It is conceivable that they differ in their 
location or fine level of organisation within the 
mitochondrion and they may play distinct met * 
bolic roles. It has been suggested [4] that there ma' 
be a connection between G-STK activity and 
ketone body metabolism. Now that we have 
demonstrated the presence of both G-STK and A 
STK in mammals, with tissue-dependent variation 
investigations are in progress to explore their par­
ticular physiological functions.
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pistinct physiological roles of animal succinate thiokinases
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b o d y  u t i l iz a t io n
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Two distinct succinate thiokinases have recently been shown to exist in animal tissues, one specific for gua­
nine nucleotide and the other for adenine nucleotide. Their physiological roles have here been investigated  
by comparing the levels o f  the two enzymes in liver and brain o f  normal and diabetic rats. A marked rise 
in the level o f  brain guanine nucleotide-linked succinate thiokinase in the diabetic condition is consistent 
with an enhanced utilization o f  ketone bodies and hence with the associated elevated demand for succinyl- 
CoA for the activation o f  acetoacetate. Taken together with the reported mitochondrial values o f  the A T P/
A D P and G T P/G D P ratios, the results are interpreted to indicate that the adenine nucleotide-linked enzyme 
functions as a com ponent o f  the citric acid cycle whereas the guanine nucleotide-linked enzyme functions 
in the opposite m etabolic direction to produce succinyl-CoA from succinate.
Succinate thiokinase Guanine nucleotide D iabetes S trep tozo tocin  Ketone body utilization (B rain)
M etabolism
1. INTRODUCTION
Succinate thiokinase (succinyl-CoA synthetase) 
(STK) catalyses the reversible reaction:
ADP/GDP + Pi + succinyl-Coa^ATP/GTP + 
succinate + CoA-SH
It is generally presented in textbooks of 
biochemistry that animal STKs are linked to the 
guanine nucleotides (G-STK) whereas bacterial 
and plant STKs operate with the adenine 
nucleotides (A-STK). W e  recently reported [1] the 
existence of distinct A-STK and G-STK enzymes in 
mammalian tissues with wide variation in the ratio 
o f  the two.
* To whom correspondence should be addressed
The presence of these two STKs poses the ques­
tion of their physiological roles. One role for STK 
lies in the citric acid cycle, where it converts 
succinyl-CoA into succinate. In mammalian 
tissues, succinyl-CoA also plays a crucial role in 
ketone body metabolism, activating acetoacetate 
to acetoacetyl-CoA, with 3-oxoacid CoA- 
transferase (OAT). To maintain the flux of ketone 
body utilization, it is necessary to re-cycle the suc­
cinate to succinyl-CoA (see fig.l) again using STK. 
These different demands on the STK-catalysed 
reaction may well be accommodated by the action 
of distinct STKs.
Ketone body meteabolism is perturbed in 
diabetes; the ability to induce diabetic 
ketoacidosis, e.g. by treatment with streptozotocin 
[2], thus offers a means of investigating the par­
ticipation of STK. The results reported here clearly 
implicate G-STK in ketone body metabolism and,
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00l45793/86/$3.50 ©  1986 Federation o f  European Biochem ical Societies 215
V olum e 205, num ber 2 FEB S LET TE R S
September i986
as a corollary, we propose that A-STK may func­
tion in the citric acid cycle.
2. EXPERIMENTAL
Female Wistar rats (180-190 g) were fed ad 
libitum. Diabetes was induced by intravenous ad­
ministration, under anaesthesia, of streptozotocin 
(150 mg/kg body wt). After 48 h the animals were 
decapitated; blood samples were deproteinised and 
glucose concentrations determined as in [3]. Con­
trol rats received no treatment. Tissues (groups of 
5 rats) were removed immediately and homogen­
ized in 0.1 M  Na/K phosphate buffer (pH 8.0) con­
taining 1 m M  EDTA using an Ultra-Turrax 
homogenizer (5 x  15 s bursts with cooling). After 
centrifugation (30000xg for 30 min at 4°C) the 
supernatants were used without further treatment.
STK activity was assayed as polarographically
[4] in the presence of 0.5 m M  ADP or GDP. Pro­
tein concentrations were determined as in [5].
3. RESULTS A N D  DISCUSSION
Blood glucose levels in the streptozotocin- 
treated rats were high (5.38 ±0.77 mg/ml) in com­
parison with the control rats (0.61 ±0.05 mg/ml). 
These elevated levels indicate the diabetic condi­
tion of the treated rats and resemble those found 
by Schein et al. [2] who also reported a 5-fold rise 
in ketone body concentration.
Diabetes is accompanied by enhancement of 
ketone body production by the liver and utilization 
by the brain [6,7]. We therefore examined liver and 
brain in diabetic and normal rats. Typical results 
are shown in table 1. In both tissues, A-STK activi­
ty doubled in diabetes. In brain, this may be 
associated with increased ketone body oxidation 
via the citric acid cycle; enhanced respiration in 
liver has also been reported to accompany 
ketogenesis [8].
The G-STK activity of liver fell in diabetes but 
that of brain increased strikingly (5- to 10-fold in 
a series of experiments). As a consequence, the 
ratios G-STK/A-STK changed very significantly. 
Whereas in the untreated animals A-STK was the 
dominant form in brain and G-STK in liver, the 
reverse was the case in the diabetic rats (table 1).
The ability of the brain to use ketone bodies is 
not believed to be an enzymic adaptation, as the
Table 1
Effect o f  diabetes on the levels o f  succinate thioki
Treatment Tissue Activity (nm ol/
min per mg G-STR/
protein A-STK
G-STK A-STK
Control brain 0.9 1.5 0.6
liver 4.5 1.5 3.0
Streptozotocin brain 10.0 2.5 4.0
liver 1.3 3.0 0.43
enzymes responsible for ketone body metabolism 
(hydroxybutyrate dehydrogenase, 3-oxoacid CoA- 
transferase and acetoacetyl-CoA thiolase) are pre­
sent in high activities that are unchanged by 
diabetes [9].
Changes in the activity of STK in diabetes have 
not previously been studied, though it has been 
suggested that the availability of succinyl-CoA 
could control ketone body utilization [10,11]. Our 
finding that G-STK increases in brain suggests that 
it may produce the succinyl-CoA required for 
ketone body activation. Fig.l shows the scheme 
for ketone body activation and subsequent ox­
idative metabolism via the citric acid cycle. At two 
points succinyl-CoA is converted to succinate, by 
reaction with acetoacetate (catalysed by OAT) and 
by reaction with nucleoside diphosphate and in­
organic phosphate (catalysed by STK). In the latter 
case, the succinate is further oxidised by the later 
steps of the citric acid cycle to reform oxaloacetate 
for condensation with the acetyl-CoA produced 
from the ketone bodies. In the former case, by 
contrast, the succinate must be reconverted to 
succinyl-CoA in order to maintain the flow of 
acetoacetate to acetoacetyl-CoA. This re-cycling 
could be achieved either by metabolism of suc­
cinate round the citric acid cycle, via oxaloacetate 
and citrate, or by the action of STK operating in 
the reverse direction.
Ottaway and co-workers [12-14] suggested that 
ketone body utilisation requires the partitioning of 
succinyl-CoA (formed by oxoglutarate dehydroge­
nase) between O A T  and STK; as the K m f°r 
succinyl-CoA is very much lower for STK than for 
OAT, they proposed that inhibition of STK is
216
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Hydroxybutyrate









NTP + CoA NDP + P. i
Fig.l. Scheme o f  ketone body m etabolism . N D P and 
NTP represent nucleoside diphosphate and triphosphate 
respectively. A and B are two points at which the suc­
cinate thiokinase reaction occurs.
necessary to permit ketone body activation. Such 
inhibition might be effected by maintaining a high 
NTD/NDP ratio. In support of this proposal they 
cited [14] mammalian mitochondrial values of 
ATP/ADP ~1 and GTP/GDP -100. The pro­
posed inhibition of STK to permit ketone body 
metabolism, when that very metabolism requires 
citric acid cycle flux, presents a difficulty, but our 
discovery of the existence of two STK enzymes, 
each specific for its nucleotide substrate, offers a 
solution. The two enzymes allow metabolic com- 
partmentation of the two distinct roles of STK. As 
part of the citric acid cycle, the A-STK can func­
tion to phosphorylate A D P  to ATP at an 
ATP/ADP ratio of — 1, while the G-STK can 
catalyse the opposite reaction (succinate to 
succinyl-CoA) at a high GTP/GDP ratio. Our 
finding that the level of G-STK in brain increases
dramatically with increased ketone body utiliza­
tion supports this proposal and also suggests that 
re-cycling of succinate to succinyl-CoA is indeed 
achieved directly by the action of G-STK. It is con­
ceivable that the two STKs are differentially 
organised within the mitochondrion.
It has been commented above that diabetes leads 
to increased ketogenesis in the liver. The reduction 
in the level of liver G-STK which we have observed 
following streptozotocin treatment may be related 
to the recent report [15] of the succinylation and 
inactivation of hydroxymethylglutaryl-CoA syn­
thase by succinyl-CoA. This enzyme functions in 
ketone body formation; its inactivation by 
succinyl-CoA may therefore be a control 
mechanism in ketogenesis. Stimulation of 
ketogenesis, e.g. by glucagon, appears to be ac­
companied by reduction in the concentration of 
succinyl-CoA in the liver [16]; this reduction might 
lead to de-inhibition of hydroxymethylglutaryl- 
CoA synthase and hence to increased ketogenesis
[15]. Our observation of a decreased level of liver 
G-STK is therefore consistent with a reduction in 
succinyl-CoA formation and may be associated 
with these other processes.
It was recently reported [17] that streptozotocin 
has a direct inhibitory action on mouse liver G- 
STK in vitro (50% inhibition at 10 nM strep­
tozotocin), though no in vivo alteration of the ac­
tivity of this enzyme was observed. We have tested 
the effect of 100 nM streptozotocin on rat liver and 
brain G-STK but failed to observe any inhibition. 
Hence our finding of reduced G-STK in rat liver in 
vivo following streptozotocin treatment is unlikely 
to be due to inhibition of activity but rather to a 
reduction in the level of the enzyme.
In conclusion our results indicate that A-STK 
and G-STK play distinct metabolic roles within 
animal tissues. Moreover, as succinyl-CoA is not 
only involved in citric acid cycle and ketone body 
metabolism but also acts as a precursor of por­
phyrins, it may be that STK performs a further 
function in providing the succinyl-CoA for that 
biosynthetic process. This is being investigated.
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T w o  s u c c i n a t e  t h i o k i n a s e  a c t i v i t i e s  s p e c i f i c  f o r  e i t h e r  a d e n i n e  o r  
guanine n u c l e o t i d e s  h a v e  b e e n  f o u n d  i n  T r y p a n o s o m a  b r u c e i . K e y  g l y c o l y t i c  a n d  
citric a c i d  c y c l e  e n z y m e s  w e r e  m e a s u r e d  t o  s h o w  r e p r e s s i o n  o f  g l y c o l y s i s  a n d  
d e r e p r e s s i o n  o f  t h e  c i t r i c  a c i d  c y c l e  i n  t h e  p r o c y c l i c  f o r m ,  r e l a t i v e  t o  t h e  
b l o o d s t r e a m  f o r m .  A  m a r k e d  r i s e  i n  a d e n i n e - l i n k e d  s u c c i n a t e  t h i o k i n a s e  
activity a c c o m p a n i e d  a  r i s e  i n  a c t i v i t y  o f  c i t r i c  a c i d  c y c l e  e n z y m e s .
However, g u a n i n e - l i n k e d  s u c c i n a t e  t h i o k i n a s e  w a s  f o u n d  t o  i n c r e a s e  o n l y  
slightly i n  a c t i v i t y .  T h e s e  r e s u l t s  i m p l i c a t e  t h e  a d e n i n e - l i n k e d  e n z y m e  a s  a n  
essential c o m p o n e n t  o f  t h e  c i t r i c  a c i d  c y c l e ,  w h e r e a s  t h e  g u a n i n e - l i n k e d  
enzyme a p p e a r s  t o  b e  u n d e r  s e p a r a t e  c o n t r o l . T h i s  c o m m u n i c a t i o n  a l s o  r e p o r t s  
for t h e  f i r s t  t i m e  t h e  o c c u r r e n c e  o f  c i t r a t e  s y n t h a s e  a c t i v i t y  i n  t h e  
| b l o o d s t r e a m  ( l o n g  s l e n d e r )  f o r m  o f  T . b r u c e i . ®  1988 A c a d e m i c  p r e s s ,  i n c .
S u c c i n a t e  t h i o k i n a s e  ( s u c c i n y l - C o A  s y n t h e t a s e )  ( S T K )  c a t a l y s e s  t h e  
f o l l o w i n g  r e v e r s i b l e  r e a c t i o n :
'1DP +  P ^  +  s u c c i n y l - C o A  , * N T P  +  s u c c i n a t e  +  C o A - S H
where N D P  a n d  N T P  r e p r e s e n t  n u c l e o s i d e  d i p h o s p h a t e  a n d  t r i p h o s p h a t e .
O r i g i n a l l y ,  a n i m a l  t i s s u e s  w e r e  t h o u g h t  t o  p o s s e s s  o n l y  t h e  g u a n i n e - l i n k e d  
e n z y m e  ( 1 ) .  H o w e v e r ,  w e  h a v e  r e c e n t l y  r e p o r t e d  t h e  o c c u r r e n c e  o f  d i s t i n c t  
s u c c i n a t e  t h i o k i n a s e s  i n  a n i m a l  t i s s u e s  s p e c i f i c  f o r  g u a n i n e  ( G - S T K )  o r  
a d e n i n e  ( A - S T K )  n u c l e o t i d e s  ( 2 ) .
S u b s e q u e n t  s t u d i e s  ( 3 )  h a v e  i n d i c a t e d  t h a t  i n  v i v o  A - S T K  a n d  G - S T K  m a y  
b e  r e s p o n s i b l e  f o r  t h e  o p e r a t i o n  o f  t h e  s u c c i n a t e  t h i o k i n a s e  r e a c t i o n  i n  
o p p o s i n g  d i r e c t i o n s .  G - S T K  i n  m a m m a l i a n  b r a i n  s h o w s  a  m a r k e d  e l e v a t i o n  i n  
a c t i v i t y  w i t h  i n c r e a s e d  k e t o n e  b o d y  u t i l i z a t i o n .  T h i s  s u p p o r t s  t h e  p r o p o s a l  
t h a t  t h e  r e - c y c l i n g  o f  s u c c i n a t e  t o  s u c c i n y l - C o A ,  r e q u i r e d  f o r  k e t o n e  b o d y  
a c t i v a t i o n ,  i s  a c h i e v e d  d i r e c t l y  b y  t h e  a c t i o n  o f  G - S T K  ( 3 ) .  W e  t h e r e f o r e
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proposed (3) that the A-STK functions in the energy-conserving role of the 
citric acid cycle and the present work was undertaken to explore this 
suggestion further.
During the life cycle of Trypanosoma brucei from mammalian host to 
insect vector, dramatic changes occur in morphology and metabolism (4). In 
the mammalian bloodstream T.brucei is exclusively dependent upon glucose for 
energy, being unable to utilise fatty acids or amino acids due to the absence 
of a functional citric acid cycle (5). In the insect gut the situation is 
reversed. Here glucose is scarce and amino acids such as proline constitute 
the main energy source for the procyclic form (6), proline being oxidized and 
eventually entering a functional citric acid cycle as oxoglutarate (7).
The bloodstream and procyclic cell forms of T.brucei thus provide an 
example of a eukaryotic organism in which the enzymes of either glycolysis or 
the citric acid cycle are repressed or derepressed. We have therefore 
examined the levels of A-STK and G-STK in both bloodstream and procyclic forms 
of T. brucei, together with key enzymes of the glycolytic and citric acid 
cycle pathways. The results reported here clearly identify A-STK with the 
citric acid cycle whereas a different metabolic role is likely for the G-STK.
METHODS
T.brucei in the bloodstream form were isolated from the blood of 250 g 
Wistar rats, 71h after injection with 10? cells of strain MITat 1.1 (obtained 
from Dr H.P.Voorheis of Trinity College Dublin) by intraperitoneal injection. 
The cells were separated from blood components by centrifugation (600 x g) for 
10 min at 4°C and further purified on a short column of DEAE-cellulose in 
isotonic phosphate-buffered saline, pH 8.0, containing 10 mM glucose, as 
described by Lanham and Godfrey (8). T.brucei in the procyclic cell form 
(strain EATRO-427, kindly supplied by Dr W.Gibson, Tsetse Fly Research Centre, 
Langford, Bristol) were cultivated at 26°C on SDM-79 medium (9) supplemented 
with 10% foetal calf serum. The cells were harvested by centrifugation (600 x 
g) for 5 min at room temperature and then washed in 100 mM Hepes buffer, pH
7.5, containing 25 mM NaHCO^, 50 mM NaCl, 5 mM L-proline, 5 mM KC1 and 5 mM 
glucose.
Pellets of both bloodstream and procyclic cell forms, after their 
respective washings, were resuspended in 0.1M Na+/K+ phosphate buffer, pH 7.5, 
containing 20% glycerol and disrupted by ultrasonication (MSE 100W sonicator 
operated at 40W for 6 x 15 sec with cooling). After centrifugation (5000 x g) 
for 2 min at room temperature, the supernatant solutions were used without 
further treatment.
Citrate synthase and succinate thiokinase were assayed polarographically 
as previously described (10,11). The remaining citric acid cycle and 
glycolytic enzymes were measured according to Bergmeyer (12). Protein 
concentrations were determined as in (13).
258
151, N o. 1, 1988 BIOCHEMICAL AND BIOPHYSICAL RESEARCH C O M M UNICATIO NS
Table 1. Glycolytic and citric acid cycle enzymes in both bloodstream and 
procyclic cell forms of T.brucei
Enzyme Enzyme activities 
, (nmol/min/mg protein)
Bloodstream (B)* Procyclic (P)* Ratio P/B









NADP-Isocitrate dehydrogenase 3.4 
(EC 1.1.1.42)
28 8.2






Phosphoglucose isomerase 500 
(EC 5.3.1.9)
74 0.15
Pyruvate kinase 31 
(EC 2.7.1.40)
9 0.29
♦Both freshly harvested or frozen cells, stored at -21°C overnight, yielded
1 o
similar specific activities for each enzyme. Total cell counts of 1.4 x 10
i o
and 1.02 x 10 cells were obtained from bloodstream and procyclic cell forms 
respectively.
R E S U L T S  A N D  D I S C U S S I O N
I n  T . b r u c e i  t h e  t r a n s f o r m a t i o n  f r o m  m a m m a l i a n  b l o o d s t r e a m  t o  i n s e c t  g u t  
s t a g e  i n v o l v e s  d r a m a t i c  c h a n g e s  i n  m o r p h o l o g y  a n d  m i t o c h o n d r i a l  a c t i v i t y .  T h e  
l o n g  s l e n d e r  b l o o d s t r e a m  f o r m  a p p e a r s  e n t i r e l y  d e p e n d e n t  u p o n  g l y c o l y s i s  f o r  
i t s  e n e r g y  r e q u i r e m e n t s .  I n  c o n t r a s t ,  t h e  p r o c y c l i c  f o r m ,  w i t h  a c t i v e  
m i t o c h o n d r i a ,  r e l i e s  m a i n l y  o n  t h e  o x i d a t i o n  o f  a m i n o  a c i d s ,  c i t r i c  a c i d  c y c l e  
i n t e r m e d i a t e s  o r  f a t t y  a c i d s ,  r e s u l t i n g  i n  g r e a t e r  v e r s a t i l i t y  a n d  l e s s  
d e p e n d e n c e  u p o n  g l y c o l y s i s .  I n  f a c t  t h e  p r o c y c l i c  c e l l  f o r m s  a r e  a b l e  t o  g r o w  
e v e n  i n  t h e  a b s e n c e  o f  f r e e  g l u c o s e  o r  g l u c o s a m i n e  ( 1 4 ) .
T h e  t y p i c a l  r e s u l t s ,  p r e s e n t e d  i n  T a b l e  1 ,  d e m o n s t r a t e  t h e  e n z y m i c  c h a n g e s  
a s s o c i a t e d  w i t h  t h e  d i f f e r i n g  m e t a b o l i c  r e q u i r e m e n t s  o f  b l o o d s t r e a m  a n d  
P r o c y c l i c  f o r m s  o f  T . b r u c e i . T h e  s p e c i f i c  a c t i v i t i e s  o f  h e x o k i n a s e  a n d  
P h o s p h o g l u c o s e  i s o m e r a s e  ( b o t h  g l y c o s o m a l )  a n d  p y r u v a t e  k i n a s e  ( c y t o s o l i c )  a r e  
r e p r e s s e d  i n  t h e  p r o c y c l i c  c e l l  f o r m .  S i m i l a r  c h a n g e s  h a v e  a l s o  b e e n  r e p o r t e d
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by Hart et al. (15). As predicted, the specific activities of citric acid 
cycle enzymes increase in the procyclic cell form. Interestingly, citrate 
synthase activity was detected for the first time in the long slender 
bloodstream form of T.brucei. Succinate dehydrogenase now appears to be the 
only enzyme of the citric acid cycle absent in the bloodstream form, with the 
remaining enzymes of the cycle all attenuated (16,17).
The results in Table 1 indicate that the specific activities of the citric 
acid cycle enzymes increase in concert from bloodstream to procyclic form. 
Significantly, it is A-STK and not G-STK which displays this marked elevation, 
thus clearly implicating A-STK as a component of the cycle.
As previously mentioned, studies on A-STK and G-STK from mammalian tissues 
have shown that one of the roles of G-STK is associated with ketone body 
activation (3). This, together with predicted high ratios of GTP:GDP in 
mitochondria (18), implies that G-STK functions in vivo in the direction of 
succinyl-CoA formation. By contrast, mitochondrial ATP:ADP ratio values are 
less than or close to 1.0, being as much as 2 orders of magnitude lower than 
GTP:GDP ratios (18). The A-STK is therefore likely to operate in the 
direction of succinyl-CoA breakdown coupled to the phosphorylation of ADP to 
ATP. The results presented in this communication strengthen the suggestion 
that A-STK functions as an integral part of energy generation by the citric 
acid cycle.
Our findings concerning STK activities and the first identification of citrate 
synthase in the long slender bloodstream form of T.brucei were greatly 
facilitated by our use of the polarographic method of enzyme assay (19). We 
have previously commented on the superiority of this assay system (10,11) in 
comparison with other assay methods used for these two enzymes.
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Physiological roles of animal succinate thiokinases
Specific association of the guanine nucleotide-linked enzyme with haem 
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T h e  d i s c o v e r y  o f  t w o  dist i n c t  s u c c i n a t e  t h i o k i n a s e s  in m a m m a l i a n  tissues, o n e  ( G - S T K )  specific f o r  G D P / G T P  a n d  t h e  
o t h e r  ( A - S T K )  f o r  A D P / A T P ,  p o s e s  t h e  q u e s t i o n  o f  their differential m e t a b o l i c  roles. E v i d e n c e  h a s  s u g g e s t e d  t h a t  t h e  
A - S T K  f u n c t i o n s  in t h e  citric a c i d  c y c l e  in t h e  d i r e c t i o n  o f  s u c c i n y l - C o A  b r e a k d o w n  ( a n d  A T P  f o r m a t i o n )  w h e r e a s  o n e  
r o l e  o f  t h e  G - S T K  a p p e a r s  t o  b e  t h e  r e - c y c l i n g  o f  s u c c i n a t e  t o  s u c c i n y l - C o A  (at t h e  e x p e n s e  o f  G T P )  f o r  t h e  p u r p o s e  
o f  k e t o n e  b o d y  ac t i v a t i o n .  A  t h i r d  m e t a b o l i c  p a r t i c i p a t i o n  o f  s u c c i n y l - C o A  is in h a e m  b i o s y n t h e s i s .  T h i s  c o m m u n i c a t i o n  
s h o w s  t h a t  in c h e m i c a l l y  i n d u c e d  h e p a t i c  p o r p h y r i a ,  w h e n  t h e  d e m a n d  f o r  s u c c i n y l - C o A  is i n c r e a s e d ,  it is t h e  level o f  
G - S T K  o n l y  w h i c h  is e l e v a t e d ,  t h a t  o f  A - S T K  b e i n g  u n a f f e c t e d .  T h e  r esults i m p l i c a t e  G - S T K  in t h e  p r o v i s i o n  o f  s u c c i n y l -  
C o A  f o r  h a e m  b i o s y n t h e s i s ,  a  c o n c l u s i o n  w h i c h  is f u r t h e r  s u p p o r t e d  b y  t h e  o b s e r v a t i o n  o f  a  h i g h  G - S T K / A - S T K  r a tio
in b o n e  m a r r o w .
S u c c i n a t e  t h i o k i n a s e ;  G u a n i n e  n u c l e o t i d e ;  H e m e  s y n t h e s i s ;  P o r p h y r i n  sy n t h e s i s ;  P o r p h y r i a ;  M i t o c h o n d r i a l  m e t a b o l i s m
1. INTRODUCTION
Mammalian succinate thiokinase (succinyl-CoA 
synthetase) (STK) catalyses the following reversi­
ble reaction:
N T P  +  s u c c i n a t e  +  C o A - S H  N D P  +  P i  +  s u c c i n y l - C o A
where NTP and NDP represent nucleoside 
triphosphate and diphosphate. We have recently 
reported the existence and separation of two 
distinct STKs in mammalian tissues specific for 
guanine (G-STK) (EC 6.2.1.6) or adenine (A-STK) 
(EC 6.2.1.5) nucleotides [1] and have investigated 
the possible distinct metabolic roles for each en­
zyme [2,3], These studies have suggested that, in 
vivo, A-STK and G-STK may be responsible for 
catalysing opposing directions of the STK reac-
Correspondence address: P . D . J .  W e i t z m a n ,  D e p a r t m e n t  o f  
B i o c h e m i s t r y ,  U n i v e r s i t y  o f  B a t h ,  B a t h  B A 2  7 A Y ,  E n g l a n d
tion. In mammalian brain G-STK shows a marked 
elevation in activity with increased ketone body 
utilization [2], thus supporting the proposal that 
the re-cycling of succinate to succinyl-CoA, re­
quired for ketone body activation, is achieved 
directly by the action of G-STK. On the other 
hand, in the eukaryotic parasitic protozoan 
T rypanosom a brucei, during its transformation 
from bloodstream to procyclic cell form, it is A- 
STK, not G-STK, which accompanies a concerted 
rise in the activity of other citric acid cycle en­
zymes, thus implicating A-STK as an integral com­
ponent of the citric acid cycle operating in the 
direction of succinyl-CoA hydrolysis [3].
The other main metabolic role for succinyl- 
CoA, in the mammalian mitochondrion, apart 
from its involvement with the citric acid cycle and 
ketone body activation, is in haem biosynthesis. 
The first and rate-limiting enzyme of the haem 
biosynthetic pathway, -^aminolevulinic acid syn­
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thetase (ALA-S) (EC 2.3.1.37), utilises succinyl- 
CoA in the following reaction:
s u c c i n y l - C o A  +  g l y c i n e  — * t $ - a m i n o l e v u l i n a t e  +  C O 2 +
C o A - S H
All mammalian cells contain haemoproteins and 
possess the capability to synthesize haem [4]. 
However, the highest rates of haem biosynthesis 
are located in bone marrow, responsible for 
erythrogenesis, and in the liver.
There are a number of disease states of haem 
biosynthesis, collectively known as porphyrias [4]. 
In hepatic porphyria, perturbation of haem 
biosynthesis occurs, due to a deficiency or inhibi­
tion of an intermediate enzyme. This leads to over­
production and excretion of porphyrin precursors 
due to derepression of ALA-S synthesis [5]. As a 
result, the biosynthetic pathway, normally under 
strict negative feedback control, then operates with 
elevated levels of ALA-S, thus presenting in­
creased demand for succinyl-CoA. Such demand 
may be met by an enhanced activity of STK.
Here, we present evidence for the involvement 
of G-STK in haem biosynthesis. Hepatic porphyria 
was induced in mice by the drug 3,5-diethoxycar- 
bonyl 1,4-dihydrocollidine (DDC) and the levels of 
A-STK and G-STK activities were measured. Addi­
tionally, bovine bone marrow (sternum) was in­
vestigated with respect to A-STK and G-STK 
activities in view of its essential role as a site for 
erythrogenesis.
2. EXPERIMENTAL
2 . 1 .  Preparation o f  bovine bone marrow extracts
B o v i n e  b o n e  m a r r o w  ( s t e r n u m )  w a s  o b t a i n e d  i m m e d i a t e l y  
a f t e r  s l a u g h t e r .  1 0  g  t i s s u e  ( p o s s e s s i n g  a  r e d  o s s i f i e d  a p ­
p e a r a n c e )  w a s  a d d e d  t o  3 0  m l  i c e - c o l d  0 . 1  M  N a / K  p h o s p h a t e  
b u f f e r  ( p H  8.0), 1 m M  E D T A  a n d  h o m o g e n i z e d  in  a  S o r v a l l  
O m n i - m i x e r  ( 4  x 1 5 - s  b u r s t s  i n t e r s p e r s e d  w i t h  c o o l i n g ,  at  full 
p o w e r ) .  A f t e r  c e n t r i f u g a t i o n  ( 3 0 0 0 0  x g f o r  3 0  m i n  at  4 ° C )  t h e  
s u p e r n a t a n t  s o l u t i o n  w a s  u s e d  w i t h o u t  f u r t h e r  t r e a t m e n t .
2 . 2 .  Induction o f hepatic porphyria in mice
F e m a l e  m i c e  (str a i n  C F L P ) ,  e a c h  a b o u t  3 0  g  a n d  i n d i v i d u a l l y  
h o u s e d ,  w e r e  g i v e n  d r i n k i n g  w a t e r  a d  l i b i t u m  a n d  s t a r v e d  f o r  
2 4  h .  E a c h  m o u s e  o f  t h e  t r e a t m e n t  g r o u p  t h e n  r e c e i v e d  5  g  
l a b o r a t o r y  c h o w  c o n t a i n i n g  1 0  m g  D D C  ( k i n d l y  s u p p l i e d  b y  D r  
F .  D e  M a t t e i s ,  M R C  T o x i c o l o g y  U n i t ,  C a r s h a l t o n ) ;  t h e  c o n t r o l  
g r o u p  r e c e i v e d  o n l y  5 g  l a b o r a t o r y  c h o w .  M i c e  w e r e  killed 2 4  h  
l a t e r  a n d  livers w e r e  i m m e d i a t e l y  r e m o v e d .  A l i q u o t s  ( 0 . 5  g )  o f  
c o n t r o l  a n d  t r e a t e d  livers w e r e  r e t a i n e d  f o r  t o t a l  liver p o r p h y r i n
d e t e r m i n a t i o n ;  t h e  r e m a i n d e r  o f  t h e  livers w e r e  p o o l e d  i n t o  c o n ­
trol a n d  t r e a t e d  g r o u p s  f o r  t h e  p r e p a r a t i o n  o f  m i t o c h o n d r i a .
2 . 3 .  Preparation o f  mouse liver mitochondrial extracts 
L i v e r  tissue, a f t e r  gall b l a d d e r  r e m o v a l ,  w a s  d i c e d  i n t o  ice-
c o l d  e x t r a c t i o n  b u f f e r  c o n t a i n i n g  0 . 2 5  M  s u c r o s e ,  5 0  m M  T r i s -  
H C 1  b u f f e r  ( p H  8.0), 1 m M  E D T A ,  0 . 1  m M  E G T A  a n d  0 . 1 %  
a l b u m i n  ( f a t t y  a c i d  free). H o m o g e n i z a t i o n  (5 s t r o k e s )  in  a  
P o t t e r - t y p e  h o m o g e n i z e r  (0. 3  m m  g a p )  w a s  f o l l o w e d  b y  d i f ­
f e r e n t i a l  c e n t r i f u g a t i o n ,  first t o  r e m o v e  cell d e b r i s  ( 1 6 0 0  x g f o r  
1 0  m i n  at  4 ° C )  a n d  s e c o n d l y  t o  pellet m i t o c h o n d r i a  ( 3 0 0 0 0  x g 
f o r  2 5  m i n  at  4 ° C ) .  M i t o c h o n d r i a  w e r e  t h e n  w a s h e d  in  f r e s h  e x ­
t r a c t i o n  b u f f e r  c o n t a i n i n g  n o  a l b u m i n .  F i n a l l y ,  m i t o c h o n d r i a  
w e r e  r e s u s p e n d e d  i n  0 . 1  M  N a / K  p h o s p h a t e  b u f f e r  ( p H  8 . 0 )  
c o n t a i n i n g  0 . 0 5 %  ( v / v )  T r i t o n  X - 1 0 0  a n d  d i s r u p t e d  b y  
u l t r a s o n i c a t i o n  ( M S E  1 0 0  W  s o n i c a t o r  o p e r a t e d  at  4 0  W  f o r  4  
x 1 5  s w i t h  c o o l i n g ) .  A f t e r  c e n t r i f u g a t i o n  ( 3 0 0 0 0  x g f o r  
3 0  m i n  at  4 ° C )  t h e  s u p e r n a t a n t  s o l u t i o n  w a s  u s e d  w i t h o u t  f u r ­
t h e r  t r e a t m e n t .
2 . 4 .  Measurement o f enzyme activities and protein 
concentrations
S T K  a n d  citrate s y n t h a s e  w e r e  m e a s u r e d  p o l a r o g r a p h i c a l l y
[6] a s  d e s c r i b e d  in  [7,8]. S T K  a s s a y s  c o n t a i n e d  1 m M  A D P  o r  
G D P .  P r o t e i n  c o n c e n t r a t i o n s  w e r e  d e t e r m i n e d  a s  i n  [9].
2 . 5 .  Measurement o f total liver porphyrins
T o t a l  liver p o r p h y r i n s  w e r e  e x t r a c t e d  i n t o  1 0 . 2  M  p e r c h l o r i c  
a c i d / e t h a n o l  m i x t u r e  ( 1 : 1 )  a n d  m e a s u r e d  f l u o r i m e t r i c a l l y  i n  a n  
A m i n c o - B o w m a n  s p e c t r o p h o t o f l u o r i m e t e r  u s i n g  a n  i n t e r n a l  
m e s o p o r p h y r i n  s t a n d a r d  [10].
3. RESULTS A N D  DISCUSSION
Porphyric mouse liver, gall bladder contents and 
prepared liver mitochondria were all 
characteristically dark red in appearance when 
compared with controls. The total liver porphyrin 
content of DDC-treated mice was increased 
100-fold, from a control value of 4 nmol/g liver to 
a DDC-treatment value of 406 nmol/g liver, thus 
confirming the porphyric state.
The initial and final steps of the haem biosyn­
thetic pathway occur within the mitochondrion
[11]. Ferrochelatase (EC 4.99.1.1), the final en­
zyme of the pathway, catalyses the insertion of fer­
rous iron into protoporphyrin IX [4]. In the liver 
of DDC-treated animals, transfer occurs of the 
4-methyl group from D D C  to one of the pyrrole 
nitrogens of protoporphyrin IX, converting it to 
Af-methylprotoporphyrin [12] which is a potent ir­
reversible inhibitor of ferrochelatase. The decrease 
in haem production removes the negative feedback 
control on the system and leads to over-production 
of ALA-S and subsequently haem precursors [5].
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Table 1
Effect o f porphyria on citrate synthase and STK activities in 
mouse liver mitochondria





Citrate G-STK A-STK 
synthase
Control liver
mitochondria 8.9 ±  0.8 3.7 ± 0.4 1.5 ±  0.5 2.5
DDC-treated liver
mitochondria 8.7 ±  0.5 7.4 ±  1.1 1.6 ±  0.3 4.6
This increase in ALA-S activity and demand for 
succinyl-CoA can be seen to be accompanied by an 
increase in G-STK activity (table 1). Both citrate 
synthase and A-STK showed no significant change 
in activities, whereas G-STK doubled in specific 
activity in the porphyric state compared with the 
control.
Significantly, bovine bone marrow (sternum) 
possesses the highest G-STK/A-STK ratio of any 
mammalian tissue so far examined. Thus, we 
found the specific activities of G-STK and A-STK 
to be 2.5 and 0.33 nmol/min per mg protein 
respectively, giving a ratio of 7.6. This value is 
considerably greater than the highest ratio 
reported for any other tissue, i.e. 3.5 for rat kidney 
[1]. This result, taken together with the sharp in­
crease in mouse liver G-STK in the porphyric state, 
offers strong support to our proposal that G-STK 
does indeed supply succinyl-CoA for haem biosyn­
thesis.
Over 20 years ago it was demonstrated that 
hepatic porphyria is accompanied by an elevation 
of STK activity [13]. However, at that time it was 
not known that liver and other mammalian tissues 
contain both A-STK and G-STK enzymes. Our re­
cent discovery of these two enzymes has made it 
pertinent to investigate their differential response 
to the porphyric condition.
This communication, together with the report 
on G-STK involvement with ketone body activa­
tion [3], emphasises the distinct metabolic roles of 
A-STK and G-STK in mammalian cells. It would 
seem that in the mitochondrion the STK reaction 
is required to operate in both directions at the same 
time (citric acid cycle flux and porphyrin biosyn­
thesis/ketone body activation). To achieve this bi­
directionality, two STKs are required, possessing 
mutually exclusive nucleotide specificity and 
control.
In conclusion, we propose that A-STK is in­
volved in energy conservation in the citric acid cy­
cle, while G-STK is responsible for the supply of 
succinyl-CoA for other important metabolic 
needs. Further studies are currently aimed at ex­
ploring the fine level organisation and association 
of the two enzymes within the mitochondrion.
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Novel nucleotide diversity of succinate thiokinase
friMOTHY M. JENKINS and P. D. J. WEITZMAN
jpepartment o f  Biochemistry, University o f  Bath,
Tlaverton Down, Bath BA2 7A Y, U.K.
pThe nucleotide specificity o f succinate thiokinase (STK) 
pom  a variety of sources has been studied (Palmer & 
■Redding, 1966; McClellan & Ottaway, 1980; Weitzman & 
Baskowska-Hodges, 1982). Gram-negative bacteria can 
u^tilize both adenine and guanine nucleotides (ADP/ATP  
Ind GDP/GTP) on a single ‘large’ (tetrameric) enzyme. In 
iontrast, the utilization o f these nucleotides by animal STKs 
fcccurs on two distinct ‘small’ (dimeric) enzymes (Weitzman 
m al., 1986). Gram-positive bacteria were previously 
thought to contain a single ‘small’ (dimeric) STK specific for 
^DP ATP. However, this communication presents evidence 
f o r  the existence o f a second STK activity in Gram-positive 
bacteria which is specific for inosine nucleotides (IDP/ITP). 
I In animal tissues, where both A-STK and G-STK activi­
ties are present, I-STK activity can be detected, but in 
Issues with apparently only A-STK, no I-STK is measur­
able. Similarly, in Gram-negative bacterial STK, inosine 
Nucleotides may replace their guanine counterparts with 
s i m i l a r  kinetic characteristics. In Gram-positive bacteria, 
where no G-STK occurs, an STK specific for inosine nucleo- 
Ides has been found and this I-STK appears distinct from 
the A-STK.
■Bacteria were grown in nutrient broth at 30°C or 37°C. 
Bacillus megaterium was also grown in minimal salts 
medium, with 25 mM-succinate, glucose or glutamate as the 
sole carbon source, to detect any changes in levels o f A-STK  
and I-STK activities. STK activity was assayed polaro- 
graphically (Weitzman & Jaskowska-Hodges, 1982). Hp.l.c. 
analysis o f all the nucleotides confirmed their purity and 
hence ruled out the possibility o f the detection of activity 
with a minor impurity. I-STK was detected in the following 
Oram-positive bacteria: B. megaterium, Bacillus subtilis, 
Staphylococcus aureus, Arthrobacter simplex and Kurthia 
Iopfii. Partial additivity which has previously been used as 
■criterion for distinct enzymes (Weitzman et al., 1986) was
■ Abbreviations used: STK, succinate thiokinase; Hp.l.c., high press­
ure liquid chromatography; NDP, nucleoside diphosphate.
o b s e r v e d  i n  t h e  p r e s e n c e  o f  b o t h  A D P  a n d  I D P  a t  s a t u r a t i n g  
l e v e l s  ( T a b l e  1 A ) .  I n t e r e s t i n g l y ,  a l t h o u g h  G D P  is n o t  util­
i z e d  b y  e i t h e r  e n z y m e ,  it a p p e a r s  t o  i n h i b i t  t h e  t w o  S T K s  
d i f f e r e n t i a l l y  ( T a b l e  1 A ) .  T h e  I - S T K  s h o w s  a  g r e a t e r  d e g r e e  
o f  i n h i b i t i o n  b y  G D P  t h a n  d o e s  t h e  A - S T K ,  a n d  t h i s  m a y  
b e  d u e  t o  t h e  s t r u c t u r a l  s i m i l a r i t y  b e t w e e n  I D P  a n d  G D P .  
I n  a d d i t i o n ,  t h e  t w o  S T K s  e x h i b i t  d i f f e r e n t  p H  p r o f i l e s  a n d  
h a v e  d i f f e r e n t  Km v a l u e s  f o r  t h e i r  r e s p e c t i v e  n u c l e o t i d e s :  Km 
( I D P )  =  2 6 . 7  ±  2 . 1  pM a n d  Km ( A D P )  =  8 9 . 4  ±  1 1 . 9 / x m .
T h e  r e l a t i v e  s p e c i f i c  a c t i v i t i e s  o f  t h e  t w o  S T K s  i n  B. mega­
terium w e r e  f o u n d  t o  v a r y  d e p e n d i n g  u p o n  t h e  s t a g e  o f  
g r o w t h  a n d  a l s o  u p o n  t h e  g r o w t h  m e d i u m .  O n  n u t r i e n t  
b r o t h  a  1 0 - f o l d  v a r i a t i o n  i n  t h e  r a t i o  o f  A - S T K / I - S T K  
o c c u r r e d  b e t w e e n  e a r l y - l o g a r i t h m i c  a n d  l a t e - s t a t i o n a r y  
g r o w t h  p h a s e s ,  a n d  b e t w e e n  d i f f e r e n t  g r o w t h  m e d i a  a t  t h e  
s a m e  s t a g e  o f  g r o w t h  ( T a b l e  I B ) .  A l o n g  w i t h  t h e  e v i d e n c e  
p r e s e n t e d  i n  T a b l e  1 A ,  t h e s e  r e s u l t s  s t r o n g l y  s u g g e s t  t h e  
p r e s e n c e  o f  t w o  d i s t i n c t  n u c l e o t i d e - s p e c i f i c  S T K s ,  t h e  r e l a ­
t i v e  p r o p o r t i o n s  o f  w h i c h  d i f f e r  a c c o r d i n g  t o  p h y s i o l o g i c a l  
c o n d i t i o n s .  T h e  m a r k e d  e l e v a t i o n  o f  I - S T K  a c t i v i t y  d u r i n g  
g r o w t h  o n  s u c c i n a t e  m a y  r e f l e c t  i n c r e a s e d  f o r m a t i o n  o f  
s u c c i n y l - C o A  f r o m  s u c c i n a t e  u n d e r  t h e s e  c o n d i t i o n s .  T h e  
s i t u a t i o n  i n  G r a m - p o s i t i v e  b a c t e r i a  m a y  t h e r e f o r e  r e s e m b l e  
t h a t  i n  a n i m a l  t i s s u e s ,  i n  w h i c h  it h a s  b e e n  s u g g e s t e d  t h a t  
A - S T K  m a y  f u n c t i o n  i n  t h e  e n e r g e t i c  r o l e  o f  t h e  citric a c i d  
c y c l e ,  w h e r e a s  t h e  s e c o n d  S T K  m a y  o p e r a t e  i n  t h e  o p p o ­
site m e t a b o l i c  d i r e c t i o n ,  c o n v e r t i n g  s u c c i n a t e  t o  s u c c i n y l -  
C o A  f o r  b i o s y n t h e s i s  ( J e n k i n s  &  W e i t z m a n ,  1 9 8 6 ) .  I n v e s ­
t i g a t i o n s  i n  p r o g r e s s  a r e  a i m e d  a t  f u r t h e r  e x p l o r a t i o n  o f  t h i s  
p o s s i b i l i t y .
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A
lu trien t broth
T ab le  1. Succinate thiokinase activities from  Bacillus megaterium
+  ADP +  IDP +  GD P + (A D P +  IDP) + (A D P +  GDP) % Inhibition +  (IDP +  GDP) % Inhibition
1 Late-stationary 74.7 16.12 0.0 80.1 58.2 22.2 7.27 54.8
B
»rowth media A-STK I-STK Ratio A-STK/I-STK
futrient broth
■Early-logarithmic 31.0 0.35 88.57
Mid-logarithmic 73.3 4.8 15.27
■Late-stationary 48.74 5.56 8.77
25 mM-Succinate
■ Late-stationary 41.09 6.75 6.1
|5 mM-Glucose
B-ate-stationary 57.9 1.04 55.67
25 niM-Glutamate
■ ate-s ta tionary 28.06 0.426 65.87
jfcfN D P = 0.5 mM; all activity values are in nmol/min per mg protein.)
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Modification of the regulatory properties of Acinetobacter citrate synthase by cross-linking
A D R IA N  J. LLOYD and P. D . J. W EITZM AN
Department o f Biochemistry, University o f  Bath,
Claverton Down, Bath BA2 7A Y, U.K.
Gram-negative bacterial citrate synthases display a diversity 
of regulatory behaviour depending on the source organism  
(Weitzman, 1981). The citrate synthase o f Acinetobacter 
calcoaceticus is allosterically inhibited by N A D H  and 
re-activated by AM P, and it exhibits sigmoidal response 
curves to both effectors. Additionally, the enzyme is desen­
sitized to N A D H  inhibition in the presence o f 0.2 m-KCI. 
The interaction o f the enzyme with N A D H  is accompanied 
by gross conformational changes (Rowe & Weitzman, 1969) 
and also results in a greatly enhanced thermal stability o f  
enzymic activity. Cross-linking studies (Mitchell & Weitz­
man, 1983) have been shown to abolish the sigmoidal res­
ponse to N A D H  and AM P but to leave the enzyme still 
sensitive to inhibition and re-activation. The present studies 
have further extended our previous work.
Cross-linking was achieved by treating the enzyme with 
the reagent dimethyl 3,3'-dithiobispropionimidate and was 
confirmed by electrophoretic analysis. Treatment o f the 
cross-linked enzyme with dithiothreitol reversed the process 
by cleaving the disulphide bonds in the cross-links.
Although the cross-linked enzyme was inhibited by 
N A D H , the ability o f KC1 to overcome the inhibition was 
abolished. Cleavage o f the cross-links restored the ability o f  
KC1 to desensitize the enzyme to N A D H . On the other 
hand, when the enzyme was cross-linked in the presence o f  
KC1 the resulting enzyme (tested in the absence o f KC1) was 
insensitive to N A D H  inhibition. Again, cross-link cleavage 
restored the sensitivity to N A D H .
These results suggest that KC1 induces a conformational 
change in the enzyme which is prevented by the physical 
constraints o f cross-linking. When, however, the cross- 
linking is undertaken in the presence o f KC1, the enzyme is 
‘fixed’ in the desensitized conformation and can no longer 
respond to N A D H . Our earlier electron microscopic study 
o f the enzyme also indicated KCl-induced conformational 
changes (Rowe & Weitzman, 1969).
Thermal stability studies were carried out on the native 
and cross-linked forms o f  the enzyme and also on the cross- 
linked form after treatment with dithiothreitol. First-order 
rate constants were determined in the absence and presence 
o f  N A D H  (Table 1). The results show that whereas NADH  
conferred considerable protection against thermal inacti­
vation o f the native enzyme, only slight protection was 
afforded to the cross-linked enzyme. Cleavage o f the cross­
links largely restored the protective effect o f NADH . Clearly, 
the conformational changes induced in the enzyme by 
N A D H  which enhance thermostability are prevented by the 
constraints o f cross-linking.
These results show that cross-linking may be a valuable 
experimental tool in the investigation o f the conformational 
changes undergone by citrate synthase in response to its 
allosteric effectors.
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Table 1. Effect o f NADH on the thermal inactivation o f various forms o f Acinetobacter
calcoaceticus citrate synthaSe
With forms (a) and (c) the temperature was 63°C; with form (b) the temperature was 
lowered to 59°C because of the reduced stability of this form.
First-order rate constants 
of thermal inactivation (s_ i) Change
--------------------------------------- :------------------------------  in rate
Enzyme form No NADH With 1.8 mM-NADH constant (%)
(a) Native 6.24 0.32 90
Ib) Cross-linked 4.47 4.02 10
(c) Cross-linked 
treated with
dithiothreitol 4.80 1.26 74
Changes in citric acid cycle enzymes in ageing tomato fruit mitochondria
DAVID JEFFERY, P. D A V ID  J. W EITZM AN and 
PETER W. GOO DENOUGH*
Department o f  Biochemistry, University o f  Bath, Bath,
BA2 7A Y and *AFRC Institute o f  Food Research,
Shinfield, Reading, RG2 9AT, U.K.
Tomato fruit undergo major biochemical changes as they 
ripen, the most obvious o f which are the degradation o f  
chlorophyll and the synthesis o f lycopene. Other changes 
include the rise in C 0 2 concentration which just precedes 
ethylene evolution. Possible routes for the increased C 0 2 
evolution are either through dark respiration or by stimu­
lation o f malate decarboxylation. However, it has never
been established whether the flux through the citric acid 
cycle is responsible for this increase in C 0 2 evolution. It is 
known that mitochondria remain intact and functional 
during cellular degradation in many fruits (Simpson et al-, 
1976), and to facilitate degeneration several enzymes are 
synthesized de novo (Tucker & Grierson, 1982). We inves­
tigated the specific activities o f some citric acid cycle enzymes 
in intact mitochondria in addition to their total cellular 
specific activities. We also investigated the enzymes involved 
in malate decarboxylation in the mitochondria and the cell 
and finally, we determined whether the specific activities 
increased in the presence o f  ethylene.
The specific activities o f citrate synthase, malate dehyd'
1987
